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Executive summary
Although health outcomes have improved in low-income 
and middle-income countries (LMICs) in the past several 
decades, a new reality is at hand. Changing health needs, 
growing public expectations, and ambitious new health 
goals are raising the bar for health systems to produce 
better health outcomes and greater social value. But 
staying on current trajectory will not suffice to meet these 
demands. What is needed are high-quality health systems 
that optimise health care in each given context by 
consistently delivering care that improves or maintains 
health, by being valued and trusted by all people, and by 
responding to changing population needs. Quality should 
not be the purview of the elite or an aspiration for some 
distant future; it should be the DNA of all health systems. 
Furthermore, the human right to health is meaningless 
without good quality care because health systems cannot 
improve health without it.
We propose that health systems be judged primarily on 
their impacts, including better health and its equitable 
distribution; on the confidence of people in their health 
system; and on their economic benefit, and processes of 
care, consisting of competent care and positive user 
experience. The foundations of high-quality health systems 
include the population and their health needs and 
expectations, governance of the health sector and 
partnerships across sectors, platforms for care delivery, 
workforce numbers and skills, and tools and resources, 
from medicines to data. In addition to strong foundations, 
health systems need to develop the capacity to measure 
and use data to learn. High-quality health systems should 
be informed by four values: they are for people, and they 
are equitable, resilient, and efficient.
For this Commission, we examined the literature, 
analysed surveys, and did qualitative and quantitative 
research to evaluate the quality of care available to people 
in LMICs across a range of health needs included in the 
Sustainable Development Goals (SDGs). We explored the 
ethical dimensions of high-quality care in resource-
constrained settings and reviewed available measures and 
improvement approaches. We reached five conclusions:
The care that people receive is often inadequate, and poor-
quality care is common across conditions and countries, 
with the most vulnerable populations faring the worst
Data from a range of countries and conditions show 
systematic deficits in quality of care. In LMICs, mothers 
and children receive less than half of recommended 
clinical actions in a typical preventive or curative visit, 
less than half of suspected cases of tuberculosis are 
correctly managed, and fewer than one in ten people 
diagnosed with major depressive disorder receive 
minimally adequate treatment. Diagnoses are 
frequently incorrect for serious conditions, such as 
pneumonia, myocardial infarction, and newborn 
asphyxia. Care can be too slow for conditions that 
require timely action, reducing chances of survival. At 
the system level, we found major gaps in safety, 
prevention, integration, and continuity, reflected by 
poor patient retention and insufficient coordination 
across platforms of care. One in three people across 
LMICs cited negative experiences with their health 
system in the areas of attention, respect, communi-
cation, and length of visit (visits of 5 min are common); 
on the extreme end of these experiences were 
disrespectful treatment and abuse. Quality of care is 
worst for vulnerable groups, including the poor, the 
less educated, adolescents, those with stigmatised 
conditions, and those at the edges of health systems, 
such as people in prisons.
Universal health coverage (UHC) can be a starting 
point for improving the quality of health systems. 
Improving quality should be a core component of UHC 
initiatives, alongside expanding coverage and financial 
protection. Governments should start by establishing a 
national quality guarantee for health services, specifying 
the level of competence and user experience that people 
can expect. To ensure that all people will benefit from 
improved services, expansion should prioritise the poor 
and their health needs from the start. Progress on UHC 
should be measured through effective (quality-corrected) 
coverage.
High-quality health systems could save over 8 million 
lives each year in LMICs
More than 8 million people per year in LMICs die from 
conditions that should be treatable by the health system. 
In 2015 alone, these deaths resulted in US$6 trillion in 
economic losses. Poor-quality care is now a bigger 
barrier to reducing mortality than insufficient access. 
60% of deaths from conditions amenable to health care 
are due to poor-quality care, whereas the remaining 
deaths result from non-utilisation of the health system. 
High-quality health systems could prevent 2·5 million 
2 www.thelancet.com/lancetgh   Published online September 5, 2018   http://dx.doi.org/10.1016/S2214-109X(18)30386-3
The Lancet Global Health Commission
 Pretoria, South Africa 
(M P Matsoso LLM); 
Department of Global Health 
and Social Medicine, Harvard 
Medical School, Boston, MA, 
USA (Prof J G Meara MD); Duke 
University Sanford School of 
Public Policy, Durham, NC, USA 
(M Mohanan PhD); Ministry of 
Health and Social Action of the 
Republic of Senegal, Dakar, 
Senegal (Y Ndiaye MD); 
Department of Global Public 
Health and Primary Care, 
University of Bergen, Bergen, 
Norway (Prof O F Norheim MD); 
Public Health Foundation of 
India, New Delhi, India 
(K S Reddy MD); Malaria Branch, 
Division of Parasitic Diseases 
and Malaria, Center for Global 
Health, US Centers for Disease 
Control and Prevention, 
Atlanta, GA, USA 
(A K Rowe MD); Stanford 
Medical School, Stanford, CA, 
USA (Prof J A Salomon PhD); 
Legislature Parliament of 
Nepal, Kathmandu, Nepal 
(G Thapa MA); MAZA, Accra, 
Ghana (N A Y Twum-Danso MD); 
and Big Win Philanthropy, 
London, UK (M Pate MD)
Correspondence to: 
Dr Margaret E Kruk, Harvard T H 
Chan School of Public Health, 
Department of Global Health and 
Population, Boston, MA 02115, 
USA 
mkruk@hsph.harvard.edu
deaths from cardio vascular disease, 1 million newborn 
deaths, 900 000 deaths from tubercu losis, and half of all 
maternal deaths each year. Quality of care will become 
an even larger driver of population health as utilisation 
of health systems increases and as the burden of disease 
shifts to more complex conditions. The high mortality 
rates in LMICs for treatable causes, such as injuries and 
surgical con ditions, maternal and newborn compli-
cations, cardio vascular disease, and vaccine preventable 
diseases, illustrate the breadth and depth of the health-
care quality challenge. Poor-quality care can lead to other 
adverse outcomes, including un necessary health-related 
suffering, persistent symptoms, loss of function, and a 
lack of trust and confidence in health systems. Waste of 
resources and catastrophic expenditures are economic 
side effects of poor-quality health systems. As a result of 
this, only one-quarter of people in LMICs believe that 
their health systems work well.
Health systems should measure and report what matters 
most to people, such as competent care, user experience, 
health outcomes, and confidence in the system
Measurement is key to accountability and improve-
ment, but available measures do not capture many of 
the processes and outcomes that matter most to people. 
At the same time, data systems generate many metrics 
that produce inadequate insight at a substantial cost in 
funds and health workers’ time. For example, although 
inputs such as medicines and equipment are commonly 
counted in surveys, these are weakly related to the 
quality of care that people receive. Indicators such as 
proportion of births with skilled attendants do not 
reflect quality of childbirth care and might lead to false 
complacency about progress in maternal and newborn 
health.
This Commission calls for fewer, but better, measures 
of health system quality to be generated and used at 
national and subnational levels. Countries should 
report health system performance to the public 
annually by use of a dashboard of key metrics 
(eg, health outcomes, people’s confidence in the 
system, system competence, and user experience) 
along with measures of financial protection and equity. 
Robust vital registries and trust worthy routine health 
information systems are prerequi sites for good 
performance assessment. Countries need agile new 
surveys and real-time measures of health facilities and 
populations that reflect the health systems of today and 
not those of the past. To generate and interpret data, 
countries need to invest in national institutions and 
professionals with strong quantitative and analytical 
skills. Global develop ment partners can support the 
generation and testing of public goods for health 
system measurement (civil and vital registries, routine 
data systems, and routine health system surveys) and 
promote national and regional institutions and the 
training and mentoring of scientists.
New research is crucial for the transformation of 
low-quality health systems to high-quality ones
Data on care quality in LMICs do not reflect the current 
disease burden. In many of these countries, we know 
little about quality of care for respiratory diseases, cancer, 
mental health, injuries, and surgery, as well as the care of 
adolescents and elderly people. There are vast blind spots 
in areas such as user experience, system competence, 
confidence in the system, and the wellbeing of people, 
including patient-reported outcomes. Measuring the 
quality of the health system as a whole and across the 
care continuum is essential, but not done. Filling in 
these gaps will require not only better routine health 
information systems for monitoring, but also new 
research, as proposed in the research agenda of this 
Commission. For example, research will be needed to 
rigorously evaluate the effects and costs of recommended 
improvement approaches on health, patient experience, 
and financial protection. Implementation science studies 
can help discern the contextual factors that promote or 
hinder reform. New data collection and research should 
be explicitly designed to build national and regional 
research capacity.
Improving quality of care will require system-wide action
To address the scale and range of quality deficits we 
documented in this Commission, reforming the foun-
dations of the health system is required. Because health 
systems are complex adaptive systems that function at 
multiple interconnected levels, fixes at the micro-level (ie, 
health-care provider or clinic) alone are unlikely to alter the 
underlying performance of the whole system. However, 
we found that interventions aimed at changing provider 
behaviour dominate the improvement field, even though 
many of these interventions have a modest effect on 
provider performance and are difficult to scale and sustain 
over time. Achieving high-quality health systems requires 
expanding the space for improvement to structural 
reforms that act on the foundations of the system.
This Commission endorses four universal actions to 
raise quality across the health system. First, health system 
leaders need to govern for quality by adopting a shared 
vision of quality care, a clear quality strategy, strong 
regulation, and continuous learning. Ministries of health 
cannot accomplish this alone and need to partner with the 
private sector, civil society, and sectors outside of health 
care, such as education, infrastructure, communication, 
and transport. Second, countries should redesign service 
delivery to maximise health outcomes rather than 
geographical access to services alone. Primary care could 
tackle a greater range of low-acuity conditions, whereas 
hospitals or specialised health centres should provide care 
for conditions, such as births, that need advanced clinical 
expertise or have the risk of unexpected complications. 
Third, countries should transform the health workforce by 
adopting competency-based clinical education, introducing 
training in ethics and respectful care, and better supporting 
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and respecting all workers to deliver the best care possible. 
Fourth, governments and civil society should ignite 
demand for quality in the population to empower people to 
hold systems accountable and actively seek high-quality 
care. Additional targeted actions in areas such as health 
financing, management, district-level learning, and others 
can complement these efforts. What works in one setting 
might not work elsewhere, and improvement efforts 
should be adapted for local context and monitored. 
Funders should align their support with system-wide 
strategies rather than contribute to the proliferation of 
micro-level efforts.
In this Commission, we assert that providing health 
services without guaranteeing a minimum level of quality 
is ineffective, wasteful, and unethical. Moving to a high-
quality health system—one that improves health and 
generates confidence and economic benefits—is primarily 
a political, not technical, decision. National governments 
need to invest in high-quality health systems for their own 
people and make such systems accountable to people 
through legislation, education about rights, regulation, 
transparency, and greater public participation. Countries 
will know that they are on the way towards a high-quality, 
accountable health system when health workers and 
policymakers choose to receive health care in their own 
public institutions.
Introduction
The past 20 years have been called a golden age for global 
health.1 Fuelled by a major increase in domestic health 
spending and donor funding, LMICs have vastly 
expanded access to health determinants (eg, clean water 
and sanitation) and health services alike (eg, vaccination, 
antenatal care, and HIV treatment).2–4 These expansions 
have saved the lives of millions of children, men, and 
women, largely by averting deaths from infectious 
diseases.5 However, these past decades were not as 
favourable for preventing deaths from non-
communicable diseases and acute conditions, such as 
ischaemic heart disease, stroke, diabetes, neonatal 
mortality, and injuries, for which mortality stagnated or 
increased.6 The lowest-income countries and the poorest 
people within countries generally had the worst 
outcomes, despite considerable efforts to increase use of 
health care.7 The strategy that brought big wins for child 
health and infectious diseases will not suffice to reach 
the health-related SDGs. The newly ascendant health 
conditions, including chronic and complex conditions, 
require more than a single visit or standardised pill pack; 
they require highly skilled, longitudinal, and integrated 
care. Such care is also needed to address the substantial 
residual mortality from maternal and child conditions 
and infectious diseases. In short, it is becoming clear 
that access to health care is not enough, and that good 
quality of care is needed to improve outcomes. India 
learned this with Janani Suraksha Yojana, a cash 
incentive programme for facility births, which massively 
increased facility delivery but did not measurably reduce 
maternal or newborn mortality.8
High-quality care involves thorough assessment, 
detection of asymptomatic and co-existing conditions, 
accurate diagnosis, appropriate and timely treatment, 
referral when needed for hospital care and surgery, and 
the ability to follow the patient and adjust the treatment 
course as needed.
Health systems should also take into account the needs, 
experiences, and preferences of people and their right to 
be treated with respect.9 Although many consumer 
services make user experience a central mission, health 
systems—like other public sector systems—are often 
difficult to use, indifferent to the time and preferences of 
people, and reluctant to share decision-making processes.10 
Indeed, some providers are rude and even abusive—a 
fundamental abrogation of human rights and health 
system obligations.9 At the same time, health workers 
might not receive the support and respect required to have 
a fulfilling professional life. Finally, systems can be 
inefficient, wasting scarce resources on unnecessary care 
and on low-quality clinics that people bypass, while 
imposing high costs on users.11
The SDG era demands new ways of thinking about 
health systems. Although they are only one contributor to 
good health—other major contributors being social 
determinants of health such as education, wealth, 
employment, and social protections, and cross-sectoral 
public health actions such as tobacco taxation and 
improved food, water, and road and occupational safety 
regulations12—access to high-quality health care is a 
human right and moral imperative for every country.13 
Moreover, health systems are a powerful engine for 
improving survival and wellbeing and they are the focus 
of our report.14,15 We endorse WHO’s definition of a health 
system as consisting of “all organisations, people, and 
actions whose primary intent is to promote, restore, or 
maintain health”, and we focus this Commission on the 
organised health sector, public and private, including 
community health workers.16 Although informal providers 
(those with little or no formal clinical training) also 
provide care in some countries, there are—with a few 
notable exceptions—insufficient data on the quality of 
care offered by these providers, and we do not cover them 
in this Commission. 
Addressing quality of care is particularly pertinent as 
countries begin to implement UHC.17 UHC represents a 
substantial new investment of national resources—one 
that embodies new concrete commitments about the 
type of care that people have a right to expect. Newly 
transparent benefit packages can, in turn, create public 
expectations that governments will be under pressure to 
fulfil. Furthermore, new investments in health care will 
face scrutiny from finance ministers, who will demand 
efficient use of resources and better results measured in 
longer lifespans, restored physical and mental functions, 
user satisfaction, and economic productivity.
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What should a high-quality health system look like 
in countries with resource constraints and competing 
health priorities that aspire to reach the SDGs? 
The Lancet Global Health Commission on High-Quality 
Health Systems in the SDG Era, comprised of 
30 academics, policy makers, and health system experts 
from 18 countries, seeks to answer this question.18 In 
this Commission, we propose new ways to define, 
measure, and improve the performance of health 
systems. We review evidence of past approaches and 
look for strategies that can change the trajectory of 
health systems in LMICs. 
Our work is informed by several principles. First, the 
principle that health systems are for people. Health systems 
need to work with people not only to improve health 
outcomes, but also to generate non-health-related value, 
such as trust and economic benefit for all people, including 
the poor and vulnerable. Second, the principle that people 
should be able to receive good quality, respectful care for 
any health concern that can be tackled within their 
country’s resource capacity. Third, the principle that high-
quality care should be the raison d’être of the health system, 
rather than a peripheral activity in ministries of health. 
Finally, the principle that fundamental change should be 
prioritised over piecemeal approaches. We recognise that 
health systems are complex adaptive systems that resist 
change and can be impervious to isolated interventions; 
indeed, multiple small-scale efforts can be deleterious. 
Quality of care is an emergent property that requires shared 
aims among all health system actors, favourable health 
system foundations, and is honed through iterative efforts 
to improve and learn from successes and failures. These 
considerations guided our analysis.
We are also aware of other major efforts on quality of 
care at the time of the writing of this Commission. WHO 
convened the Quality of Care Network to facilitate joint 
learning, accelerate scale-up of quality maternal, 
newborn, and child services, and strengthen the evidence 
for cost-effective approaches. WHO, the World Bank, and 
the Organisation for Economic Co-operation and 
Development (OECD) published a global report on 
quality of health care earlier in 2018.19 The US National 
Academy of Medicine has begun a study on improving 
the quality of health care across the globe.
There is also new interest in stronger primary care that 
can promote health, prevent illness, identify the sick 
from the healthy, and efficiently manage the needs 
of those with chronic disease.20 The Primary Health 
Care Performance Initiative, a multistakeholder effort, is 
focusing on measuring and comparing the functioning 
of primary health-care systems and identifying pathways 
for improvement.21 Primary care has been a main 
platform for provision of health care in low-income 
countries, but there—as elsewhere—the changing 
disease burden, urbanisation, and rising demand for 
advanced services and excellent user experience are 
challenging this current model of care.
Our work was substantially strengthened with input 
from nine National High-Quality Health Systems 
Commissions that were formed to explore quality of care 
in their local contexts alongside the global Commission. 
To ensure that our work reflects the needs of people and 
communities, we have sought input from a people’s 
voice advisory board and we obtained advice and policy 
perspectives from an external advisory council. Our 
intended audiences for the report are people, national 
leaders, health and finance ministers, policy makers, 
managers, providers, global partners (bilateral and 
multilateral institutions and foundations), advocates, 
civil society, and academics.
This report is arranged in the following manner: in 
section 1, we propose a new definition for high-quality 
health systems; in section 2, we describe the state of 
health system quality in LMICs, bringing together 
multiple national and cross-national data on quality of 
care for the first time; in section 3, we tackle the ethics of 
good quality of care and propose mechanisms for 
ensuring that the poor and vulnerable benefit from 
improvement; in section 4, we review the current status 
of quality measurements and propose how to measure 
better and more efficiently; in section 5, we reassess the 
available options for improvement and recommend new 
structural solutions; in section 6, we conclude with a 
summary of our key messages, our recommendations, 
and a research agenda.
We recognise that the level of ambition implied in our 
recommendations might be daunting to low-income 
countries that are struggling to put in place the basics of 
health care. In this Commission, we are describing a new 
aspiration for health systems that can guide policies and 
investments now. Regardless of starting point, every 
country has opportunities to get started on the path to 
high-quality health systems.
Section 1: Redefining high-quality health systems
The systematic examination of health-care quality began 
with the work of Avedis Donabedian, whose 1966 article22 
proposed a framework for quality of care assessment that 
described quality along the dimensions of structure, 
process, and outcomes of care. At the turn of the 
21st century, the Committee on Quality of Health Care in 
America of the Institute of Medicine (IOM) produced 
two influential quality reports23,24 that galvanised the 
examination of quality in the US health system and 
prompted similar investigations in other industrialised 
countries. The IOM Committee defined quality of care as 
“the degree to which health services for individuals and 
populations increase the likelihood of desired health 
outcomes and are consistent with current professional 
knowledge”.23 The committee noted that 21st century 
health systems should seek to improve performance on 
six dimensions of quality of care: safety, effectiveness, 
patient-centredness, timeliness, efficiency, and equity. 
The committee also observed that “the current care 
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systems cannot do the job. Trying harder will not work. 
Changing systems of care will.”23 In 2010, Michael Porter 
proposed25 that health systems be fundamentally account-
able for producing value, which should be defined 
around the user. International organisations, such as 
WHO, and many low-income and high-income countries 
have relied on the IOM definition of quality and its core 
dimensions. WHO has also separately defined integrated 
people-centred health systems as systems where “all 
people have equal access to quality health services that 
are coproduced in a way that meets their life course 
needs”.26
Building on this and other work, this section sets out 
our rationale for an updated definition of high-quality 
health systems and a conceptual framework ready for the 
health challenges, patient expectations, and rising 
ambitions of today.27,28
The improvement of health outcomes is the sine qua 
non of health systems; these outcomes include longer 
lives, better quality of life, and improved capacity to 
function. In addition to better health, people derive 
security and confidence from having a trusted source of 
care when illness renders them most vulnerable. In 
this way, health systems also function as key social 
institutions, both deriving from and shaping social 
norms and able to promote or corrode public trust.29,30 
Finally, health systems cannot be static and must adapt to 
changing societal needs. This Commission defines a 
high-quality health system as the following:
A high-quality health system is one that optimises health 
care in a given context by consistently delivering care 
that improves or maintains health outcomes, by being 
valued and trusted by all people, and by responding to 
changing population needs.
Context is paramount in this definition; health systems 
have been shaped by different histories and, as a result, 
function differently across LMICs. 
High-quality health systems are underpinned by four 
values: high-quality health systems are for people and are 
equitable, resilient, and efficient. A focus on people 
begins with the self-evident observation that health 
systems must reach people—access is a prerequisite for 
benefiting from health care. However, this focus also 
signifies that people are not just beneficiaries of health 
services, but have a right to health care and have agency 
over their health and health-care decisions. Therefore, 
people become accountability agents, able to hold health 
system actors to account. The emphasis on people-
centredness is especially crucial in health care because of 
the asymmetry of power and information between 
provider and patient. The focus on people works not only 
as a moral imperative to protect against the adverse 
effects of this power imbalance, but also as a corrective 
action that reduces the imbalance through patient 
empowerment and better accountability. Health systems 
must also treat well the people that work within them, 
who deserve a supportive work environment (safe 
working conditions, efficient and supportive manage-
ment, and appropriate role assignment) and are them-
selves health-care users. Demotivated providers cannot 
contribute to a high-quality health system.
A focus on equity means that high-quality health care 
needs to be available and affordable for all people, 
regardless of underlying social disadvantages. Measures 
of quality need to be disaggregated by stratifiers of social 
power—such as wealth, gender, or ethnicity—and quality 
improvements should explicitly include poor and 
vulnerable people to redress existing inequities. 
Health systems in LMICs have been slow to change 
from their legacy functions focused on infectious 
diseases and maternal and child health, but health needs 
and expectations are shifting, sometimes quickly. Health 
crises, such as the Ebola epidemic, acutely illustrate the 
need for resilient systems, defined as systems that can 
prepare for and effectively respond to crises while 
maintaining core functions and reorganising if needed.31 
High-quality health systems also need everyday resilience 
to respond to routine challenges, and this requires 
accountable leaders who respect and motivate their front-
line staff.32 
Lastly, health systems must be efficient: although 
spending on health systems is tightly associated with 
income and therefore varies greatly across LMICs, all 
health systems should aim to avoid waste and achieve the 
maximum possible improvement in health outcomes 
with the investment received.
We propose a new conceptual framework for high-
quality health systems with three key domains: found-
ations, processes of care, and quality impacts (figure 1). 
This framework stems from our definition of high-quality 
health systems and is informed by past frameworks in the 
fields of health systems and quality improvement, 
including Donabedian’s framework,22 WHO’s building 
blocks16 and maternal quality of care27 frameworks, Judith 
Bruce’s family planning quality framework,28 Getting 
Health Reform Right,33 the Juran trilogy, and the Deming 
quality cycle.34
Figure 1: High-quality health system framework
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Our high-quality health system framework focuses on 
health system function, user experience, and how people 
benefit from health care. This Commission believes that 
the quality of health systems should be primarily 
measured by these processes and impacts rather than by 
inputs. Facilities staffed by health workers and equipped 
with running water, electricity, and medicines are 
essential for good quality care, but the presence of these 
inputs is not itself a measure of high-quality care. 
Empirical work shows that the quantity of such inputs 
does not predict the care that people receive and whether 
their health will improve—poor care often happens in 
the presence of adequate tools.35
Table 1 summarises the components of the three 
framework domains (quality impacts, processes of care, 
and foundations). The quality impacts begin with better 
health, including reduced mortality and morbidity, and 
positive health markers such as quality of life, function 
and well being, and absence of serious health-related 
suffering.36 These health outcomes should also encompass 
patient-reported measures. Another impact of high-quality 
health systems is confidence in the system, including trust 
in health workers and appropriate care uptake. Confidence 
goes beyond the more traditional measure of satisfaction 
with care; it is the extent to which people trust and are 
willing to use health care. Trust is essential for maximising 
outcomes because it can motivate active participation in 
care—ie, adherence to recommendations and uptake of 
services, including in emergencies.37 Trust is also essential 
for the success of UHC, because financing for UHC will 
be primarily domestic and people are unlikely to agree to 
contribute taxes or pay premiums for health services that 
they do not value. Finally, although good quality of care 
might require additional investment in many health 
systems of LMICs, high-quality health systems have the 
potential to generate economic benefits. First, by reducing 
premature mortality and improving people’s health, ability 
to work, and ability to attend school, high-quality health 
systems can foster economic productivity. Second, high-
quality health systems can reduce waste from unnecessary, 
ineffective, and harmful care and prevent inappropriate 
hospital admissions and the bypassing of cost-effective 
options, such as primary care. Additionally, high-quality 
health systems with appropriate financing mechanisms, 
particularly manda tory insurance, can reduce the incidence 
of catastrophic or impoverishing health expenditures. 
Therefore, financing that provides people with financial 
protection and promotes high-quality, efficient care is an 
integral foundation of a high-quality health system.
 The processes of care include competent care and user 
experience, which we consider to be complementary 
elements of quality. These elements must be present in 
both the health system as a whole and in individual care 
visits. Competent systems provide people and communities 
with health promotion and prevention when healthy and 
effective and timely care when sick. People should be able 
to count on their conditions being detected and managed 
in an integrated manner. Systems should also be user-
focused: easy to navigate, with short wait times and 
attention to people’s values and preferences—this is the 
definition of people-centredness. When people visit 
providers, they should expect to receive evidence-based 
care, including careful assessment, correct diagnosis, and 
appropriate treatment and counselling. And providers 
Components
Quality impacts
Better health Level and distribution of patient-reported outcomes: function, symptoms, pain, wellbeing, quality of life, and avoiding serious health-related suffering
Confidence in system Satisfaction, recommendation, trust, and care uptake and retention
Economic benefit Ability to work or attend school, economic growth, reduction in health system waste, and financial risk protection
Processes of care
Competent care and 
systems
Evidence-based, effective care: systematic assessment, correct diagnosis, appropriate treatment, counselling, and referral; capable systems: safety, prevention and 
detection, continuity and integration, timely action, and population health management
Positive user experience Respect: dignity, privacy, non-discrimination, autonomy, confidentiality, and clear communication; user focus: choice of provider, short wait times, patient voice and 
values, affordability, and ease of use
Foundations
Population Individuals, families, and communities as citizens, producers of better health outcomes, and system users: health needs, knowledge, health literacy, preferences, 
and cultural norms
Governance Leadership: political commitment, change management; policies: regulations, standards, norms, and policies for the public and private sector, institutions for 
accountability, supportive behavioural architecture, and public health functions; financing: funding, fund pooling, insurance and purchasing, provider contracting and 
payment; learning and improvement: institutions for evaluation, measurement, and improvement, learning communities, and trustworthy data; intersectoral: 
roads, transport, water and sanitation, electric grid, and higher education
Platforms Assets: number and distribution of facilities, public and private mix, service mix, and geographic access to facilities; care organisation: roles and organisation of 
community care, primary care, secondary and tertiary care, and engagement of private providers; connective systems: emergency medical services, referral systems, 
and facility community outreach
Workforce Health workers, laboratory workers, planners, managers: number and distribution, skills and skill mix, training in ethics and people-centred care, supportive 
environment, education, team work, and retention
Tools Hardware: equipment, supplies, medicines, and information systems; software: culture of quality, use of data, supervision, and feedback
Table 1: High-quality health system framework components
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should treat all people with dignity, communicate clearly, 
and provide autonomy and confidentiality. Disrespectful 
and discriminatory behaviours are crucial quality failures, 
as are work environments that demean or disempower 
providers. 
The foundations of high-quality health systems begin 
with the populations that they serve: individuals, families, 
and communities. People are necessary partners in 
providing health care and improving health outcomes; 
they are not only the core beneficiaries of the health 
system, but also the agents who can hold these systems to 
account. The health needs, knowledge, and preferences 
of people should shape the health system response. High-
quality health systems require strong governance, and 
financing, to promote the desired outcomes and policies 
to regulate providers, organise care, and instit ution alise 
accountability to citizens. However, regulation will not be 
enough; health system leaders will need to inspire and 
sustain the values of professionalism and excellence that 
underpin high-quality health care. In most countries, 
health care is provided by three platforms: community 
health, primary care, and hospital care. An appropriate 
facility and provider mix, quality-centred service delivery 
models, and functioning connect ions between levels of 
care (eg, referral, prehospital transport) will be required 
to ensure that the whole system maximises outcomes and 
the efficient use of resources. Providers, from health 
workers to managers, are fundamental for health systems, 
and require adequate numbers, preparation, profession-
alism, and motivation. Providers need high-quality, 
competency-focused clinical education, with training in 
ethics, and a supportive environment for achieving the 
desired performance. Finally, health systems require not 
only physical tools, such as equipment, medicines, and 
supplies, but also new attitudes, skills, and behaviours, 
including quality mindsets, supervision and feedback, 
and the ability and willingness to learn from data. The 
foundations alone will not create good care, and the 
system will not be able to adapt to new challenges without 
built-in mechanisms for learning and improve ment, 
including having timely information on performance, 
assessment of new ideas, and the means to retire 
ineffective approaches.
This framework can be used to measure health systems 
over time on elements that matter to people (through 
processes and impacts) and to guide opportunities 
for improvement (through shoring up or rethinking 
foundations). 
Section 2: What quality of care are people 
receiving in LMICs today?
In this section, we describe the current state of health-
care quality in LMICs. We compiled data from multiple 
sources to present the most comprehensive and detailed 
picture of health system quality. We analysed data from 
health facility, household, telephone, and internet 
surveys collected in the past 10 years, and summarised 
findings from global estimates, systematic reviews, and 
individual studies (data sources are listed in appendix 1 
and a comparison of methods used to collect the data can 
be found in appendix 2). Within the constraints of the 
available data, we describe quality across all health 
conditions addressed by the SDGs (list of conditions in 
appendix 1) and across health system platforms 
(community outreach, primary and hospital care, and the 
linkages between them: referral systems and emergency 
medical services).
Following the Commission’s framework, we describe the 
current situation with regard to provision of evidence-
based care, competent health systems, and user experience 
and we present available evidence on the links between 
quality and health, confidence, and economic benefits. 
Our focus is on describing the processes of care and their 
impacts. Foundations—the facilities, people, and tools 
See Online for appendix 1
See Online for appendix 2
Panel 1: Section 2 key findings
1 Poor-quality health systems result in more than 8 million 
deaths per year in LMICs, leading to economic welfare losses 
of $6 trillion. 
2 Health providers in low-income and middle-income countries 
(LMICs) often do less than half of recommended evidence-
based care actions. For example, only two in five women who 
delivered in a facility were examined within 1 h after birth.
3 Approximately one third of patients experience disrespectful 
care, short consultations, poor communication, or long wait 
times. 
4 Inadequate integration across platforms and weak referral 
systems undermine the ability of health systems to care for 
complex and emerging conditions. 
5 Less than one quarter of people in LMICs believe that their 
health system works well, compared with half of people in 
high-income countries. 
6 Clinics and providers with good performance can be found 
in every country and studying them can inform country-
wide efforts for improvement. 
7 High-quality health care is inequitably distributed in many 
countries, with poor and vulnerable groups having worse 
quality care—both in terms of competent care and user 
experience. 
8 People can be especially vulnerable to poor-quality care on 
the basis of particular settings of care, health conditions, 
and demographic factors.
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required for care—are crucial to high-quality health 
systems, but their availability does not guarantee quality 
care. Lastly, we explore why some population groups are 
more vulnerable to poor-quality care. Where multicountry 
medians are presented throughout the section, country-
specific data are included in appendix 2. Key findings are 
shown in panel 1.
Processes of care
Evidence-based care
Evidence-based care includes systematic patient assess-
ments, accu rate diagnoses, provision of appropriate 
treatments, and proper patient counselling. In this 
section, we assess how these aspects are being followed, 
across selected SDG conditions.
Data from direct observations of clinical consultations 
allowed us to measure the quality of reproductive, maternal, 
and child health services. Using guidelines from WHO, we 
identified essential elements of reproductive, maternal, 
and child health care and built quality indices (appendix 1). 
On the basis of these indices, data from observations of 
81 856 consultations in 18 countries showed that adherence 
to evidence-based guidelines is low (figure 2A). On average, 
providers fulfilled only 47% of recommended care—with 
median performance ranging from 44% for family 
planning consultations to 64% for labour and delivery care 
(appendix 2). However, median figures can mask important 
variations within countries (appendix 2). These large 
variations in performance across providers suggest that 
better quality of care is possible in these countries. 
Identifying and replicating local best practices might be 
valuable to inform improvement strategies.38
Other studies have also shown that providers often fail 
to adhere to clinical guidelines. In Uttar Pradesh, India, 
facility-based birth attendants did only 40% of items on 
the WHO safe childbirth checklist in a typical birth.39 
Across 12 countries, only 50% of diarrhoea cases were 
correctly managed in health-care facilities according to 
WHO and UNICEF recommendations.40 In standardised 
patient studies in China41 and Kenya,42 only 13–45% of 
suspected tuberculosis cases were correctly managed by 
primary care providers according to the International 
Standards for Tuberculosis Care guidelines.
A systematic patient assessment involves gathering 
clinically relevant information by asking appropriate 
medical history questions and doing recommended 
examinations and tests. Data from LMICs showed that 
systematic patient assessments are not always done. For 
example, after giving birth, women should be assessed for 
abnormal bleeding, perineal tears, signs of infections, and 
high blood pressure.43 However, in many countries, few 
women reported receiving any postpartum check-up after 
giving birth in a health-care facility, including only 27% of 
women in Swaziland and 44% in Ethiopia, Burundi, and 
Rwanda (appendix 2). Similarly, during antenatal care, 
monitoring of blood pressure and urine and blood sample 
analyses are crucial to detect pre-eclampsia, nutritional 
deficiencies, infections, and other pregnancy risks.44 Across 
91 countries, only 73% of women attending antenatal care 
with a skilled provider reported receiving these elements of 
care—ranging from an average of 54% in 30 low-income 
countries to 94% in 27 upper-middle-income countries 
(appendix 2).45 Poor availability of laboratory facilities and 
diagnostic equipment are also barriers to patient 
assessment and diagnosis, even when providers are aware 
of the necessary tests. For example, pathology service 
coverage in sub-Saharan Africa is approximately one-tenth 
of that in high-income countries.46 Even simple tests are 
often unavailable: studies showed that blood glucose 
meters and urine strips were available in only 18–61% of 
facilities across Mali, Mozambique, and Zambia.47 A study 
of ten countries found that only 2% of health-care facilities 
had the eight diagnostic tests defined as essential for basic 
service readiness by WHO.48
Incorrect diagnoses have deleterious consequences on 
health and contribute to treatment delays and anti-
microbial resistance. For example, diagnostic uncertainty 
Figure 2: Adherence to evidence-based guidelines and diagnostic accuracy 
Dots represent country-specific means, vertical bars indicate median performance across countries, and boxes 
delineate the IQR. Indicator definitions are shown in appendix 1, and country specific means are shown in appendix 2. 
(A) Data are from Service Provision Assessment (SPA) surveys done in ten countries (Ethiopia 2014, Haiti 2013, 
Kenya 2010, Malawi 2013, Namibia 2009, Nepal 2015, Rwanda 2007, Senegal 2015–16, Tanzania 2015, and 
Uganda 2007) and baseline facility surveys of Results-based Financing impact evaluations (RBF) in eight countries 
(Burkina Faso 2013, Central African Republic 2012, Cameroon 2011, Republic of the Congo 2014, Democratic 
Republic of the Congo 2015, Kyrgyzstan 2012–13, Nigeria 2013, and Tajikistan 2014–15). (B) Data are from clinical 
vignettes from the Service Delivery Indicators surveys  done by the World Bank, in cooperation with the African 
Economic Research Consortium and the African Development Bank in Kenya (2012), Nigeria (2013), Tanzania (2014), 
Togo (2013), and Uganda (2013) and from the Service Provision Assessment survey in Ethiopia (2014).
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about undifferentiated fever often leads to over prescription 
of antimicrobial therapy.49 Our analyses of data from 
clinical vignettes done in LMICs revealed wide variations 
in diagnostic accuracy. In six sub-Saharan African 
countries, correct diagnoses ranged from 0 providers in 
Togo identifying malaria with anaemia to 94% of providers 
in Kenya diagnosing post-partum haemorrhage (figure 2B, 
appendix 2). Other work has shown that, across six eastern 
European and central Asian countries, acute myocardial 
infarctions were correctly diagnosed by only 33% of 
providers.50 Performance in practice is also likely to be 
worse than on vignettes: diagnostic accuracy ranging from 
only 8% to 20% has been reported for childhood 
pneumonia in Malawi51 and for a range of primary care 
conditions in India.52 Poor quality of laboratory testing 
and a heavy reliance on outdated diagnostic technologies 
can also contribute to misdiagnoses. For example, an 
external quality assessment53 in the Democratic Republic 
of the Congo found that only 4% of laboratories correctly 
identified the parasites that cause malaria and human 
African trypanosomiasis on all slides analysed. Similarly, 
studies54 in Latin America have reported Pap smear 
sensitivity as low as 20–25% and lower than expected 
rates of HER2 (human epidermal growth factor 
recep tor 2) positivity in women with early breast cancer. 
For tuberculosis, uptake of newer diagnostics has 
been slow and many countries continue to rely on 
often inaccurate smear microscopy.55 In high-burden 
countries, nine sputum smears are done for every gold 
standard test (Xpert MTB/RIF) used.55
Poor-quality care also includes the underuse56 of effective 
care and the overuse11 of unnecessary care. Our analyses of 
survey data revealed that individuals in LMICs often do not 
receive appropriate treatments during consultations, 
including preventive interventions during skilled antenatal 
care, oral rehydration therapy for children with diarrhoea, 
or antibiotics for those with symptoms of pneumonia 
(figure 3, appendix 2). Similarly, another study57 in Malawi 
reported that only 38·7% of patients with non-severe 
pneumonia confirmed on re-examination were correctly 
prescribed first-line antibiotics during consultation. 
Additionally, despite being diagnosed, many patients are 
untreated or undertreated for conditions such as HIV, 
tuberculosis, hypertension, diabetes, and depression.58–63 
In LMICs where data are available, only 68% of people 
aware of their HIV status are on antiretroviral therapy, and 
only 5% of people with a diagnosis of major depressive 
disorder receive minimally adequate treatment (figure 3, 
appendix 2). Individuals in severe pain are also system-
atically undertreated in LMICs.36 Of the 298·5 metric 
tonnes of morphine-equivalent opioids distributed in the 
world every year, only 0·03% of that is distributed in low-
income countries, leading to a 98% unmet need for 
morphine.36 A study64 showed that, among patients with 
ST-segment elevation myocardial infarctions admitted to 
Chinese hospitals, only half of ideal candidates for 
reperfusion therapy received the treatment. Other 
treatments that reduce mortality in patients were also 
underused, with only 58% of eligible patients receiving 
β blockers and 66% receiving angiotensin-converting-
enzyme inhibitors.64 All these reports represent major 
missed opportunities to improve outcomes among people 
already using the health system.
Overuse of unnecessary or ineffective care has also 
been documented in LMICs. In the previously mentioned 
study64 in China, almost a third of patients received 
magnesium sulphate—a treatment that is ineffective—
on admission and more than half of patients were given 
traditional Chinese medicine, despite little evidence of its 
efficacy and safety.64 Other instances of inappropriate care 
in LMICs include unnecessary use of antibiotics for 
diarrhoea, inappropriate cardiac interventions, overuse of 
steroids, and unnecessary hysterectomies.11,65,66 Although 
many women still do not have access to needed caesarean 
sections, rates of un necessary caesarean sections have 
been increasing in LMICs.11,67 Inappropriate use and 
Figure 3: Proportion of individuals receiving appropriate treatments among those who seek care in 112 low-income and middle-income countries
Dots represent country-specific means, vertical bars indicate median performance across countries, and boxes delineate the IQR. Data sources for tetanus injections and iron 
during antenatal care were Demographic and Health surveys (DHS) and Multiple Indicator Cluster surveys in 75 countries; for oral rehydration therapy (ORT) were DHS in 
54 countries; for antibiotics for pneumonia were DHS and Multiple Indicator Cluster surveys in 63 countries; for antiretroviral therapy among those aware of their HIV status 
were UNAIDS estimates in 78 countries; and for minimally adequate depression treatment were World Mental Health Surveys in 8 countries. Indicators are defined in 
appendix 1; country specific means are shown in appendix 2.
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overprescription of antimicrobials, combined with poor 
sanitation, in adequate access to diagnostic tools, and low 
diagnostic accuracy, have fuelled antimicrobial resistance 
through out LMICs.68 A 2018 study69 assessed the quality of 
antimicrobial prescribing for hospital inpatients in 
53 countries, including 25 LMICs. Inappropriate antibiotic 
prescribing practices included prescriptions for unknown 
diagnoses, prescriptions with out stop or review dates (to 
avoid unnecessarily long antibiotic courses), and prolonged 
surgical prophylaxis.
Proper counselling and health education are essential 
elements of evidence-based care. We found that during 
antenatal care, many skilled providers do not advise 
women on the signs of pregnancy complications or how 
to prevent HIV infections, and, when prescribing 
contraceptives, many providers fail to discuss their 
potential side-effects (appendix 2). Similarly, providers 
often do not state their diagnosis during the consultation.52 
In observations of sick child consultations in 17 countries, 
only 43% of providers informed caregivers about the 
diagnosis of their child (appendix 2). Counselling is 
particularly important for chronic disease management. 
Tobacco use, excess weight, unhealthy diets, and physical 
inactivity are the leading risk factors for non-
communicable diseases. Data from the WHO STEPS 
survey in seven LMICs showed that providers did not 
counsel many patients diagnosed with cardiometabolic 
diseases: only 16% of patients were counselled on tobacco, 
29% on exercise, and 55% on dietary changes (appendix 2). 
In six Latin American and Caribbean countries, only 56% 
of patients diagnosed with at least one chronic condition 
reported receiving advice on diet and exercise from 
primary care providers (appendix 2).70
Competent systems
Beyond the content of the health-care visit, competent 
care requires the whole health system to function for the 
patient. Here, we describe current evidence on four 
elements of competent health systems: safety, prevention 
and detection, continuity and integration, and timely care.
The literature documents a range of safety problems in 
health care, including adverse drug events, adverse 
events and injuries due to medical devices, injuries due 
to surgical and anaesthesia errors (including wrong-site 
surgery), health-care-associated infections, improper 
transfusion and injection practices, falls, burns, and 
pressure ulcers.71 Despite lower health-care use rates, 
LMICs bear the majority of the global burden of adverse 
events from unsafe care.72 Surgical site infections, the 
most common type of health-care-associated infection, 
are markedly higher in LMICs than in high-income 
countries.73 Patient safety literature has been largely 
focused on inpatient care, but adverse events also occur 
to outpatients, including medication errors, infections 
resulting from poor hand hygiene, unsafe injections, 
blood samples, or reusable equipment. LMICs are 
estimated to have rates of medication-related adverse 
events similar to those of high-income countries, but 
they result in twice as many years of healthy life lost 
because more younger patients are affected in LMICs.72 
One study found that, across 54 LMICs, 35% of health-
care facilities do not have water and soap for handwashing 
and 19% do not have improved sanitation.74 This absence 
of services compromises efforts to improve hygiene 
behaviours and reduce health-care-associated infections. 
However, although water and sanitation are necessary, 
handwashing does not necessarily associate with their 
presence: low adherence to hand hygiene was found even 
in facilities with available supplies.75 Beyond their costs to 
human lives and disability, adverse events from unsafe 
care are also costly in terms of loss of trust in the health 
system.
The prevention and early detection of diseases, 
including through recommended screenings, is an 
important function of high-quality health systems. Across 
six Latin American and Caribbean countries, less than 
half of adults reported having had their blood pressure 
checked in the past year and their cholesterol checked in 
the past 5 years.76 Rates of cervical and breast cancer 
screening also vary widely.54 Across six LMICs surveyed 
by the WHO study on global ageing and adult health 
(SAGE), mammo gram coverage averaged 20% of all 
women of screening age and was as low as 1% in India 
and 2% in Ghana (appendix 2).63 Across nine countries in 
the Americas, average Pap smear coverage was 36% of 
women in need, ranging from 10% in Nicaragua to 97% in 
Panama.77 Even people in the health system might not 
receive the needed screening or early detection. In 
countries with HIV prevalence higher than 5%, WHO 
recommends that all pregnant women be tested for 
HIV.78 In five of nine high-prevalence countries, more 
than 95% of pregnant women attending antenatal care 
were tested for HIV. However, despite a HIV prevalence 
of 27% in Swaziland and 12% in Mozambique, only 
56% of women in Swaziland and 69% in Mozambique 
are tested during antenatal care (appendix 2).
Continuity of care is reflected by the ability of the 
health system to retain people in care and by the patient’s 
ability to see a clinician familiar with their medical 
history. Integration is the extent to which health services 
are delivered in a complementary and coherent manner. 
These two dimensions are important for the management 
of non-communicable diseases and other chronic 
conditions, such as HIV, that require continuous patient 
support after diagnosis and a comprehensive treatment 
approach.58 Across services including antenatal care, child 
vaccination, antiretroviral therapy, and mental health care, 
retention rates ranged from 87% for diphtheria-tetanus-
pertussis (DTP3) vaccination in 83 LMICs to only 
55% retention for mental health care in 12 LMICs 
(appendix 2).79,80 Similarly, lapses in the follow-up of test 
results have also been reported and pose severe challenges 
for infectious conditions such as HIV and tuberculosis.59,71 
A systematic review81 estimated patient losses to the 
For STEPS see http://www.who.
int/ncds/surveillance/steps/en/
For the WHO SAGE data see 
http://www.who.int/healthinfo/
sage/en/
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system between diagnosis and treatment for tuberculosis 
to be as high as 18% in Africa and 13% in Asia. Regarding 
integration, all tuberculosis patients should be tested 
for HIV, because of risk factors shared between the 
two infections.78 In the WHO African Region, where the 
burden of HIV-associated tuberculosis is highest, 82% of 
patients with tuberculosis were tested for HIV.82
For people with life-threatening emergencies, such as 
labour complications, trauma, and stroke, treatment delays 
substantially increase mortality risk. Timeliness is also 
central for other conditions that can be cured if treated 
early—including many cancers—and conditions such as 
tuberculosis or diabetes, in which early treatment prevents 
transmission or disease progression. Time intervals from 
admission to surgery for traumatic fractures of the femur 
were found to be substantially longer in LMIC hospitals 
than in high-income country hospitals.83 Numerous 
studies have described the delays that occur during labour 
complications in women deciding to seek care and in 
reaching health facilities—the so-called first and second 
delays. However, the third delay—in providing high-
quality care once women reach health-care facilities—is 
emerging as an important contributor to maternal and 
newborn child mortality.84 For example, a study85 in India 
found that attending to women within 10 min of their 
arrival to the facility could have prevented 37% of recorded 
stillbirths. Additionally, the absence of immediate post-
partum care can lead to serious obstetric complications 
being missed. Across 41 countries with a demographic and 
health survey, we found that only 41% of women delivering 
in a health-care facility reported someone checking on 
their health within 1 h of delivery (appendix 2).
For infectious diseases, such as tuberculosis, making a 
timely diagnosis is crucial for interrupting transmission 
and optimising treatment outcomes. A review86 of studies 
done in LMICs found that an average of 28·4 days passed 
between the first contact of patients with the health system 
and the date of tuberculosis diagnosis, ranging from 
2 days in China to 87 days in Pakistan. Regarding cancer 
care, delays caused by both patient and health system 
contribute to advanced disease at presentation and high 
cancer mortality rates in LMICs. Studies54,87,88 from Brazil, 
Ghana, Mexico, Peru, and Rwanda reported delays of up 
to 28 weeks between presentation to a doctor and definitive 
diagnoses of cervical or breast cancer. Data from the 
Mexican Institute of Social Security, the largest health 
system in Mexico, revealed that 51% of women with breast 
cancer waited more than 30 days between mammography 
and diagnosis, and 44% of women with cervical cancer 
waited more than 30 days between Pap smear and 
diagnosis.89 Delays in initiating treatments further affected 
the prognosis of patients. According to the Mexican 
Institute of Social Security, as many as 70% of women 
with breast cancer and 61% of women with cervical cancer 
waited more than 21 days between receiving the diagnosis 
and beginning therapy.89 Similarly, a study90 done in 
Buenos Aires hospitals, Argentina, found that the median 
time elapsed between diagnosis of breast cancer and 
treatment with chemo therapy was 76 days in public 
hospitals and 60 days in private hospitals. These delays are 
concerning because waiting more than 5 weeks before 
starting definitive treatment can worsen survival for 
cervical cancer, and delays in diagnosis longer than 
12 weeks are considered suboptimal for breast cancer.54,87
Figure 4: User experience in 49 low-income and middle-income countries (LMICs) and 11 high-income countries
Dots represent country-specific means, vertical bars indicate median performance across countries, and boxes delineate the IQR. High-income countries do not contribute to the illustrated medians. 
Data are from the surveys indicated. AFRO=Afrobarometer survey done in 34 African LMICs (2011–13). HQSS=Commission-led internet survey done in 12 LMICs (2017). IDB=nationally representative 
phone survey on primary care access, use, and quality done by the Inter-American Development Bank in six Latin-American and Caribbean LMICs (2013). SPA=Service Provision assessment surveys 
done in ten LMICs (2007–16). CWF=International Health Policy Survey done by the Commonwealth Fund in 11 high-income countries (2013). Indicators are defined in appendix 1; country specific 
means are shown in appendix 2.
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User experience
Competent care and competent health systems are 
necessary for achieving high-quality care, but a positive 
user experience is also important. In addition to having 
an intrinsic value, positive user experience can improve 
retention in care, adherence to treatments, and, 
ultimately, confidence in health systems.91 Additionally, 
some studies have found that positive user experience is 
linked to better technical quality.91,92
To address insufficient cross-national data on user 
experience, this Commission did an internet survey on 
user experience in 12 countries in Africa, Latin America, 
Asia, and the Middle East. Full results will be presented in 
forthcoming papers, but some of the key results of this 
survey are shown in figure 4, along with indicators from 
four other surveys done in 49 LMICs and 11 high-income 
countries (appendix 2).70 We found that an average of 
34% of people in LMICs reported poor user experience, 
citing a lack of attention or respect from facility staff (41%), 
long wait times (37%), poor communication (21%), or 
short time spent with providers (37%). This result on the 
short time spent with providers was echoed by a 
2017 review93 that found that primary care consultations 
lasted fewer than 5 min on average in LMICs.
Some differences across surveys are worth noting. In 
Afrobarometer survey countries, 42% of respondents 
reported never experiencing a lack of attention or respect, 
whereas in the internet survey, 75% of respondents 
reported respectful care at their last visit. Differences in 
countries and income groups (our survey was done 
in more middle-income countries than those of Afro-
barometer), wording (“never experienced” was used in 
Afrobarometer surveys), time frames (past year vs last 
visit), and survey sampling (internet users have a higher 
average socioeconomic status than household respondents) 
might explain these differences. Differing expectations of 
quality can also influence the perception of user experience.
No benchmarks exist for what constitutes good user 
experience. However, user ratings of communication 
and time spent with providers were consistently higher 
in high-income countries than in LMICs (figure 4), with 
only 11% of respondents reporting poor communication 
and 17% reporting insufficient time with providers 
(compared with 74% and 60% on average in the six Latin 
American and Caribbean countries surveyed by  the 
Inter-American Development Bank).
Disrespect and abuse of women during childbirth has 
been widely reported in LMICs,9 including documented 
instances of physical abuse, non-consented clinical care, 
no confidentiality and dignity, discrimination, abandon-
ment, and detention in facilities. A review9 of studies 
showed a range of 19–98% of women reporting 
mistreatment during childbirth across LMICs, with 
3–36% reporting physical abuse. Beyond being an 
indicator of poor-quality care, disrespect and abuse 
should be unacceptable in any health system.
Nonetheless, these numbers can only tell part of the 
story. The quality of the processes of care, particularly of 
the user experience, is also reflected in the patient voices 
in panel 2.
Quality impacts
High-quality care—both competent care and positive user 
experience—can have an effect on people’s health, their 
confidence and trust in health systems, and economic 
outcomes. In this section, we present available evidence 
on morbidity and mortality linked to poor quality care. 
We also synthesise data on people’s confidence in health 
systems, and we address the potential economic benefits 
of high-quality care.
Health
Although the causes of death are often multifactorial, 
and are not solely influenced by health care, deaths from 
some conditions are highly dependent on quality of care 
and are regarded as sensitive indicators of how well a 
health system is functioning. For this Commission, we 
did an analysis of the mortality burden of poor-quality 
Panel 2: Beyond the numbers—experiences in the health system*
Interviews with patients help to paint a more comprehensive picture of their experiences 
within the health system. The Word Bank’s landmark publication, Voices of the Poor,A1 
in 2000 shared the narratives of individuals across the world and described the challenges 
that the poor face in not only accessing health care but also successfully navigating the 
health system. Since then, several qualitative studies have further illuminated the ways in 
which people receive differential treatment while seeking care. We did a rapid review of 
these studies (methods are described in appendix 1). The stories described in these studies 
highlight disparities in both competent care and user experience.
Patients across a wide range of low-income and middle-income countries have described 
the lack of competent care and health systems. In Egypt, a woman said that “at the 
hospital, they do nothing to people unless they are staff relatives, or rich people that have 
power or authority.” A1 A focus group participant in TanzaniaA2 stated that “they are very 
often saying that medicines are available or not available. When someone tells you they 
aren’t, it’s her siri (secret). She is the only one who knows. She decides when she sees you 
coming. … This really upsets us…. The obstacles are like these ones of medicines even if 
there are no medicines what makes me feel bad is the game.” Patients also reported 
improper examinations and care. A focus group participant in EthiopiaA3 described her 
delivery care: “they left the placenta inside me. Because they are impatient, they did not 
examine me. After I gave birth, I rested there for 5 h but no one came and asked me 
whether I was bleeding... After 3 days, my face got swollen... I almost died.”
Studies also highlight poor user experience, including verbal abuse and neglect from 
health-care workers. According to a patient in Russia, “the hospital is like a prison”.A1 
A person in GhanaA4 recounted that “people always say that the nurses are shouting too 
much, and saying bad things to them, and maybe they don’t want to treat them. They 
only care for those big people who have money to give them.” Poor patients, such as this 
respondent in Timor Leste,A5 also frequently report disrespectful, discriminatory 
treatment from health-care workers: “Health workers yell at us like a slave… they give 
priority to the important people, rich and intellectual and neglecting the poor, no money, 
stupid and dirty…That is the reason why people do not want to go to the hospital 
although they have a letter of referral.”
*Panel references can be found in appendix 1.
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care across health conditions relevant to SDGs.94 We 
compared mortality for conditions amenable to health 
care between LMICs and countries with well performing 
health systems, to estimate the mortality that can be 
attributed to poor-quality health systems.
We estimated that 8·6 million deaths per year 
(uncertainty interval [UI] 8·5–8·8 million) in 137 LMICs 
are due to inadequate access to quality care. Of these, 
3·6 million (UI 3·5–3·7 million) are people who did not 
access the health system, whereas 5·0 million 
(UI 4·9–5·2 million) are people who sought care but 
received poor-quality care. Poor-quality care resulted in 
82 deaths per 100 000 people in LMICs—an annual 
mortality rate equivalent to that from cerebrovascular 
disease globally.94
Cardiovascular deaths make up 33% of deaths amenable 
to health care (figure 5).94 Ischaemic heart disease is the 
largest contributor to amenable cardio vascular disease 
deaths, with 1·4 million deaths due to poor-quality care 
and 260 000 due to non-utilisation of health systems. Of 
the 2 million deaths from neonatal conditions and 
tuberculosis that are amenable to health care, 56% occurred 
in people who used the health system, but did not receive 
good quality care. Across several other health priorities for 
which coverage is still low, including chronic respiratory 
disease, cancer, mental health, and diabetes, non-
utilisation of health systems plays a larger role than poor-
quality care, but this will change as access increases. Our 
results highlight that health systems could be more 
effective in saving lives across a spectrum of conditions by 
improving quality of care along with expanding coverage. 
An analysis done with similar methods for a shorter list of 
conditions found that, globally, 8·0 million deaths could be 
averted with access to high-quality care.95
Maternal and newborn deaths are a particularly 
sensitive measure of health system quality, because 
many deaths stemming from labour complications can 
be averted with appropriate treatment.96 Figure 6 shows 
the comparison of rates of maternal and newborn deaths 
in countries with similar, high coverage of skilled 
attendants during birth (80–90% of births). Countries 
were grouped by income to reduce the influence of social 
and economic determinants. Across countries with 
similar coverage, large disparities in maternal and 
neonatal mortality are apparent. The ratio of worst to 
best performing country for maternal mortality was 
2·1 in low-income, 12·2 in lower-middle-income, and 
5·7 in upper-middle-income countries; for neonatal 
mortality it was 1·4, 3·7, and 2·9, respectively, suggesting 
differences in quality of care.
The frequency of stillbirths can also be reduced 
with high-quality care.97 An analysis done for this 
Commission—with use of the Lives Saved Tool—in 
81 countries that are the focus of the Countdown to 2030 
collaboration, estimated that 520 000 stillbirths could be 
prevented and 670 000 neonatal and 86 000 maternal lives 
could be saved in these countries by 2020 if adequate 
quality of care is provided at current levels of health 
system use (appendix 1). Because quality was measured by 
use of inputs to care rather than by processes of care, 
these figures might underestimate actual mortality. An 
older analysis that used different methods found similar 
effects on stillbirths, but more maternal and newborn 
lives saved.98 In addition to improving the quality of labour 
and delivery care, improving the quality of antenatal care 
and family planning is crucial to reducing stillbirths.97
Population-based cancer survival is also an indicator of 
overall health system effectiveness.99 Using cancer 
registries from 71 countries, a 2018 study99 found varying 
rates of cancer survival between countries and for 
different cancers. For example, most countries reported 
an increasing trend in 5-year net survival from breast 
cancer since 1995, but survival did not always increase in 
countries such as India, Thailand, and several eastern 
European countries.99
More broadly, hospital mortality can be useful for gauging 
the quality of care in facilities, when adjusted for disease 
severity and underlying risk, and can provide useful insight 
on the quality of secondary care in a region or country, when 
aggregated. Delivering high-quality hospital care requires 
well functioning facility systems that include appropriate 
triage in emergency departments, rapid decision making for 
very sick patients, close inpatient monitoring, and rigorous 
infection prevention practices, among other elements. 
Studies in LMICs have revealed high institutional maternal, 
perioperative, and emergency department mortality rates 
and high in-hospital mortality rates in patients admitted for 
acute myocardial infarctions. For example, the WHO 
multicountry survey100 on maternal and newborn health 
found intrahospital maternal mortality ratios that were 
2–3 times higher than expected on the basis of case severity. 
High rates of perioperative and anaesthetic-related mortality 
were also found in LMIC hospitals, reflecting gaps in 
Figure 5: Deaths from Sustainable Development Goal conditions due to poor-quality care and non-utilisation 
in 137 low-income and middle-income countries94
External factor deaths are those due to poisonings and adverse medical events. Other infectious diseases deaths 
are those due to diarrhoeal diseases, intestinal infections, malaria, and upper and lower respiratory infections.
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surgical and hospital care quality.101–104 The African surgical 
outcomes study101 found that patients in Africa were twice as 
likely to die after surgery compared with the global average, 
despite being younger, with a lower surgical risk profile, and 
undergoing less complex surgeries. Most of the deaths 
occurred post surgery, suggesting that many lives could be 
saved by effective surveillance for physiological deterioration 
in patients who have developed complications. Similarly, 
although the quality of emergency and trauma care in 
LMICs is understudied, one study found that mortality 
recorded in emergency departments in LMICs is many 
times higher than that generally reported in high-income 
countries, pointing to gaps in the quality and appropriateness 
of services being provided in these emergency departments.105 
In patients admitted with ST-segment elevation myocardial 
infarction in China, in-hospital mortality did not significantly 
change between 2001 and 2011, suggesting a need for 
improvements in quality.64
Mortality alone does not capture the full burden of 
poor-quality care. People accessing poor-quality care can 
develop morbidities, including physical sequelae, 
persistent symptoms, reduced function, pain, and poor 
quality of life. For example, for many people in LMICs, 
access to health care does not result in control of 
manageable conditions such as hypertension, diabetes, 
HIV, tuberculosis, chronic lung diseases, and depression. 
Poor quality of care during childbirth can also result in 
morbidities with lifelong consequences.
A study106 of 1·7 million adults in China found that only 
24% of patients under treatment for hypertension had 
achieved blood pressure control. A nationally representative 
study,107 also from China, found that among patients 
receiving treatment for diabetes, only 40% had achieved 
adequate glycaemic control. Complications of diabetes 
such as blindness, kidney failure, and lower limb 
amputation can be largely averted through high-quality 
primary care. However, in 2016, the Mexican Social 
Security Institute reported 4518 major lower limb 
amputations in patients with diabetes, for an incidence of 
120 per 100 000 patients. This continues a previously 
documented trend of increasing incidence of diabetic 
amputations and is higher than the comparable incidence 
in most, but not all, OECD countries.89,108
According to 2017 UNAIDS estimates,79 only 71% of 
people on antiretroviral therapy in LMICs have achieved 
viral suppression, and only ten countries have reached 
the 90% viral suppression target. Tuberculosis treatment 
success rates are also reflective of the quality of care, and 
only eight of the 30 countries with high tuberculosis 
burden have reached 90% first-line treatment success 
rate.109 In countries with high drug-resistant tuberculosis 
burden, treatment success rates range between 50% and 
85%.109 These figures show a need for better follow-up, 
treatment, and counselling of patients with manageable 
conditions in LMICs.
Obstetric fistula is a highly debilitating condition with 
severe social and health consequences. Women with 
fistula have leakage of urine or stool through the vagina 
and are ostracised because of this in some regions.110 
Fistulas typically develop in women with prolonged 
obstructed labour. Although cultural factors, such as child 
marriage, increase the risk of obstructed labour, the 
existence of fistulas on a wide scale, as documented in 
studies, is an indicator of poor quality obstetric care and a 
broader health system failure.111 Using data from  demo-
graphic and health surveys in 25 countries, we estimated 
the proportion of women who suffered from symptoms of 
an obstetric fistula among those whose last birth was 
attended by a skilled provider. In women whose last 
delivery was done with a skilled attendant, ten per 
1000 women reported symptoms of an obstetric fistula, 
Figure 6: Differences in maternal and neonatal mortality rates across low-income and middle-income 
countries with 80–90% skilled birth attendance coverage
Mortality estimates are from WHO, using 2015 modelled estimates.A6,A7 Skilled birth attendance is from the World 
Bank World Development Indicators,A8 using the most recent data available in the past 10 years. Horizontal lines 
indicate Sustainable Development Goal targets. Few deaths in these countries are recorded in complete vital 
registration systems; global estimates must account for missing and unreliable data. Mortality estimates should be 
interpreted with caution because of uncertainty from measurement error. References can be found in appendix 1.
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ranging from 0·54 per 1000 in Burkina Faso to 32 per 
1000 in Pakistan (appendix 2). By contrast, obstetric fistulas 
have been almost eliminated in high-income countries.
Another goal of treatment is remission or reduction of 
symptoms. In the WHO SAGE, only 50% of patients 
receiving treatment for chronic lung disease and only 
7% receiving treatment for depression reported having 
no symptoms from the two diseases in the preceding 
2 weeks (appendix 2). The Lancet Commission36 on 
palliative care and pain relief quantified the global 
burden of serious health-related suffering and found that 
more than 80% of the global 61 million patients affected 
by serious health-related suffering live in LMICs.
Confidence in the system
The quality of care that people receive also has important 
consequences for their confidence and trust in their 
government and health system, which can affect their 
decisions of when and where to seek care.
Figure 7 shows varying degrees of confidence and trust 
in health systems across 45 LMICs. Only 24% of people 
stated that they believe that their health system worked 
“pretty well” and that only minor changes were necessary 
to make it work better.112 In comparison, 47% of 
respondents agreed with the same statement in 11 high-
income countries, ranging from 24% in the USA to 61% 
in the UK (appendix 2).113 Differences in survey sampling 
and indicator wording might account for some of the 
variation across surveys. For example, increased 
confidence in the ability to receive the care needed 
present in the internet survey led by this Commission 
might be explained partly by a higher socioeconomic 
status of internet users. Gallup World polls114 also showed 
large gaps in satisfaction between low-income and high-
income countries: in sub-Saharan Africa, northern 
Africa, and the Middle East, only 42–49% of respondents 
were satisfied with the availability of high-quality care 
near them, compared with 86% in northern Europe. 
Nonetheless, patient satisfaction should be interpreted 
with caution as a measure of quality (panel 3).
Other research has found that increased technical 
quality of health services, combined with responsive 
service delivery, fair treatment, better health outcomes, 
and financial risk protection, was associated with an 
increase in the probability of having trust in government.29 
Similarly, a better user experience (communication and 
time spent with providers) was associated with better trust 
in health systems in Latin America and the Caribbean.112
Panel 3: Why are people satisfied with poor quality?*
Perhaps paradoxically, because of the prevalence of poor-quality health care, patients in 
low-income and middle-income countries tend to report high satisfaction with the care 
received. Across eight low-income countries, 79% of patients and caregivers reported 
being very satisfied with the care received during consultations in which providers did less 
than half of essential clinical actions (results in appendix 2). This percentage ranged from 
75% for care of sick children to 85% for family planning (appendix 2). High satisfaction 
with health care is common across low-income and middle-income country surveys, but 
patient satisfaction as a measure of quality should be carefully interpreted.
Although satisfaction is influenced by the quality of care, it is also influenced by care 
accessibility, costs, health status, expectations, immediate outcomes of care, and 
gratitude.A9 Additionally, satisfaction measures can be subject to substantial survey bias.
A10 In the Commission’s internet survey of patient experience, we tested one factor 
thought to be influential in generating high satisfaction: low expectations for quality of 
care. Respondents were asked to rate the quality of care on the basis of short vignettes. 
A vignette that described a nurse changing the medication of a patient with hypertension 
without measuring blood pressure or asking about symptoms was rated as good to 
excellent quality of care by an average of 53% of 17 966 respondents across 12 countries, 
and as high as 62% of 1292 respondents in Senegal, suggesting a low threshold for what 
is considered to be good care (appendix 2). Low expectations of what constitutes good 
quality might be a consequence of the prevailing poor-quality care, low agency, and 
inadequate functioning mechanisms to hold systems accountable.
Other studies have also shown that patient satisfaction surveys are influenced by 
acquiescence bias. Surveys framing statements in a positive way and inviting patients to 
agree or disagree will lead to positive responses much more frequently than surveys with 
more neutral statements.A10 More discussion on the utility of patient satisfaction as a 
measure of health system quality can be found in Section 4.
*Panel references can be found in appendix 1.
Figure 7: Confidence and trust in health systems in 45 low-income and middle-income countries (LMICs) and 11 high-income countries
Dots represent country-specific means, vertical bars indicate median performance across countries, and boxes delineate the IQR. High-income countries do not 
contribute to the illustrated medians. Data are from the surveys indicated. AFRO=Afrobarometer survey done in 34 African countries (2011–13). HQSS=Commission-led 
internet survey done in 12 LMICs (2017). IDB=nationally representative phone survey on primary care access, use, and quality done by the Inter-American Development 
Bank in six Latin-American and Caribbean LMICs (2013). CWF=International Health Policy Survey done by the Commonwealth Fund in 11 high-income countries (2013). 
Indicators are defined in appendix 1; country specific means are shown in appendix 2.
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Research suggests that quality, particularly that 
perceived by the patient, might have an effect on health-
care utilisation patterns, retention in care, and people’s 
decision to bypass facilities.115,116 In the internet survey led 
by this Commission, more than half of patients who 
decided not to seek care in the preceding year (despite 
needing medical attention) stated that their decision was 
made for quality reasons (eg, poor provider knowledge, 
long wait times, or disrespect), as opposed to cost of care 
or distance to facilities. The highest proportion of 
patients was in Mexico, where 73% cited quality reasons 
for not seeking care. Similarly, a study117 in Haiti found 
that higher quality primary care facilities were associated 
with higher utilisation.
Perceived poor quality of care can also lead people to 
bypass certain facilities. Households might choose to 
travel further distances or pay more out of pocket to seek 
better quality care.118,119 In India, many patients choose to 
seek care from the private sector, which is viewed as more 
competent than public facilities. India’s District Level 
Household and Facility Survey found that 51% of 
households bypassed their nearby public facility for their 
usual care; of these, 80% cited at least one quality concern 
as a reason (figure 8, appendix 1). Some people might also 
Figure 8: Proportion of households that report quality concerns as reason for bypassing public facilities in districts in India
Data are from the fourth cycle of the District Level Household and Facility Survey done by the International Institute of Population Sciences from 2012 to 2014, in 
21 states of India. A quality concern was defined as mentioning any of the following as a reason for bypassing government facilities: inadequate infrastructure, 
doctor not available, absent health workers, poor quality, drugs not available, inconvenient hours, long wait time, or distrust. In darker coloured districts, a higher 
proportion of households cited quality concerns.
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choose to bypass primary care facilities and seek care at 
hospitals or higher-level facilities for conditions that could 
be treated in primary care.120 A survey121 in China found 
that poor quality of care and lack of trust in primary care 
institutions were among the most common reasons for 
bypassing primary care and going directly to hospitals. 
Primary care is the cornerstone of a high-quality health 
system, serving as the main entry point for most concerns 
and playing a crucial role in coordinating care and ensuring 
continuity across health system platforms. Nonetheless, 
primary care facilities often fail to fulfil their role. Using 
facility surveys from nine countries, we built a primary 
care quality score based on three domains of quality—
evidence-based care, competent systems, and user 
experience—and found an average score of only 0·41 out 
of 1, ranging from 0·32 on average in Ethiopia to 0·46 in 
Namibia (appendix 2). By contrast, some studies122 have not 
found a relation between utilisation and measures of 
quality, such as doctors’ competence, probably because of 
information asymmetry. A crucial area for future research 
will be to estimate the demand response to higher quality 
of care, focusing on the role of information and perception 
of quality in influencing utilisation patterns.
Economic benefit
Improving health system quality can be justified on ethical, 
epidemiological, and economic grounds. Little evidence 
exists on the link between levels of quality of care and 
economic outcomes. Here, we describe three types of 
economic consequences that could be averted by high-
quality health systems: macroeconomic effects of pre-
mature mortality, health system waste, and catastrophic or 
impoverishing health expenditures faced by households.
A 2018 analysis95 estimated the macro economic effect 
of mortality that could be prevented with access to high-
quality care in LMICs. The analysis was done by use of 
two distinct approaches to quantify economic losses 
from preventable mortality. The first approach projected 
gross domestic product (GDP) losses over 15 years due to 
the consequences of mortality on labour force and 
physical capital accumulation. In 91 LMICs, amenable 
deaths due to insufficient good quality care would result 
in a projected cumulative loss of US$11·2 trillion 
(UI 8·6–15·2 trillion) between 2015 and 2030. This 
economic output loss was greatest in low-income 
countries, costing 2·6% of their GDP compared with 
0·9% in upper-middle-income countries.95 The second 
approach estimated the current value of total economic 
welfare losses on the basis of the concept of a statistical 
life, which attempts to capture the value placed on good 
health in and of itself. In 2015 alone, poor access to 
quality care resulted in an estimated $6·0 trillion of 
losses in 130 LMICs.95 Upper-middle-income regions lost 
the least, whereas losses in sub-Saharan Africa accounted 
for more than 15% of GDP. This analysis shows that 
poor-quality care can result in a great macroeconomic 
burden that is inequitably distributed across countries.
Beyond the economic losses from premature mortality, 
poor-quality care can also lead to important waste and 
inefficiency. Waste in health care has been defined as any 
“health-care spending that can be eliminated without 
reducing the quality of care”.123 Health-care waste includes 
the overuse of unnecessary care or ineffective approaches, 
medical errors, unsafe care, incoordination of care, 
misuse (including inappropriate hospital admissions and 
bypassing), fraud, and abuse. There have been few 
measurements of health-care waste attributable to poor-
quality care in LMICs. However, evidence from high-
income settings suggests that averting these costs could 
help LMICs make better use of scarce resources. For 
example, the annual costs of extra hospital stays and 
readmissions for treatments of surgical site infections 
were estimated to range between $3·5 billion and 
$10 billion in the USA and between €1·47 billion to 
€19·1 billion in Europe.73 Similarly, the global economic 
effects of antimicrobial resistance remain largely un-
known, but in the USA alone, its yearly cost to the health 
system is estimated to range between $21 billion and 
$34 billion.124 Lastly, the global cost of unnecessary 
caesarean sections done each year is estimated to be 
$2·32 billion, which far surpasses the cost of needed 
caesarean sections.125 Because care delivered in hospitals 
has a greater risk of complications and is more costly, 
inappropriate hospital admissions also represent a 
substantial burden to the health system. High-quality 
primary care can prevent the need for hospital admissions 
for several health conditions called ambulatory care-
sensitive.11 In the USA, $31 billion are spent annually on 
hospital admissions for these conditions.123 Better perceived 
quality and greater trust in health systems can also 
improve care-seeking patterns and reduce the bypassing 
of primary care facilities for overcrowded hospitals in 
LMICs.
Finally, people living in countries with poorly 
functioning health systems, without appropriate financing 
mechanisms and insurance, risk suffering from 
catastrophic or impoverishing expenditures when seeking 
care. Out-of-pocket payments (ie, health spending made 
by patients themselves at the point of care) as a share of 
household consumption have been increasing world-
wide.126 In 2010, 808 million people (11·7% of the world’s 
population) incurred catastrophic health expenditures—
ie, exceeding 10% of household consumption.17 Cata-
strophic spending increased by 2 percentage points 
since 2000 and was associated with economic growth and 
per capita health spending. Nearly 100 million people are 
pushed into extreme poverty each year because of out-of-
pocket expenses.17 For poorer households, out-of-pocket 
payments often mean choosing between paying for health 
and paying for other necessities, such as food or rent, 
straining their day-to-day survival capacity and affecting 
their physical, social, and economic wellbeing.127 High-
quality health systems with appropriate financing 
mechanisms can enable facilities and providers to give 
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affordable care to the population. To help reduce im-
poveri shing and catastrophic expenditures, prepaid health 
expenditures should replace out-of-pocket pay ments. A 
study128 published in 2018, found that the proportion of the 
population covered by health insurance schemes or by 
national or subnational health services was not associated 
with financial protection. Conversely, increased shares 
of prepayment in total health expenditure, typically 
achieved through taxes and mandatory contributions, 
were important for protecting people against catastrophic 
spending.128
The economic consequences we have described could be 
attenuated or averted in high-quality health systems. 
However, improving health system quality will require 
additional investments in many countries. Analyses have 
suggested that these will be substantial but affordable in 
most settings, excepting the poorest countries. In 2017, 
WHO published129 an estimation of the cost of interventions 
and health-system strengthening strategies required for 
reaching all SDG-related health goals in 67 LMICs. WHO 
estimated additional annual costs of $263 billion, which 
would save 97 million lives from 2016 to 2030. The 
estimated total costs per person ranged from $112 in 
low-income countries to $536 in upper-middle-income 
countries. The Disease Control Priorities Project14,130 
estimated the costs for reaching 80% effective coverage for 
218 interventions, to meet UHC targets, in 83 LMICs and 
found that an additional $260 billion per year would be 
required. This represents $76 per person in low-income 
countries and $110 in lower-middle-income countries; this 
investment would result in 6·2 million deaths averted by 
2030. Further research is needed to measure the costs of 
specific quality improvement strategies, including those 
advanced by this Commission.
A health systems view must also be used to understand 
quality. This section addressed health care that is 
delivered at different levels of the health system, 
including through community outreach, primary care, 
Figure 9: Quality of care across health system platforms in low-income and middle-income countries (LMICs)
DALYs=disability-adjusted life-years. HDI=Human Development Index. References can be found in appendix 1.
H
Emergency 
medical services
• 54% of LMICs have a 
 national universal access 
 phone number for pre-hospital care.A17
• 37% of LMICs are able to transport the majority 
 of seriously injured patients by ambulance after 
 road traffic crashes.A17
Referral systems • 55% of respondents across six LMICs reported that specialists did not have basic medical information from their regular
 doctor and 54% reported that their regular doctor did not subsequently receive up-to-date information after the specialist 
 visit (appendix 2).A19
• 10% of patients in a study in Ethiopia used the referral system.A24
• 5% of simulated patients in a study in Nairobi, Kenya, were correctly referred in primary care facilities.A22
• 51%: Ethiopia’s national health extension worker programme score on referral linkage, including availability and means of 
 transport, facility feedback mechanisms, and willingness of patients to go to the referral facilities.A15
Community outreach
• 52–78% of child 
 pneumonia cases 
 correctly managed 
 by community 
 health workers 
 in studies in 
 Ethiopia, Zambia, 
 and Malawi.A11–A13   
Competent systems: safety
• 32% mean compliance with appropriate infection prevention practices in 
 primary care facilities in Kenya, ranging from 2% for hand hygiene to 87% for 
 injection and blood sampling safety.A18
Competent systems: prevention and detection
• 48% of adults across six LMICs are up to date with preventive exams (blood 
 pressure and cholesterol check).A19
• 20% of women aged 50–69 years across six LMICs had a mammogram in the 
 past 3 years (appendix 2).A20
Competent systems: continuity
• 66% of respondents across six LMICs report that their regular doctor knows 
 important information about their medical history (appendix 2).A19
• 40% of patients across six LMICs report assistance from their primary care 
 doctors in coordinating their care (appendix 2).A19
User experience
• 23% effective access to primary care in Haiti, defined as the proportion of the 
 population living within 5 km of a primary care facility of good quality.A21
• 49 min average waiting time in primary care facilities in a simulated patient 
 study in Nairobi, Kenya.A22
• <5 min mean primary care physician consultation length across studies in 
 18 LMICs, covering about 50% of the world’s population.A23
Impacts: bypassing
• 44% of patients across six LMICs used emergency rooms for conditions that 
 could have been treated at the primary care level (appendix 2).A19
• 40% of people in a study in Ethiopia sought routine maternal and child care 
 (including antenatal care, family planning, and vaccinations) from hospitals.A24
• 1·4 to 13 times higher 
 likelihood of correct 
 management of paediatric 
 diarrhoea among 
 community providers 
 compared with children not 
 taken to a provider for care 
 across five LMICs.A14
Competent systems: safety
• 45%: Ethiopia’s Health 
 Extension Worker 
 programme appropriate 
 infection prevention score.A15
User experience
• 82%: community health 
 workers interpersonal 
 treatment score, compared 
 with 65% for facility-based 
 workers, in western Kenya.A16
Primary care
Evidence-based care
• 35% and 54% average adherence to clinical guidelines 
 for the management of childhood illnesses and the 
 provision of antenatal care across primary care facilities 
 in nine LMICs (appendix 2).
CLINIC
Hospitals
Evidence-based care 
• 55% of small and sick newborn babies in a study in Nairobi hospitals 
 received appropriate evidence-based treatments during inpatient care.A25
• 50% of ideal candidates for reperfusion therapy across Chinese 
 hospitals received the treatment among patients admitted for 
 acute myocardial infarctions.A26
Evidence-based care
Competent systems: safety
• 66% of the global burden of adverse events from unsafe care, and the DALYs lost 
 from them, occur in LMICs.A27
• 6·1 per 100 surgical procedures: rate of surgical site infections in LMICs, 
 compared with 0·9 per 100 surgical procedures in the USA.A28
Competent systems: timely care
• 11·7 days: mean time from hospital admission to surgery for femur fractures in 
 four African LMIC hospitals, compared with 0·6 day in the USA.A29
Impacts: mortality and morbidity
• 1·8%: median mortality in emergency departments across 65 LMIC hospitals, 
 45 times higher than mortality in US emergency departments.A30
• 7·8%: perioperative mortality after emergency peripartum hysterectomies in 
 LMIC studies, compared with 0·76% in high-income countries.A31
• 22·2: relative risk of death after caesarean sections in LMICs, compared with the 
 Netherlands (2·4 for appendectomy, and 1·8 for groin hernia repair).A32
• Number of perioperative cardiac arrests is two times higher in low-HDI countries 
 than in high-HDI countries.A33
• Anaesthetic-related mortality and perioperative mortality of emergency 
 abdominal surgery is three times higher in low-HDI countries than in high-HDI 
 countries.A34
• One in ten surgical patients in Africa dies and one in five develops a postoperative 
 complication, according to the African Surgical Outcomes Study done in 25 LMICs 
 for all in-patient surgeries.A35
• 164 per 100 000 livebirths: intrahospital maternal mortality ratio across 27 
 LMICs, ranging from zero maternal deaths in sampled facilities in China, Jordan, 
 occupied Palestinian territory, and Vietnam, to 620 deaths per 100 000 women 
 in Nigerian hospitals.A36
www.thelancet.com/lancetgh   Published online September 5, 2018   http://dx.doi.org/10.1016/S2214-109X(18)30386-3 19
The Lancet Global Health Commission
and hospital care, and the linkages between them—
referral systems and emergency medical services. 
Figure 9 summarises evidence on quality across these 
key health system platforms.
Equity of high-quality care
We have thus far reviewed the available evidence on 
quality of care at a national or multinational level. 
However, these estimates mask important variations 
within countries. Equitable distribution of high-quality 
health care is essential to make the gains in health set out 
by the SDGs and ultimately contribute towards the 
realisation of the right to health. We now explore why 
some groups are more vulnerable to poor-quality care 
than others and who receives worse quality care.
Defining equity in the quality of health care
Braveman and Gruskin131 defined health equity as “the 
absence of systematic disparities in health (or in the 
major social determinants of health) between groups 
with different levels of underlying social advantage/
disadvantage—that is, wealth, power, or prestige”. This 
definition emphasises equitable health outcomes. The 
health-care system is one major determinant of health, 
and equitable access to the system is, therefore, 
important. But equitable access will not result in more 
equitable health outcomes unless all people—not just 
the privileged—are able to access high-quality services. 
Equity in the quality of health care can be defined as the 
absence of disparities in the quality of health services 
between individuals and groups with different levels of 
underlying social disadvantage. 
Groups vulnerable to poor quality of care
In 1971, Julian Tudor Hart132 stated that “the availability of 
good medical care tends to vary inversely with the need 
for it in the population served.” There is evidence of this 
inverse care law in many health systems—LMICs and 
high-income countries alike. For instance, tuberculosis 
has a strong socioeconomic gradient between countries, 
within countries, and within communities.133 Drug 
resistance arises in areas with poor tuberculosis control 
programmes and among subpopulations that face 
barriers to quality treatment. Similarly, a systematic 
review134 focused on diabetes showed that low individual 
socioeconomic status and deprivation in the residential 
area are associated with worse process indicators and 
intermediate outcomes, resulting in higher risks of 
microvascular and macro vascular complications.
The 2030 agenda for sustainable development is built 
on principles of universality and aims to ensure that no 
one is systematically left behind.135,136 This commitment 
is echoed in the World Health Assembly resolution 
number 69·11,137 which calls for “health system strength-
en ing for UHC, with a special emphasis on the poor, 
vulnerable, and marginalised segments of the popu-
lation”. Therefore, an effective implementation demands 
the defining and targeting of those most vulnerable.136 
WHO’s definition of vulnerability encompasses the 
effects of “marginalisation, exclusion, and discrimination 
that contribute to poor health outcomes”.138 Vulnerability 
can vary substantially, change over time, and be multi-
dimensional.139 Factors such as gender, ethnicity, dis-
place ment, disability, and health status can increase 
vulnerability of both individuals and communities. 
These factors are often fluid and have intersecting 
points, presenting serious obstacles to individuals in 
accessing high-quality health services.139 However, many 
countries fail to recognise the existence and impact of 
intersecting discrimination. As a result, the experiences 
and needs of these populations are not integrated into 
national health strategies, further entrenching the 
discrimination and disadvantage that they face.
In this Commission, we highlight three dimensions 
that might make people especially vulnerable to 
poor-quality care: settings of care, conditions, and 
demographic factors (figure 10). Within settings of care, 
vulnerability is greater for individuals on the margins of 
mainstream services or displaced from home, such as 
those who are in a humanitarian crisis or in refugee 
camps, internally displaced, living in informal settlements, 
prisoners, and migrant populations. People with 
stigmatised conditions can face worse treatment in the 
health system than others; these conditions can include 
HIV and AIDS, mental health and substance abuse 
disorders, and some reproductive health services such as 
abortion. Finally, previously recognised social and 
demographic factors that indicate asymmetric power, 
such as gender, age, sexual orientation, ethnic group, 
disability, and insurance coverage, can predispose people 
to experiencing poor-quality care.
Reasons for poor-quality care in these three dimensions 
include the collapse of health services, insufficient financial 
and human resources, low patient empower ment, barriers 
to continuity of care, insufficient legislative controls, and 
Figure 10: Dimensions of vulnerability to poor-quality care
      Settings of care
• Humanitarian crisis 
 and refugee camps
• Internally displaced people
• Prisons
• Migrant populations
        Conditions
• Reproductive health 
 (eg, abortion)
• HIV and AIDS
• Mental health
• Substance abuse
          Demographics
• Gender
• Age
• Geographical 
 location
• Education
• Income
• Ethnicity
• Sexual
   orientation 
• Disability
• Insurance
 coverage
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breakdown in trust between patient and system. These 
dimensions of vulnerability, along with an understanding of 
why these groups could receive poor-quality care and suffer 
worse health outcomes than others, can inform policies and 
programmes that target specific vulnerability factors.
Panel 4 and panel 5 illustrate how conditions (eg, mental 
health) and settings of care (eg, humanitarian crisis or 
refugee camps) can exacerbate poor-quality care and what 
might be done to address these inequalities.
Who receives worse quality care?
The monitoring and tracking of equity in health inter-
vention coverage has been the focus of major international 
efforts.140 Many studies61,140,141 have shown that some 
population groups are systematically less likely to have 
access to or use health services for several conditions. 
However, there has been less work done on equity in the 
quality of care. As described earlier in this section, quality of 
care varies between and within countries. Quality of care 
can also vary between certain population groups and across 
conditions in the same area. For example, a study142 in Kenya 
showed that the quality of labour and delivery care was 
generally low, but care available to the poor was substantially 
worse than that for wealthier people. Similarly, it was found 
that in Madhya Pradesh, India, poor people living in 
poor communities received especially poor-quality care.143 
Additionally, poor people throughout the world live and die 
with little to no palliative care or pain relief.36
We disaggregated several indicators of quality in 
maternal and child health presented earlier in this 
section by wealth, urban and rural residence, maternal 
age, gender, and education (appendix 1); we also assessed 
variation in quality between the public and private sector. 
We found evidence that quality care is inequitably 
distributed across these stratifiers.
Regarding evidence-based care, figure 11A shows the 
proportion of women and caregivers reporting different 
elements of antenatal and child health care by wealth 
quintiles. We found evidence of a wealth gradient across 
most of these indicators. Among women attending 
antenatal care with a skilled provider, wealthier women 
were more likely to report receiving antenatal care 
assessments and appropriate preventive treatments and 
more likely to be retained in care until the fourth 
antenatal care visit. For example, among women 
attending antenatal care, we found that the wealthiest 
were four times more likely to report blood pressure 
measurements and urine and blood tests than the 
poorest women in their country (relative index of 
inequality 4·0, 95% CI 3·9–4·1).45 When seeking care at 
facilities for pneumonia, children in the wealthiest 
quintiles in low-income countries were more likely to 
receive antibiotics than those in the lowest; among all 
children who received the first diphtheria, tetanus, and 
pertussis vaccine dose, those from wealthier families 
were more likely to complete the vaccination series 
(receiving the third dose by age 1 year) than children 
from poorer families. These inequities tended to be 
larger in low-income countries than in lower-middle-
income and upper-middle-income countries.
Panel 4: Why quality of maternal mental health care might suffer for vulnerable groups: perinatal depression care in primary 
care setting in Nigeria*
Women with perinatal depression can experience stigma 
associated with mental illness in some low-income and middle-
income countries. People with mental disorders are often victims 
of discrimination and denial of basic rights.A37 They can also 
internalise shame, anticipate rejection and discrimination, and 
accept diminished expectations from others. These two forms of 
stigma, enacted and felt, have the effect of exposing individuals 
with mental disorders to poor and inequitable quality of care. 
Therefore, in the context of perinatal depression, stigma would 
increase the likelihood that those suffering are denied access to 
the basic and often rudimentary services available.
A formative study done as part of the project Scaling up Care for 
Perinatal Depression for Improving Maternal and Infant Health 
in Nigeria, assessed the factors that might promote or hinder 
the delivery of quality services to women with perinatal 
depression (appendix 1). All 23 facilities sampled had the lowest 
level of institutional support for continuous care for depression. 
Of the 218 patients who screened positive for perinatal 
depression by use of a validated tool, only three were identified 
by primary health-care workers. The treatment offered to these 
three patients was non-existent or grossly inadequate. 
None were provided with structured psychosocial interventions 
or offered specific follow-up to address their depression. 
However, 96% of the women in all sampled facilities reported 
that the quality of care provided in the clinics was good and of 
sufficient quality, and 98% reported that they were satisfied 
with the care they had received.
The low capacity of all the sampled facilities to provide quality 
care for depression, and the extremely low detection rates of 
depression by primary health-care workers recorded in the 
study showed important gaps in both the organisational 
structures and the manpower capacity of the front-line facilities 
to respond to common perinatal mental health conditions in a 
fully functional integrated chronic care model. Despite the 
objectively rated poor quality of service being provided, the 
women using these facilities still rated them high regarding 
quality of care and personal satisfaction with the level of service 
provided. This paradox is an important indicator of the existing 
inequity in the system: people who have never experienced 
high-quality services set their expectations low and do not 
know how to demand higher-quality health care.
Source: Olatunde Ayinde and Oye Gureje. *Panel references can be found in appendix 1.
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We also found important urban–rural differences in 
several of these quality indicators, whereby women and 
caregivers in urban areas were significantly more likely 
to report better maternal and child health-care quality 
than those in rural settings (figure 11B). These urban–
rural differences were also largest in low-income 
countries.
In terms of user experience, this Commission’s 
12-country internet survey also showed that people with 
some primary education consistently rated their user 
experience as worse than did those with secondary 
education or higher (figure 11C). The largest gap was 
found in the rating of the overall quality of the last 
outpatient visit, for which people with primary education 
or less reported significantly lower quality than did those 
with more education. A total of 34% of respondents 
reported that staff had treated them poorly because of 
their identity and, of those, 10% attributed this to their 
poverty (appendix 1). These inequalities could be under-
estimated because studies have shown that less educated 
people tend to be more accepting of the care they 
receive.144,145
Additionally, adolescent women seeking maternal and 
child health care can also face particular stigma and 
poorer quality care (appendix 2). Among women 
attending antenatal care and delivering in health-care 
facilities, young adolescents were less likely to report 
receiving different elements of care than women 
aged 20–35 years. Younger mothers were less likely than 
others to receive post-partum checkups before discharge 
after giving birth in a health-care facility. The youngest 
adolescents (15-year-olds) appeared to be substantially 
less likely to receive all four recommended antenatal 
care visits, and their children were less likely to complete 
the diphtheria, tetanus, and pertussis vacci nation series.
An analysis of data from the STEPS survey on receipt 
of lifestyle advice from health-care providers among 
adults diagnosed with diabetes, hypertension, or hyper-
cholesterolaemia found that women were less likely to 
receive advice about tobacco use and physical activity than 
men, and overall, those with no formal schooling were 
more likely to receive advice about tobacco use and dietary 
change than those with primary or secondary schooling. 
Individuals with secondary schooling were more likely to 
receive advice about physical activity, maintaining a 
healthy bodyweight, or losing weight than those with 
primary or no schooling. Additionally, evidence from the 
Prospective Urban Rural Epidemiology study146 found that 
the use of medication for secondary prevention of 
coronary heart disease was extremely low, with people in 
the poorest countries having the lowest rates of use. 
Within countries, women and rural dwellers had lower 
Panel 5: Quality of humanitarian health services for populations affected by armed conflict and natural disasters* 
During 2016, there were 49 active armed conflicts with about 
170 million people affected, including 60 million refugees and 
internally displaced people throughout the world.A38–A40 
Additionally, an estimated 200 million people are affected by 
natural disasters annually.A41 These crises cause excess morbidity 
and mortality through multiple pathways.A42 One of these is the 
disruption of what are often already weak public health 
systems. In most crises, the health system undergoes 
substantial degradation and fragmentation, with the void left 
by reduced government activities often filled by faith-based, 
private, and informal providers.A43
There are logistical, safety, and practical difficulties in 
undertaking research during times of conflict that have led to 
insufficient data on the quality of health services being provided 
in these situations.A44 However, methods that have been used to 
assess the quality of care showed low levels of competent care 
and user experience, issues with staff motivation, and less 
complicated conditions receiving better quality care than 
patients who were seriously ill.A45 During the past two decades, 
humanitarian actors have undertaken various, largely 
normative, initiatives to promote health-care quality. However, 
accountability and enforcement remains low, and few 
humanitarian agencies have implemented health governance 
systems. Here, we discuss several challenges that need to be 
tackled to advance the quality agenda in the humanitarian 
health sector.
First, the pursuit of quality remains weak and needs to be 
incentivised. For example, donors of humanitarian activities 
should place greater emphasis and funding on strengthening 
the use and reporting of quality standards and performance 
metrics. Failure to collect and report these data should have 
consequences for agencies, such as removal of permission to 
operate and loss of funding. Second, quality is impeded by 
insufficient capacity within the humanitarian health workforce. 
Efforts to professionalise the humanitarian health workforce 
need to be scaled up through training and updated technical 
standards and competency frameworks. Third, existing 
coordination mechanisms need to evolve into technical 
leadership arrangements, whereby, in exchange for the benefits 
of taking part in coordination (eg, access to specific funding 
pools), actors agree to operate according to a standard package 
of care and specific service quality standards. Fourth, 
governments need to explicitly consider crisis areas when 
implanting health interview and population surveys. The actors 
in these areas should collect data in a way that matches the 
quality indicators defined by the public health information 
systems, including assessment of confidence in the system. 
Lastly, health governance in the humanitarian systems remains 
weak. Robust governance arrangements, ideally interagency, 
need to be established to develop concrete accountability and 
liability in the humanitarian health sector.
Source: Bayard Roberts and Francesco Checchi. *Panel references can be found in appendix 1.
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use than men and urban dwellers; less educated patients 
were less likely to use antiplatelet drugs and statins than 
more educated patients.
Quality can also differ between public and private 
facilities, but these differences vary across contexts. 
Such differences also depend on the types of provider 
Figure 11: Equity in maternal and child health-care quality and in user experience in low-income and middle-income countries (LMICs)
(A) Data are from Demographic and Health Surveys and Multiple Indicator Cluster Surveys done in 90 LMICs (2007–16); wealth quintiles are pooled across countries 
and sampling weights are adjusted to weigh countries equally. (B) Data are from Demographic and Health Surveys and Multiple Indicator Cluster Surveys done in 
91 LMICs (2007–16) and are weighted using individual-level survey weights. (C) Data from Commission-led internet survey in 12 LMICs (2017); proportion of 
respondents who classified their experience for each indicator as “good”, “very good”, or “excellent” (vs “fair” or “poor”) for their last outpatient visit within the prior 
12 months; education levels are pooled across country. Indicators are defined in appendix 1. ORT=oral rehydration therapy. DTP=diphtheria tetanus pertussis vaccine.
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included in the definition of private sector. In terms of 
evidence-based care and competent systems in the 
Democratic Republic of the Congo, Kenya, Rwanda, and 
Uganda, adherence to WHO guidelines for sick child 
care was higher in private facilities than in public ones. 
Additionally, adherence to checklists was higher among 
private providers than among public ones in a 
standardised patient study52 in India. However, an 
analysis147 of household surveys in 46 countries found 
that public and private sectors did similarly in terms of 
antenatal care quality. By contrast, a systematic review148 
in LMICs found that private sector providers (including 
unlicensed and uncertified providers) were less likely to 
follow medical standards of practice, had poorer patient 
outcomes, and reported lower efficiency than public 
sector providers, resulting partly from perverse 
incentives for unnecessary testing and treatment. For 
user experience, public providers did worse in terms of 
timeliness and hospitality to patients than private 
providers.148 Nonetheless, quality can vary considerably 
within the same sector in a country. Additionally, 
country differences were found to be more influential 
than all other subnational factors combined in 
explaining variation in the quality of primary care 
services and labour and delivery care.38 This finding 
might point to the importance of structural factors in 
producing quality.
Section 2 conclusion
The epidemic of poor-quality care described in this 
section casts doubt on the ability of legacy health 
systems to achieve the SDG health targets. Poor-quality 
care in LMICs is reflected by inadequate adherence to 
evidence-based care, negative patient experiences, 
unequal treatment and access to health services, and by 
deficiencies in safety, prevention, continuity, and 
timeliness, leading to poor health, adverse economic 
outcomes, and loss of trust and confidence in health 
systems. Additionally, poor and vulnerable groups 
appear to experience worse quality care. Despite the 
breadth of the evidence presented in this section, there 
were still many gaps in the availability of data on quality 
of care (appendix 2).
Poor-quality care has been attributed to the poor 
knowledge and competence of providers and to fatigued 
or unmotivated health workers. However, the scale and 
range of the problem across countries, settings, and 
health conditions suggests that it is a manifestation of a 
broader systems failure. LMIC health facilities are under-
equipped, overcrowded, and frequently understaffed. 
Pre-service education and specialty trainings are 
inadequate. Processes are inefficient or inexistent, 
including financial incentives and remuneration of 
providers, referral networks, and triage in emergency 
departments. These fragmented health-care systems are 
unable to support health workers in providing high-
quality care.
Section 3: The ethical basis of high-quality 
health systems
The core principle of this Commission is that health 
systems are for people. This section asks: are they for all 
people? We review the right to high-quality care and 
provide insights into steps that national governments 
and communities can take to address the issue of equity 
and build a strong high-quality health system that targets 
the poor and vulnerable groups. The key findings of this 
section are shown in panel 6.
Implementing the right to high-quality care through a 
national quality guarantee
What is the right to quality care in settings with few resources?
The health and human rights agenda has been essential 
to motivating investments and actions to improve health 
in LMICs, as well as globally. This agenda historically 
emphasised inputs and access to care, but did not specify 
the quality of services provided. In 2000,13 the UN 
Committee on Economic, Social, and Cultural Rights 
adopted general comment 14, which states that the right 
to the highest attainable standard of health includes 
availability, accessibility, acceptability, and quality. In a 
review for this Commission149 of global health policy 
milestones since 2000, we found that the global 
discourse has been focused on access to care and 
foundations of quality, but not enough appears on 
processes of care or quality-specific impacts, such as 
trust or satisfaction. However, with the implementation 
of the 2007 WHO framework for action on strengthening 
health systems to improve health outcomes and the 
2016 WHO framework on integrated, people-centred 
health services, the trend is moving in the direction of 
patient-centred care and measures of quality focused on 
processes of care. Health systems should communicate 
the right to health through a national health plan, 
initiatives to ensure that the public knows its entitle-
ments and how to realise them, and data on health 
system quality.30
Panel 6: Section 3 key findings
1 Previous right-to-health discussions did not sufficiently 
elaborate on the quality of health services promised to 
people 
2 Spending scarce resources on expanding access to services 
without ensuring quality is wasteful and inefficient; as 
countries embark on universal health coverage, services 
should be accompanied by a national guarantee of quality
3 Quality improvement efforts should start in areas with 
the greatest quality deficits, with a focus on care received 
by disadvantaged populations
4 There are concrete mechanisms available to improve 
health system accountability; this lies at the core of 
realising the right to the highest attainable standard of 
health for all people
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Are there ethical trade-offs between improving quality and 
expanding access?
One reason that quality has lagged behind access in global 
health discussions is the perceived trade-off between 
expanding coverage and improving quality. A trade-off is a 
compromise between two or more desirable, but 
competing considerations and, thus, involves a sacrifice 
made in one dimension to obtain benefits or ensure 
respect for rights in other dimensions.150 There was (and 
still is in many low-income countries) an understandable 
sense of urgency to expand essential services to the 
population at any cost—without an explicit focus on 
quality. This finding can be interpreted as the result of a 
trade-off made by decision makers: equitable access for all 
is better than access to high-quality services for some.
Quality is essential to the equity agenda. We recognise 
that on the high end of care, such as expensive advanced 
technologies and medicines, provision of cheaper and 
somewhat less effective treatments can be an appropriate 
option in low-resource settings. One example is the use 
of the visual inspection with acetic acid method for 
cervical cancer screening instead of the more expensive 
and time consuming Papanicolaou smear and human 
papillo mavirus co-testing.151 However, we believe that a 
concern for equity implies access to a minimally assured 
level of quality for all. There are two reasons for this: 
ethical achievement of health outcomes and efficient use 
of resources. First, increased access will not translate to 
better health outcomes for disadvantaged people unless 
all people have access to high-quality services. Second, 
spending scarce resources to expand access without 
quality is wasteful and inefficient. Countries can build on 
their achievements in expanding coverage by improving 
the quality of services offered to meet the minimum 
quality level. They can then consider further expansion 
of quality services.
As countries pursue UHC, approaches such as 
progressive universalism—a determination to include 
people who are poor from the beginning—have proven 
to be effective ways to target poor and vulnerable groups 
of society.152,153 Brazil’s Family Health programme154 and 
Mexico’s Seguro Popular initiative155 are two examples of 
programmes designed to increase coverage first among 
disadvantaged groups. This Commission endorses this 
approach.
Defining a national quality guarantee
Many countries recognise the need to be accountable for 
the health care of the population. One clear manifestation 
of this is patients’ rights charters that outline a country’s 
approach to patient care and provide an ethical basis 
for care. Although these charters contain many of the 
same basic principles, such as legal and human rights 
guarantees, they vary substantially in length, scope, and 
detail. Patients’ rights charters are well intentioned, but 
not operational. South Africa is attempting to make its 
promises actionable through its National Health Insurance 
Policy, which underpins the establishment of a unified 
health system based on the principles of social solidarity, 
progressive universalism, equity, and health as a public 
good and a social investment (appendix 2).
This Commission recommends that countries adopt a 
national quality guarantee—ie, quality sufficient to 
consistently produce a health benefit. This would be 
concrete and operational for covered services. What are 
the elements of such a guarantee? First, clearly poor-
quality services, providing more harm or risks than 
benefits, fall below the thresholds of a guarantee. Second, 
the quality of services must be sufficient to generate 
health benefits. For example, a rural clinic should specify 
to the patient the level of services that it is competent 
in providing. Third, services must be provided in a 
respectful people-centred manner. An integral aspect of 
people-centred health systems is the relationship between 
provider and patient. Patient–provider relationships are 
shaped by societal norms and are susceptible to power 
imbalances. Pre-service and in-service training on respect-
ful care is one way to improve the ethical competence of 
providers in low-income settings.156 However, to end the 
poor treatment of patients and greatly improve health 
care, people-centred and patient-driven approaches that 
shift the power from the health-care system and providers 
to the patients are needed.157
The quality guarantee should accompany any efforts to 
expand service coverage; in many countries, the move-
ment to UHC is an excellent starting point. National 
standards for conditions covered by a UHC benefit 
package might include descriptions of adequate assess-
ment and diagnosis, treatment and care, assurance of 
continuum of care, and referral. This is a corrective to the 
current UHC discussion that revolves around the pooling 
of funds to expand the coverage of populations and 
services while decreasing the cost. Without building in 
quality, the increased coverage will not result in health 
gains for people. Although many countries can do more 
to provide quality health services with existing funds, 
others will require additional funds. Data from WHO4 
show that global government spending on health as a 
percentage of all government expenditures rose by an 
average of 10% between 2000 and 2015; however, it 
was flat in lower-middle-income countries, and fell 
substantially in low-income countries—the very countries 
struggling with poor-quality care.
Beyond these general considerations, countries need to 
undertake analyses and open discussions to specify their 
national standards. National guarantees should start with 
the reality of social norms and health system functions 
and be context-specific.158 Guarantees will depend on 
budget, setting, disease type, intervention, and delivery 
platform. Current national standards are often defined 
and implemented through standard operating procedures 
or clinical practice guidelines. Standards included in  the 
national quality guarantee should be developed by health 
policymakers and professionals, in collaboration with 
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users and national regulatory agencies, to ensure that 
upholding the guarantee does not fall solely on providers. 
The guarantee is not intended to be punitive against 
individual providers; any redress mechanisms should be 
targeted to the appropriate level of the health system.
Improving accountability for quality
Over the past three decades, the concept of accountability 
in provision of health care has gained increased attention. 
However, accountability for quality in health care has 
been less explored. In this subsection, we refer to 
Brinkerhoff’s definition159 of accountability, which en-
compasses both answerability and enforceability. The 
three general categories of accountability are financial, 
performance, and political or democratic. In this section, 
we use elements of financial and political or democratic 
accountability to discuss legal and social mechanisms. 
Performance accountability is discussed in the sub-
sequent sections. For accountability to function, there 
must be actors responsible for activities, standards to 
define what actors should deliver, agents to hold actors to 
account, and tools or methods to do so.
A review done for this Commission on the account-
ability ecosystem and its relation to the delivery of 
quality care (methods in appendix 1) supported the 
notion that accountability mechanisms can serve as a 
catalyst to initiate and sustain improvements in quality 
and advance the progressive realisation of the human 
right to health and quality health care. The review 
found that multiple accountability tools have been 
used, and documented in the peer-reviewed literature, 
to improve access to essential and effective health care 
(appendix 1). A key finding of the review was that single 
interventions do not have the power to induce large-
scale change. Additionally, governance and coordination 
must be strengthened, resources must be planned and 
budgeted, and a performance monitoring system must 
make the information collected available. Therefore, to 
improve quality, countries need to devise accountability 
strategies that encompass elements of legal and social 
accountability.
Legal accountability
National governments are the primary agents for 
accountability. Human rights conventions can provide 
the basis for legislation that recognises the right to 
health and health care, and can be an essential and 
minimum foundation for approaches to improve access 
and quality of care. Meaningful legislation should not 
only recognise the right to health and health care, but 
also cater for the right to meaningful public 
participation, freedom of civil society, and freedom of 
information. Where such legislation exists, it can be 
used for accelerating action. Quasijudicial mechanisms 
exist in many LMICs, such as the ombudsman in 
South Africa tasked with addressing the system failures 
that led to the deaths of 94 mental health-care users.160 
Also in South Africa, the Treatment Action Campaign 
defeated the Government in the constitutional court to 
increase access to HIV treatment to mothers and 
newborn babies. A high court in Kenya awarded a 
woman 2·5 million Kenyan shillings for mistreatment 
and abuse during childbirth, which was caught on 
film.161 Additionally, in Malawi and Mozambique, 
human rights concerns and entitlements were used by 
civil society organisations to expand national policy for 
maternal, newborn, and child health.162
Social accountability
Social accountability refers to approaches that involve 
communities, citizens, and service users directly; these 
approaches include attempts to increase community 
involvement, awareness, and demand generation for 
high-quality care.163 A 2004 World Development Report164 
suggested that social accountability tools could be used to 
increase trans parency and accountability, shortening the 
long route of democratic accountability between citizens 
and politicians. Multiple tools are available to foster 
social accountability. They include citizen report cards, 
community monitoring, social audits, participatory 
budgeting, citizen charters, and health committees. 
Mechanisms for creating and acting on such tools exist 
in LMICs today. Institutions tasked with reporting on 
quality-related indicators include the Health Data 
Advisory and Coordinating Committee in South Africa 
and the General Directorate for Quality Healthcare and 
Education in Mexico.165 There are licensing and 
assessment activities with internal and occasionally 
public reporting, such as the Ideal Clinic in South Africa, 
Big Results Now project in Tanzania, and the Kenya 
Patient Safety Impact Evaluation.166–168 Finally, direct 
public reporting of local progress can be effective, such 
as Imihigo,169 the televised reporting of progress on 
Panel 7: Actions to support legal and social accountability
A literature review done for this Commission aimed to present findings on the 
accountability–quality relationship and explore how accountability mechanisms contribute 
to improvements in quality of care. The review focused on legal and social accountability 
mechanisms pertaining to reproductive, maternal, and child health. The key findings were 
synthesised and the following actions were identified as important for effective and 
transparent accountability:
• Adopt and enact legislation that recognises the right to health and quality health care
• Invest in rights awareness and education at all levels, including among policy makers, 
parliamentarians, programme managers, service providers, and the public
• Share information on health system performance with the public and promote 
transparency of quality measurements
• Institutionalise mechanisms for remedy and redress, such as ombudsperson or 
tribunals
• Develop multipronged strategies for accountability for quality of care that combine 
legal, performance, and social accountability tools
Methods are described in appendix 1. Source: David Clarke, Rajat Khosla, Blerta Maliqi, Marcus Stahlhofer, and 
Bernadette Daelmans.
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commitments by local leaders in Rwanda, including 
maternal health outcomes. These social accountability 
mechanisms should be seen as complementary rather 
than substitutes to the legal approaches previously 
discussed.
Panel 7 synthesises the key findings from the review on 
legal and social accountability and proposes actions to 
support effective and transparent accountability at the 
national level.
Section 3 conclusion
Health systems should give priority to poor and vulnerable 
groups of society to reduce inequities and expand the right 
to quality health care through progressive universalism. 
A movement towards UHC offers countries the 
opportunity to start on this path by expanding coverage 
tied to a national quality guarantee. Legal and social 
accountability mechanisms can assist in upholding these 
quality standards. Enacting accountability is predicated on 
insight into current health system quality. In the next 
section, we assess the purpose, status, and promise of 
health system quality measurement.
Section 4: Measuring health system quality
The key findings of this section are shown in panel 8.
Why measure health system quality?
Valid and reliable information is a necessary input to a 
high-quality health system.170,171 Multiple national, inter-
national, and global efforts are underway to identify 
measures to improve care delivery and amplify patient 
voices. These efforts include the National Quality 
Forum in the USA, the Health Data Collaborative, and 
initiatives undertaken by OECD, the Inter-American 
Development Bank, and the China Joint Study 
Partnership.70,76,172–175 These efforts show that the 
measurement of health-care quality is a concern of 
populations and governments around the world; high-
income settings, in particular, have invested in 
institutions to strengthen health system performance 
through measurement. Although some efforts, such as 
the Health Metrics Network, have included LMICs, 
country ownership of this agenda has been inconsistent, 
and progress on health system measurement remains 
incomplete.
Indeed, the findings described in Section 2 on health-
care quality in LMICs reveal crucial measurement 
gaps. Existing data on quality of care have largely been 
generated within vertical programmes, resulting in 
measures that have not been combined in ways that 
could illustrate quality of the health system as a whole, 
whether at local or national levels.176 Systematic data on 
the performance of health system platforms (such 
as primary care) or on user experience, population 
confidence, and patient-reported health outcomes are 
scarce. Moreover, research on health system quality—
including the policy and implementation research 
urgently needed to bring effective interventions to 
scale—has not kept pace with the magnitude of the 
challenge, reflecting inadequacies in measurement 
approaches and data use. A bibliometric search for 
quality-related research between 2000, and 2016, 
revealed that, although this type of research is increasing 
in LMICs, it remains overwhelmingly located in high-
income countries (appendix 2). 
The demands made of health systems are growing: the 
burden of disease is shifting towards non-communicable 
diseases and injuries,6 health emergencies are rising,177 
countries are actively moving towards UHC,17 and people 
are demanding better services and outcomes.119 The 
health priorities of the SDG178 era—with ambitious 
targets of improved survival and quality of life for all—
demand new approaches that promote accountability 
and action to drive broad health system improvements. 
To meet these challenges, measurement approaches 
need to be responsive to new health system demands, 
relevant to people, and efficient. At the heart of this 
reframing is the question: why measure and for whom? 
This Commission proposes two main purposes for the 
measurement of health system quality: accountability 
and action.
Accountability requires the provision of information 
when questioned, whether for routine monitoring or 
detailed justification, paired with a mechanism for 
oversight.159 This section focuses on measurement for 
performance account ability—how the health system 
delivers on its intentions—and social accountability—
whether it is responsive to society.159 The measurement of 
performance accountability should show results against 
benchmarks, support cross national or subnational com-
parisons, disaggregate evidence for vulnerable subpopu-
lations, and do this in or near real time. For both 
performance and social accountability, data will typically 
need to be representative of the target population, 
comparable, and systematic. Measurement should 
further include elements that are of high value to people; 
for example, they should include not only health 
Panel 8: Section 4 key findings
1 Accountability and action are the guiding purposes of quality measurement; 
measurement not used for these purposes can burden the health system.
2 Current quality measurement is fragmented by disease, focused on inputs rather than 
outcomes, and poorly aligned to population health needs. Decision makers do not 
have timely information that provides a picture of the health system as a whole.
3 National and global actors should seize three opportunities to improve measurement of 
health system quality: (1) measure effective coverage—use quality-corrected coverage 
metrics to track progress towards UHC; (2) adopt fewer, but better measures by shedding 
inefficient indicators and prioritising measures of system competence, user experience, 
and outcomes, including clinical and patient-reported health, confidence in the system, 
and economic benefit; (3) invest in country-led quality measurement, including 
strengthening national capacity for data use and policy translation, releasing an annual 
health system quality dashboard, and disaggregating results for vulnerable populations. 
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outcomes such as survival, but also function, pain, and 
processes such as respectful treatment (panel 9).
Measurement for action is at the heart of learning 
health systems. These measures should provide decision 
makers with answers to specific questions about the 
functioning of the health system and the quality of care 
delivered, help identify the targets and interventions for 
improvement, and monitor the results of the changes 
implemented. Quantitative data should be complemented 
by so-called soft intelligence, the insight on the context 
and processes of care delivery, to help inform action.179 
The focus of measurement for action is likely to differ in 
a complex adaptive system: acting directly at the level of 
the process indicator (eg, attempting to address poor 
adherence to guidelines with printed reminders) might 
not yield expected effects if the indicator merely signals a 
deeper quality deficit at the health-system foundation 
level.158,179 Measurement for action is discussed further in 
Section 5.
Fulfilling either purpose of measurement—ie, for 
accountability or action—requires valid and reliable 
measures, transparency in information exchange, and 
an entity with the power to demand a response. 
Panel 10 outlines conditions required for measurement 
to induce change.
To meet the SDG targets and improve health system 
quality by 2030, countries will need to embark on a 
measurement agenda that will take time and investment 
to fulfil. This agenda starts by knowing what is currently 
being measured.
What is—and is not—measured in LMIC health systems 
today
Multiple strategies have been used to capture the range 
of information needed to assess health system quality, 
including measuring population health needs, health 
outcomes, and health system performance. Table 2 
describes the platforms in use and their best 
Panel 9: What different measures tell us about health system quality*
Measures of health system quality have usually been organised 
into inputs (eg, workforce, tools, facilities), processes of care 
(eg, adherence to guidelines, communication), and outcomes 
(eg, morbidity, mortality).A46
In low-income and middle-income countries, many quality 
measurement and improvement efforts have emphasised 
inputs to health services. Inputs are foundational to health-care 
provision and are easily measured, but they provide narrow 
insight into quality of care. Studies have found weak 
associations between input measures and care competence,A47 
particularly when facility size is considered.A25 The relation 
between input availability and the quality of care received can 
differ over the course of care delivery,A48 underscoring the need 
for motivated and competent providers and supportive 
systems for good care delivery. Similarly, multiple studiesA49,A50 
attest to the know–do gap: the deficit between provider 
knowledge and the clinical care provided. These issues do not 
mean that input measures are unimportant; indeed, timely and 
specific information on inputs, such as stock levels and 
equipment functionality, is crucial for health service planning 
and operation and should be collected by health systems. 
However, these measures should not be used as indicators that 
health systems are providing high-quality care.
Process measures can play an important role in illuminating the 
quality of care provided. These measures are immediate and 
relevant at the point of care, and they provide direct insight on 
care provision without risk adjustment, which makes them 
particularly valuable in assessing gaps or disparities in care for 
vulnerable subpopulations.A51 A judicious selection of process 
measures is essential, emphasising measures validated against 
the outcomes that matter to patients,A52,A53 whereas 
overmeasurement can divert provider time and weaken the 
quality and usefulness of data. The proliferation of process 
measures in high-income countries, for example, has increased 
the burden of measurement and resulted in unintended 
consequences, including fixation on the measure rather than 
the intent, reallocation of efforts towards meeting 
measurement targets and away from other essential tasks, and 
gaming (manipulation of the quality assessment system).A54,A55
Health outcome measures attest to the central goal of a health 
system—maintaining or improving health and wellbeing.A56,A57 
However, these measures can be challenging to attribute 
directly to health system performance because of the 
involvement of multiple factors. Baseline risk information is 
required for valid comparisons of health outcomes over time or 
between facilities.A58 Despite this complexity, there is global 
recognition of the crucial need for health-system-sensitive and 
patient-focused outcome measurements, even in very 
low-income settings.A56 Health-system-sensitive outcomes 
include perioperative mortality, inpatient suicide, 5-year cancer 
survival, obstetric fistula, caesarean section, unsuppressed HIV 
viral load, uncontrolled blood pressure, lower extremity 
amputation in patients with diabetes, and hospitalisation due 
to ambulatory care-sensitive conditions. High-income settings 
are increasingly turning to patient-reported outcomes (PRO) as 
a means of realigning health care with patient values.A59 PRO 
measures have been used to improve monitoring, decision 
making, and patient–provider communication,A60 with evidence 
suggesting that the use of these measures improved patient 
perceptions of careA61 and led to better health outcomes for 
some conditions,A62 although their usefulness in aggregate has 
yet to be fully demonstrated.A63 Routine measurement and the 
use of health-system-sensitive outcome data and PRO are 
integral to achieving patient-centred health systems.
*Panel references can be found in appendix 1.
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application; given the multiplicity of tools, central 
organisation and triangulation are needed to gain 
insight and act on these data. We, and others, have 
found that health system data collection is often costly, 
uncoordinated, and disconnected from decision 
making.173,180 Tools and indicators are fragmented by 
disease and funding source, with inadequate 
harmonisation and few national plans for coordination 
and data use.180,181 For example, 26 different bilateral, 
multilateral, governmental, and non-govern mental 
Panel 10: From measurement to action*
Measurement alone will not ensure health system quality. 
Actionable information must reach agents capable and 
empowered to use it to effect change in the health system. 
Freedom of information—the right to access information held 
by public bodies—was enshrined in the 1948 Universal 
Declaration of Human Rights and has been adopted into law by 
more than 90 countries.A64,A65 Applied to health systems, 
freedom of information demands transparency of data within 
the system and to the public.A66,A67 High-quality health systems 
are not automatically produced by governments. A regulatory 
system that engages an array of actors should hold the system 
to account for high-quality care. This system includes formal 
mechanisms such as audits, ombudsmen, and courts and 
informal actors such as patients, the press, professional 
organisations, and civil society.A67,A68
A range of barriers can inhibit the flow of information about 
health systems. Power differentials can stymie communication, 
restricting the transmission of and responsiveness to local 
knowledge;A69–A71 hierarchical norms and fear of reprisal can 
inhibit incident reporting about health-care failures;A72 and, 
ironically, a surfeit of indicators in routine measurement 
systems can prevent the ready understanding and use of locally 
relevant information.A69,A72–A74 Although governments often 
claim to want to reach users through open government 
initiatives, scant attention to how people understand and use 
information has led to an abundance of information but a 
minimal effect on care seeking and other outcomes.A75–A77 
Countries have the opportunity to take better advantage of 
increasing health system data by building trust in data, 
promoting learning cultures within the health system, and 
ensuring freedom of information. Obligatory reporting with 
data audit trails or data quality assurance institutions can 
bolster confidence in the indicators generated.A74,A79 A culture of 
information and learning within and across health facilities can 
lead to greater transparency and action.A69,A80 For instance, 
facility audits and licensing exercises should include clear 
criteria for improvement and result in non-punitive responses, 
such as support for addressing deficiencies.A81,A82 To ensure 
freedom of information, formal protection for whistle-blowers 
is an important guarantee, although a culture of secrecy and 
professional protectionism should also be addressed.A72 The free 
operation of traditional and social media can provide external 
accountability levers.A67,A69 Open government initiatives are an 
initial step, but their success should be judged on the basis of 
information use, not on quantity of data released. One path to 
fulfilling these opportunities is the development of a national 
body for monitoring health system quality, informing the 
public, and identifying and responding to failures, to serve as a 
locus for measurement, accountability, and action.
*Panel references can be found in appendix 1.
Frequency Level of collection Relevant quality subdomains 
(Commission framework)
Best uses in measuring high-quality health systems
Administrative data 
(eg, HMIS)
Routine Individual level data aggregated by 
condition within facilities and 
then by geographical unit
Population (care seeking), competent 
care and systems, and health outcomes
Monitor facility and clinician performance; monitor health status at 
the community and district level
Electronic health records Routine Individual patient Population (care seeking), competent 
care and systems, and health outcomes
Inform clinical care; monitor facility and clinician performance; 
monitor health status at the community and district level
Population surveys Periodic or 
continuous*
Population Population (care seeking), user 
experience, selected health outcomes, 
confidence, and economic benefit
Represent both users and non-users of the health system; permit 
analysis of equity for subpopulations; have potential to be adapted 
for innovations in measurement, such as patient experience and 
patient-reported outcomes
Facility assessments† Periodic or 
continuous*
Health system Workforce, tools; with observation or exit 
interviews: competent care, user 
experience, and confidence
Generate a representative assessment of health systems for 
subnational and national benchmarking; allow for assessment of user 
perspectives
Patient registries Routine Individual Health outcomes, user experience, 
confidence
Monitor patient-reported experience and outcomes measurement 
over time
Vital and civic registries Routine Population Health outcomes Monitor population health status; form basis for policy guidance, 
projections, and planning
HMIS=health management information system. Commission framework is depicted in figure 1. *Continuous household and facility survey methods that permit regular data synthesis, review, and health programme 
decision making have been proposed as an alternative to one-off surveys,A83 tested subnationally,A84 and adopted, for example by Peru since 2004, and by Senegal in 2012. †Facility assessments can include audits of 
structural inputs, interviews with health-care workers, direct observation of care, and exit interviews. References can be found in appendix 1.
Table 2: Platforms for health system measurement
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organisations fund health information systems in 
Kenya, resulting in duplication of efforts and uneven 
distribution of resources within the country.182 
120 distinct digital health-related information systems 
operate in Tanzania.173 More than 1000 indicators are 
collected at the national level across the three major 
public health systems in Mexico, but only 27 overlap at 
least two health systems, preventing comparison and 
standardisation.
The proliferation of indicators burdens health-care 
workers and systems. In sub-Saharan Africa, an estimated 
one-third of health-care providers’ time is spent on 
recording and reporting.173 Health facility assessments 
cost a minimum of $100 000 per national survey and 
typically many times that amount,183 but are rarely used 
for national planning. Furthermore, fragmentation of 
these and other data sources prevents the coherent 
assessment of health system performance, to say nothing 
of actions in response to the data.
To understand how well this plethora of tools measures 
health system quality, we analysed multicountry health 
system indicator sets or surveys and sample national 
indicator sets from LMICs against this Commission’s 
quality framework (figure 1; appendix 1). Quality 
frameworks do not imply a need for equal measurement 
of each subdomain for all health services and conditions, 
but they do make apparent the multiple aspects of quality 
and highlight duplication and gaps.
Measurement sets focused on the foundations of care, 
with global sets devoting 47% of indicators to this domain, 
crossnational sets devoting 70%, and national sets 
devoting 44% (figure 12). Inputs, such as tools and 
workforce, were the most commonly assessed sub domains 
and formed the entirety or bulk of the Service Availability 
and Readiness Assessment (SARA), Service Delivery 
Indicators, and Service Provision Assessments; our 
findings were consistent with existing research on the 
predominance of input measures in health system survey 
Figure 12: Representation of quality subdomains in global, crossnational, and national measurement sets
We mapped indicators against domains of the high-quality health systems framework (figure 1), identifying the single domain most relevant for each indicator. We 
additionally classified indicators as patient-reported if the data were collected with individual self-reports. Full methods are detailed in appendix 1. Cells are coloured by 
greatest number of indicators per row (source), with red indicating 0, orange and yellow the midrange, and green the maximum number observed for that measurement 
set. DHIS2=District Health Information System 2. DHS=Demographic and Health Surveys. HIS=Health Information System. HMIS=Health Management Information 
System. IMSS=Instituto Mexicano del Seguro Social. IPCHS=Integrated People-Centred Health System. ISSSTE=Instituto de Seguridad y Servicios Sociales de los 
Trabajadores del Estado. OECD=Organisation for Economic Co-operation and Development. SARA=Service Availability and Readiness Assessment. SDG=Sustainable 
Development Goals. SDI=Service Delivery Indicator Survey—health. SPA=Service Provision Assessment. * Population, governance, platforms, workforce, and tools.
Global measurement sets
Countdown 
2030 indicators
EURO health 
for all database
OECD health care 
indicators
WHO IPCHS global 
indicators
Mexico IMSS, ISSSTE, 
MOH
SDG health indicators
WHO core 100 (2015)
FoundationsIndicators
   137      91   41    26      1   23   0   2      0
   603    130   68    16      0   45   0   1      3
   183    160   87    11      9   42   0   6    13
     14      11     6      4      1      1   0   0      1
     89      28   11      7      1      8   0   1      1
   100      49   15    14      0   18   0   2      0
NA      72     4    51      2   14   0   1   63
NA   268 268      0      0      0   0   0      0
761   726 723      2      0      1   0   0      0
   121 30     8    11      0   11   0   0     0
   305 183   89   39      0   32   0   0     0
   398 168   51   35      3   29   5   0     0
   198 135   60   53      3   17   0   0     3
1055 471 205   97   36 103 17 13   21
1413 1269 784 349 108   22   6   0 156
Quality-relevant
indicators
All* ConfidenceCompetent
care
User
experience
Health
outcomes
Economic
benefit
Patient-
reported
Processes of care Quality impacts
DHS
SARA
SDI
SPA
Ethiopia HMIS
Kenya HIS
Nepal HMIS
Senegal DHIS2
Cross-national measurement sets
Example of national measurement sets for routine health system measurement
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tools.184 All assessed sets, except SARA, addressed 
competent care processes, particularly care delivered, such 
as oral rehydration solution for children with diarrhoea. 
Although global and national measurement sets included 
population health outcomes such as neonatal mortality 
rate, user experience and non-health effects were sparsely 
measured across all sets.
The extensive collection of input measures is problem-
atic. When collected through surveys, input data are 
quickly out of date and thus lose usefulness for supply 
planning. Moreover, our analysis found that readiness 
metrics are only weakly connected to the content of care 
delivered.35 Although the outcome indicators identified in 
this analysis are valuable for monitoring population 
health, we found few health-system-sensitive outcomes 
and almost no patient-reported outcomes.
The remaining measures in global sets pertained to 
competent care and, to a lesser extent, systems. Much of 
this measurement is focused on a subset of conditions, 
mainly maternal and child health and infectious diseases. 
Even in these areas, the validity of indicators collected 
raised concerns: for example, household surveys are not 
well suited for identifying children who truly have 
pneumonia to estimate appropriate treatment, and 
maternal morbidity and mortality in hospitals greatly 
exceeded the estimated rates based on documented 
administration of essential interventions.100,185 The validity 
of tools measuring clinical care is discussed in appendix 2.
Figure 13: Illustrative indicators for advancing Sustainable Development Goal (SDG) monitoring from coverage towards effective coverage
Tier 1=priority action is implementation (routine or targeted, as for immunisation). Tier 2=priority action is determining efficiency in indicators and data collection. 
Tier 3=priority action is development of valid indicators for use at scale. IMCI=Integrated Management of Childhood Illness. *Excludes health indicators focusing on 
population outcomes alone. †Six indicators not shown: two primarily measuring determinants outside the health system (tobacco use and access to basic household 
sanitation) and four service capacity and access indicators. References can be found in appendix 1.
Current coverage indicator Illustrative effective coverage indicator
Health system coverage* indicators from SDG Global Indicator Framework, July 2017
Health system indicators† from index of essential health service coverage proposed for measuring universal health care and SDG 3.8.1A85 
3.b.1 Proportion of the target population covered by all vaccines included in their 
 national programme
3.1.2 Proportion of births attended by skilled health personnel Proportion of vaginal births with active management of third stage of labor (tier 2)
Family planning demand satisfied with modern methods in women aged 15–49 
years who are married or in a union (%) 
Care-seeking behaviour for children with suspected pneumonia (%)
People with HIV receiving antiretroviral therapy (%) People with HIV with viral suppression (tier 1)
Population at risk who sleep under insecticide-treated bednets (%) Population at risk observed to sleep under intact long-lasting insecticide-treated 
bednets obtained or retreated within the past 5 years (tier 3)
For occasional effectiveness assessment, not routine collection
Prevalence of non-raised blood pressure regardless of treatment status Prevention and screening: prevalence of non-raised blood pressure in adults with 
no prior diagnosis of hypertension (tier 1)
Treatment: non-raised blood pressure in adults with prior diagnosis of hypertension 
(tier 1)
Mean fasting plasma glucose (mmol/L) 
Cervical cancer screening in women aged 30–49 years (%) Proportion women aged 30–49 years with cervical cancer screening with timely 
results and confirmed diagnosis as indicated (tier 3)
Prevention: prevalence of non-raised HbA1c or fasting plasma glucose in adults with 
no prior diagnosis of diabetes (tier 1)
Treatment: prevalence of non-raised HbA1c or fasting plasma glucose in adults with 
prior diagnosis of diabetes (tier 1)
Children diagnosed with pneumonia receiving appropriate treatment per national 
or IMCI guidelines (tier 2)
Tuberculosis effective treatment coverage (%) (proportion of all people with 
tuberculosis who successfully complete treatment)
As is
Family planning demand satisfied with modern methods of woman’s choice in 
women aged 15–49 years who are married or in a union (tier 3)
Four or more visits to antenatal care (%) Pregnant women receiving timely and adequate care—eg, first visit within 
13 weeks gestation, care provides protection from tetanus; repeated blood 
pressure measurements; screening for syphilis, HIV [as appropriate], and diabetes; 
and counselling on risks, delivery planning, and immediate breastfeeding (tier 2)
Children aged 1 year who have received three doses of a diphtheria, tetanus, and 
pertussis vaccine (%) 
Proportion of children aged 5 years with detectable antibodies for vaccines in
national programme (tier 1)
For occasional effectiveness assessment, not routine collection
3.5.1 Coverage of treatment interventions (pharmacological, psychosocial and 
 rehabilitation, and aftercare services) for substance use disorders
Proportion of those with substance use disorder receiving adequate treatment per 
national or global guideline (tier 3)
3.7.1 Proportion of women of reproductive age (aged 15–49 years) who have their 
 need for family planning satisfied with modern methods
Proportion of women of reproductive age (aged 15–49 years) who have their need 
for family planning satisfied with modern methods of their choice (tier 3)
3.8.1 Coverage of essential health services (defined as the average coverage of 
 essential services on the basis of tracer interventions that include reproductive, 
 maternal, newborn, and child health, infectious diseases, non-communicable 
 diseases, and service capacity and access, among the general and the most 
 disadvantaged population)
Effective coverage of essential health services (defined as the average effective 
coverage on the basis of tracer interventions that include reproductive, maternal, 
newborn, and child health, infectious diseases, non-communicable diseases, and 
service quality, capacity, and access, among the general and the most 
disadvantaged population; tier 3)
Proportion of target population with detectable antibodies for vaccines in national 
programme (tier 1)
For occasional effectiveness assessment, not routine collection
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In summary, the available measures do not promote 
accountability for high-quality health systems. Globally 
funded facility surveys overmeasure inputs that provide 
inadequate value for accountability. At the national and 
global levels, health system measurement is insufficient 
to assess performance of the health system as a whole and 
inadequate for holding the system accountable to people 
for the user experience provided or the effect on impacts—
health and non-health—that matter to patients.
Data quality
Data must be of adequate quality to be used for 
accountability or action.186 Efforts in the past few years have 
identified dimensions of data quality such as completeness 
and timeliness, internal consistency, external consistency, 
and external comparisons, although assessment tools 
focus mainly on completeness and accuracy.186
Routine health information systems, whether individ ual-
level electronic health records or aggregate reporting such 
as the District Health Information System (DHIS) 2, 
provide information on the use and content of care that, if 
the data are of adequate quality, should form a crucial 
element of health system measurement for accountability.187 
34 LMICs—chiefly upper-middle-income, but including 
13 low-income and lower-middle-income countries—
had adopted national electronic health records systems 
by 2015·188 41 LMICs, including 23 low-income countries, 
use DHIS2 at a national scale for aggregate reporting from 
electronic or paper registers in facilities.189 Notably, private 
sector facilities can be included under national health 
management information systems, although their partici-
pation and data completion are often low.148
Barriers to robust implementation and use of electronic 
health records and DHIS include restricted ownership 
by end users, scarce training on data skills, lack of 
motivation and engagement by overburdened health 
workers, large numbers of indicators required, and 
inadequate functionality of electronic platforms.181,190 As a 
result, data quality in routine health information systems 
is poor, with vertical programme assessments often 
identifying high prevalence of missing or inaccurate 
data.181,191 New evidence from Kenya, Nigeria, and Mexico 
suggests that such deficiencies in data quality also 
pertain to indicators of health system quality (appendix 2).
Moving forward: three opportunities to measure better
Opportunity 1: Measure effective coverage
Countries should incorporate measures of quality within a 
broader health system assessment to appropriately track 
the value of the health system. The geographic availability 
of facilities overstates health system performance: reduced 
mortality due to acute abdominal conditions was associ-
ated with proximity to well resourced hospitals in India, 
but not with access to lower-quality hospitals.192 New 
analysis suggests that this relation also occurs for obstetric 
conditions, acute surgical conditions, and time-critical 
adult infections in India, but less certainly for myocardial 
infarction (appendix 2). Even basic process indicators 
provide greater insight into hospital capacity than the 
availability of a facility or equipment. Service coverage 
monitoring that does not explicitly include quality will 
similarly overestimate health system performance and 
will do so substantially in many cases because of quality 
deficits. Achieving UHC requires effective coverage, such 
that “people who need health services obtain them in a 
timely manner and at a level of quality necessary to obtain 
the desired effect and potential health gains.”193 The 
current monitoring of UHC does not reflect this. Figure 13 
lists the current coverage indicators for monitoring UHC 
specifically and the health-related SDGs more broadly. 
Only one of these indicators (effective treatment coverage 
for tuberculosis) captures the health system effect on 
population outcomes. Calculating effective coverage 
requires defining the population in need, access to care, 
and receipt of quality care.194 In figure 13 we also provide 
illustrative effective coverage indicators to suggest 
directions for future monitoring, and indicators for 
additional conditions are in appendix 2. Research is 
ongoing to identify standard indicators for many SDG 
conditions. Some indicators are available but need to be 
better implemented (eg, HIV), others need to be refined 
by selecting the best indicators and determining efficient 
methods of collection (eg, maternal health), and others 
still need to be developed de novo or validated for use at 
scale in low-resource contexts (eg, substance use).
Care cascades are an extension of the concept of effective 
coverage: instead of a single number, cascades break 
performance along the continuum of care to allow analysis 
of health system function.195 Cascade steps typically follow 
a patient population from health need through diagnosis, 
timely treatment, disease control, wellbeing, and survival. 
With each step conditional on the previous one, cascades 
illustrate health system failures in functions such as 
diagnosis, retention, and evidence-based care, while link-
ing system performance to patient outcomes. Although 
specific indicators can vary across conditions (for example, 
disease control could be measured by viral load for HIV, 
blood pressure for hypertension, symptom-free days for 
major depressive disorder, and years without recurrence 
for breast cancer), the drop-offs in a disease-specific 
cascade can illustrate system-wide deficits: low rates of 
screening suggest failures in primary care as a first contact 
service, whereas poor outcomes among those on treatment 
implicate inadequate coordinated and continuous care. We 
provide examples and discussion in appendix 2.
Opportunity 2: Fewer, better metrics
For effective measurement of accountability and action, 
health system assessments must be reoriented away 
from measures that are poorly fit for purpose and 
towards people. A people-centred measurement means 
thinking about individuals across the life course and the 
total sum of their health system experiences rather than 
discrete services.196
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Processes of care and quality impacts must be better 
measured to have health systems that are truly for 
people, with three areas for improved measurement: 
positive user experience, patient-reported outcomes, 
and non-health effects of care. OECD countries are 
moving towards standard crosscutting measures of 
patient experience, particularly com munication and 
patient voice.175 Wide adaptation and validation of these 
measures would enable global comparisons. Other 
areas of user focus and respect pose more challenges 
for measurement, such as dignity, privacy, and non-
discrimination. Vertical programmes with long ex-
perience in measuring such domains, including family 
planning, maternal care, and HIV care, can offer 
insight.9,197,198
Similar efforts to make patient-reported outcome 
measures more broadly useful are underway, including a 
focus of the OECD on population outcome measures 
such as quality of life.175 The International Consortium 
for Health Outcomes Measurement released a standard 
set of outcomes (including patient-reported outcomes) 
for hypertension, with an explicit focus on LMICs.199 
Standard sets of patient-reported outcome measures for 
general adult and paediatric health are in development. 
The enhanced use of these measures will require clarity 
about minimum supporting data, such as risk factors.200 
Panel 11 highlights efforts to adapt and apply patient-
reported measures in LMICs.
Available measurements of confidence or trust in health 
systems fall short of the importance of this domain in 
shaping population behaviour and health outcomes. 
Satisfaction with health care or the health system is a 
commonly used measure and, from a legal and rights 
perspective, it reflects the ultimate judgment of the 
consumer.201 Satisfaction is associated with objective 
measures of process quality (eg, clinician competence) and 
with health outcomes (eg, mortality).92,202 However, 
satisfaction is also strongly influenced by a host of other 
factors, including user demographics and health, past care 
experiences, expectations, and potentially courtesy bias.202 
This might explain some of the counterintuitive findings 
on user satisfaction. For example, satisfaction is often high 
for demonstrably poor-quality services, particularly for 
users with lower education or less experience with high-
quality health care (panel 3). Conversely, people might 
express dissatisfaction when they expect, but do not receive 
Panel 11: Innovation in patient experience and outcome measurement*
The examples in this panel describe proof-of-principle testing of 
patient-reported indicators in low-income and middle-income 
countries. Shared investment, innovation, and learning will be 
needed to validate and define the use at scale of patient-reported 
measures for action and accountability.
Measuring maternal care experience: companion of choice
The Quality of Care Network for maternal and newborn health 
is leading efforts to standardise measures of childbirth care 
experience. Labour companion of choice is one of the quality 
measures for emotional support and is recommended in four 
WHO guidelines to date.A86,A87 Evidence shows that women who 
received continuous labour support might be more likely to 
give birth vaginally, be satisfied with their birth experience, and 
be less likely to have caesarean birth or use pain medication.A88 
Labour companions can also play a role in the prevention of 
mistreatment of the woman during childbirth by serving as an 
advocate, witness, and safeguard. A process indicator would be 
the proportion of women who wanted and had a companion 
supporting them during labour, childbirth, and immediate 
post-partum period in a health facility, based on observation or 
facility or population survey. Currently, nine countries in the 
network are in the process of including and testing different 
mechanisms for three common experience of care indicators 
(including labour companion) as part of large-scale quality 
improvement efforts for maternal and newborn health.A89
Measuring patient-reported outcome measures (PROMs) for 
pregnancy and childbirth in Nairobi, Kenya
The objective was to understand the application of value-based 
health-care principles in a low-resource setting; specifically, to 
test a model for collecting PROMs in pregnancy and childbirth 
in a low-resource setting, to determine feasibility and scalability 
of using mobile platforms to measure PROMs, and to identify 
how to engage patients in collecting PROMs and motivate 
health-care providers to measure outcomes.
Outcome variables to pilot were selected from the pregnancy 
and childbirth standard set of the International Consortium for 
Health Outcomes Measurement, on the basis of importance, 
feasibility, acceptability (cultural and social), and literacy. 
Patient-reported outcomes included health status 
(incontinence, pain with intercourse), breastfeeding (success 
with breastfeeding), mental health (ante-partum or post-
partum depression), and satisfaction with care during 
pregnancy, labour, and after birth.
Five facilities providing antenatal, delivery, and postnatal care 
services were involved and patient liaison officers were trained 
to support patient enrolment, maintain engagement, and 
oversee follow-up. Real-time collection of medical and 
financial data was done with M-TIBA, a mobile health wallet 
that tracks patients through the health system. PROM items 
were administered using text messages through mSurvey. 
173 of 200 women enrolled, with survey completion rates near 
90% through 6 weeks post delivery. See appendix 1 for full 
methods.
Sources: Özge Tunçalp and Meghan Bohren; Ishtar Al-Shammari and David Ljungman. 
*Panel references can be found in appendix 1.
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services that are not indicated, such as antibiotics for the 
common cold. Improved health literacy can reduce this 
mismatch. Although user satisfaction gives an important 
perspective, other measures should be considered that 
might capture people’s confidence more directly. These 
could include trust in the health system, confidence that 
people can get the care they need, endorsement of the 
system as is (vs requiring major reform), and metrics that 
reveal preference, such as bypassing and loss to follow-
up.37 The development and validation of measures for trust 
in the health system relevant for LMICs should be part of 
the global research agenda.
The links between health system quality and economic 
gains were detailed previously. The effects of health system 
quality on economic gains are largely mediated by health 
status (eg, incidence of surgical site infection or antibiotic-
resistant disease and ability to function for work or school) 
and confidence in the health system. Measurement should 
focus on health and confidence themselves, while research 
quantifying links between these outcomes and economic 
impact is undertaken. Direct pathways include affordability 
that shapes individual costs of care and low system 
competence generating wasteful, unnecessary procedures. 
Measure ment of cost has advanced notably in the SDG 
era: catastrophic out-of-pocket spending on health-care 
costs is the indicator for SDG 3.8.2, financial protection 
within UHC,126,128 and medical impoverishment provides 
an indication of how well financial protection for health 
services has been linked with poverty alleviation.126,128 
Indicators of health system waste, such as excess caesarean 
sections, might signal poor system quality, although few 
measures have been defined for this with adequate 
benchmarks for national assessment in LMICs to date.
Measures of system competence are a key area for 
innovation, both in identification of essential indicators 
and in use of these to produce a coherent view of system 
function. Elements of system competence include safety, 
prevention and detection, continuity and integration, 
timely action, and population health management. 
Platforms within the health system—community 
outreach, primary care, hospital care, emergency medical 
services, and referral systems—can similarly be assessed 
for overall functionality. Work published in 2016 from the 
Institute for Healthcare Improvement203 proposed system 
measures for consideration in high-income settings. 
These measures include childhood immunisations, 
timely ambulatory care, preventable hospitalisations, 
hospital-acquired conditions, and serious reportable 
events (serious harm or death of a patient due to a health-
care error). In lower-income countries, consistent and 
accurate measurement of hospital mortality for selected 
services would be an important advance.204
One approach for system competence measurement is 
to consider conditions or procedures that require 
functional integration within a health-care platform and 
identify process or outcome measures therein as tracer 
indicators. For example, indicators such as blood 
transfusion delay, surgical site infection, and peri operative 
mortality rate provide insight into hospital care quality as a 
whole.73,102,205 Although perioperative mortality rates are 
collectable in countries of all income levels, virtually no 
LMICs have outcome surveillance in place. A focus on 
bellwether procedures and definition of standard methods 
in collection and reporting of both perioperative mortality 
rates and surgical site infections would reduce hetero-
geneity in measurements and facilitate their uptake into 
existing health system measurement.73,104 Similarly, timely 
trauma care is an indicator of prehospital care, such as 
emergency medical services and hospital functioning. 
Multiple studies have assessed time from injury to 
admission or admission to surgery, but measurement 
remains heterogeneous.83 Efforts to improve measures of 
system competence should include their potential use for 
accountability and triggering action.
Opportunity 3: Invest for country-led quality measurement
The current fragmented approach to health system 
measurement results in substantial efforts and 
investments expended for little data use.176,206,207 Progress 
on the measurement challenges and proposals described 
will require a shift to country-led quality measurement.208 
This Commission calls on global, regional, and national 
donors to invest in national institutions for health system 
quality measurement. Such national bodies should be 
tasked with assessing available measurement against 
national priorities for health system quality, refining the 
measurement toolkit to better address the full high-
quality health system needs, creating an annual public 
dashboard of health system quality performance, and 
assisting with policy translation of the results.
Building such an institution or arrangement requires 
enriching human capacity at all levels of the health 
system and concentrating advanced capacity in data 
science at the national level. Without improved numeracy 
at local levels and data management capacity at district or 
subnational levels, data quality will not be sufficient to 
support the activities of the national institution. Building 
more advanced measurement capacity—including more 
masters-level and doctoral-level researchers—within such 
a national institution will be necessary to address the 
current challenges of health system measurement and 
future ones, as population health and health systems 
evolve. Investing in a central institution with the authority 
to translate a national policy on health system quality into 
priorities for measurement and to both centralise data 
and disseminate findings is crucial to make measure-
ments responsive, relevant, and efficient, particularly for 
countries with increasingly decentralised health systems. 
Having a single source of knowledge of quality deficits 
can also provide a clear basis for accountability of system 
failures and patient safety lapses.209
A truly national view of health system quality requires 
measurement from the private sector. The exclusion of 
private providers restricts health system assessments, 
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particularly in countries with substantial private sectors, 
such as India. For example, an analysis of population 
coverage of first-level hospitals in Karnataka state, India, 
found that 45% of the population had access to at least 
one public hospital within a 25 km catchment area, 
whereas 91% had access when private hospitals210 were 
included in the analysis (two-step floating catchment 
area method; appendix 2). Nonetheless, information on 
the capacity and quality of private facilities—or even their 
number and location—is scarce.204 Some health system 
assessments, such as the District Level Household 
Survey 4 in India, are restricted to public facilities, and 
routine health information systems can be compulsory 
for public providers only. A review done for this 
Commission identified multiple mechanisms for 
measuring private sector quality, including regulation, 
national information systems and surveys; purchaser-
driven, consumer-driven, or network-driven measure-
ment; and voluntary external assessments. Private-sector 
providers sometimes express a willingness to share data, 
but without strong mechanisms and incentives, little 
sharing occurs in practice.211 Future research on models 
for integrating data across the public and private sectors 
to enhance efficiency, transparency, and accountability is 
warranted.
The development of a national policy and strategy for 
health system quality is a prerequisite to country-led 
measurement and is discussed further in the next 
section.212 Assessing measurement approaches against the 
standards defined in the national strategy will provide 
insight on gaps and inefficiencies in measuring quality. 
Another responsibility of a national institution for health 
system measurement is the development of the quality 
measurement toolkit. The toolkit can differ by context and 
resource availability, but should include three tiers: 
foundational systems, routine data, and targeted studies. 
The first tier consists of vital registries to track population 
births and deaths, supply chain management, and human 
resources information systems, including provider 
payment tracking. These elements are funda mental for a 
sound understanding of the population and the capacity 
of the health system. The second tier is routine data 
collection through electronic health records or health 
information systems; many measures for effective 
coverage and system competence can be derived from 
routine health information systems. Accuracy and 
parsimony are essential to these measurements, because 
of not only their importance, but also their high potential 
burden. The third tier consists of targeted health system 
studies, which include health facility and population 
surveys and patient registries to probe more deeply into 
health needs and system performance. Facility assess-
ments must be more agile and responsive to national 
priorities, with increased emphasis on measures that 
Figure 14: Sample high-quality health system dashboard with illustrative 
indicators
High-quality health system dashboard Country, year
Children with complete immunisation: X%
Adults with up to date NCD screening: X% Percentage of cancer treated in early stage
Effective coverage for priority conditions: distribution and equity
Percentage of women receiving oxytocin within 1 min 
of delivery
Median time from injury to admission: X min
System competence
Positive user experience
Prevention and detection
Timely care
Clear communication during last visit  X%
Opportunity to ask questions during last visit  X%
Communication with health-care providers
Confidence and economic benefit
Endorsement of health system Confidence in receiving effective treatment if became
sick tomorrow
Financial protection Measure of productive time lost to poor health
Percentage of hospital-acquired infections
Percentage of unsafe injections
20
Wealth quintiles:
40
Q1
40
Incidence
X%
The system works pretty well
and only minor changes are 
necessary
Households with catastrophic expenditure on health X%
Households impoverished by health expenditure X%
The average person lost 10 days of productive time due 
to health concerns.
(Average woman: 12 days; average man: 9 days)
X%
Our health care system 
has so much wrong with 
it that we need to 
completely rebuild it
X%
Very 
confident
X%
Somewhat confident
X%
Not confident
X%
There are some good things in our 
health care system but fundamental changes are needed to make it work better
Screening Linkage to care On treatment Treatment
completion
Disease
control
Good quality
of life
0
Q2 Q3 Q4 Q5
60 80 100
Maternal health
Newborn health
Childhood illness
Tuberculosis
Diabetes
Mental health
Safety
Women with opportunity to have a companion
during labour of those who wanted one present X%
Dignity and respectful care
X%
X%
X%
Proportion of adults with NCD screened for multimorbidity
(eg, TB/diabetes, hypertension/diabetes)
Integration
X%
X%
Country score: 42%
Effective
coverage
10–19%
20–29%
30–39%
40–49%
50–59%
60–69%
Health and wellbeing
Health system sensitive outcomes Self-rated health (%) 
Severe health-related suffering
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50 000 people experience severe health-related suffering; only 5% 
of them are receiving medication to alleviate pain
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0
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Care cascade for priority condition
Patients experiencing discrimination from
a health-care provider X%Adequate time with provider during last visit  X%
Opportunity to see provider of choice  X%
Institutional stillbirth and neonatal mortality rate (per 1000 births)
Women with obstructive fistula (per 100 000)
Periopertive mortality for coronary artery bypass graft (per 1000)
Children hospitalized with ambulatory-care sensitive conditions
(per 1000)
Lower limb amputations among adults with diabetes (per 1000)
Patient voice
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might be hard to capture in a routine system, including 
timeliness and accuracy of care delivery and patient 
experience. Patient registries can be developed as a subset 
of facility assessments to provide information on health 
outcomes and patient perspectives over time for priority 
groups or conditions.213 Population surveys, ideally linked 
to health facility assessments or routine health system 
data, can be broadened to address the range of conditions 
reflected in the SDG agenda and to provide the voice of 
users and non-users on their needs and outcomes. These 
surveys will continue to be instrumental in providing data 
for equity assessment, particularly in lower-income 
countries. When optimised, the combination of these 
data sources has powerful potential to advance the quality 
of health systems. The matrix of tools will differ by 
context, because one of the aims of the SDG era is for all 
countries to own their data systems and to define their 
data needs within a common framework. National 
ownership of tools at all tiers is important for the results 
to be integrated and used.208 Regional and global partners 
can facilitate and catalyse this work by providing public 
goods of centralised evidence and tools. These can include 
repositories for available indicators, evidence and 
guidance on the role of measurement platforms and 
methods for triangulating across them (eg, in effective 
coverage estimation), and tools for synthesising insight 
for dissemination. Regional collaborations might prove 
beneficial for sharing learning and avoiding duplication 
of efforts, particularly for small countries. Initiatives such 
as the Quality of Care Network and the Health Data 
Collaborative are important steps in this direction.
Finally, this Commission recommends that countries 
compile an open-access health system dashboard for 
monitoring progress towards a high-quality health 
system. The dashboard would track health system 
quality with use of data from multiple sources. The 
dashboard would be people-facing and should reflect 
what matters most to people: health and wellbeing, user 
experience, system competence, confidence, and 
economic benefit. An example dashboard is shown in 
figure 14, featuring these recommended areas and 
illustrative indicators of each domain to show how such 
information might be presented. Effective coverage 
indicators can signal areas of underperformance by 
geography, condition, or vulnerability, whereas care 
cascades for conditions that illustrate overall system 
functioning can be used to identify strengths and failure 
points. Indicators should be selected and adapted to 
each country as described previously. The dashboard 
should evolve to reflect changing health and health 
system priorities. Efforts are already under way to 
contribute elements to such a dashboard, from real-time 
views of staff absenteeism in facilities in India214 to open 
data platforms in Kenya.215 Providing information is not 
in and of itself sufficient; information must be 
accompanied by appropriate context for public 
consumption and clear mechanisms for engagement 
and response by all people, whether they are members 
of the public, the press, or health system actors, such as 
medical associations.216
Countries should present overall dashboard results and 
results disaggregated by subnational regions and dimen-
sions of vulnerability (settings of care, disease type, or 
demographics, as discussed in Section 3), as well as results 
for public and private sectors. This Commission recom-
mends that the dashboard be released from 2021 onwards. 
It could reflect gaps in data availability and quality 
particularly early in its usage, before measurement 
platforms are realigned to provide a full system perspective. 
Missing information should not prevent the public release 
of what is available as input into mechanisms of social 
accountability. Public release of health system quality 
information is an important way of building trust in health 
system transparency, in addition to providing means for 
self-scrutiny by health system agents.217 A high-quality 
health system dashboard is an essential step in a cycle of 
accountability and a trigger towards universal action for 
improvement.
Section 5: Improving health systems at scale
The key findings of this section are shown in panel 12.
Expanding the solution space
Despite some impressive health gains in LMICs in the 
past several decades, this Commission’s analysis showed 
that health systems are beset by poor-quality care. The 
pervasiveness of poor quality suggests that the cause is not 
a few weak providers or clinics, but rather that whole health 
systems are underperforming. To successfully address 
the endemic nature of poor-quality care and to give 
providers the right support to deliver the competent and 
respectful care that people deserve, this Commission calls 
for an ambitious improvement agenda that moves beyond 
targeting the manifestations of poor quality and aims to 
transform health systems.
However, strategies for quality improvement in LMICs 
have generally focused on a narrow set of solutions, such 
as increasing health system inputs and changing people’s 
behaviours and routines at the point of care—ie, the 
lowest (micro) level of the health system. A 2018 review 
of primary care quality found that, globally, 72% of 
strategies targeted the micro level (figure 15; appendix 1). 
Although interventions aimed directly at facilities and 
staff can be motivational and promote local commitment 
to quality,218 people tend to revert to entrenched ways of 
doing things, especially when surrounding systems do 
not support transformation.23 The application of multiple 
micro-level interventions might lead to deleterious 
effects, with interventions clashing at the point of care 
because implementing them consumes a large amount 
of attention from managers, potentially detracting from 
other priorities.219,220  This raises the challenge of how to 
situate micro-level efforts as part of broader reforms that 
will improve health systems.
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A transformative quality improvement agenda is based 
on the recognition that health systems are complex 
adaptive systems, defined as systems in which many 
component parts interact in unexpected ways and often 
produce unanticipated results.221,222 Complex adaptive 
systems are resistant to change, and diffuse and isolated 
interventions, especially at the micro-level, are unlikely to 
result in large-scale improvements.221,223 An example of 
this is the proliferation of point-of-care technologies for 
health, few of which have been taken to scale or shown to 
have had an effect on health in LMICs. At the same time, 
evidence23 from health and other sectors shows that 
complex adaptive systems can thrive if actors within 
the system have a shared vision, clear rules, and space to 
allow evolution and learning. Research224 in behavioural 
economics noted that successful systems create a choice 
architecture that supports intended goals and reduces 
harmful variation. Choice architecture comprises the 
elements of a system that influence choices and behaviour, 
including information flow, incentives, presentation of 
choices, and decision-making contexts.224 Nudging, or 
steering people in a particular direction while preserving 
their choice, is a common behavioural economics strategy, 
but the broader notion is to align motivations, incentives, 
oversight, and management across levels to promote the 
best actions.
We propose a new improvement approach that addresses 
the scope of the quality challenge and recognises the 
complex adaptive nature of health systems. This approach 
emphasises macro-level reforms—what we call universal 
actions—that can not only establish and cascade systemic 
change across all levels of the health system, but also 
include a role for targeted meso-level and micro-level 
strategies. Macro-level strategies are best able to directly 
tackle the social, political, economic, and organisational 
structures that shape a health system. Meso-level (sub-
national) interventions address quality of care through the 
coordination and management of a network of facilities 
and communities. Interventions at this level are also well 
positioned to improve communication and learning 
between facilities and across levels of the health system. 
Micro-level interventions aim to directly influence the 
performance of the staff or the operations of a facility. 
Appendix 2 includes examples of interventions at the three 
levels of the health system.
System-wide improvements in quality of care will 
require effort from providers, health system admini-
strators, and communities, but they begin with a political 
commitment from heads of state and ministers. Global 
development partners can and should assist, but they 
should not drive this agenda. Contributions from across 
the health system, including the private sector, and from 
sectors outside of health will be crucial. Early gains in 
quality are likely to be visible within a few years, though 
meaningful improvement might take longer. People 
everywhere have a right to receive effective and respectful 
care—the time to get started is now.
Universal actions for improving quality
This Commission recommends four universal actions to 
improve health system quality: governing for quality, 
redesigning service delivery to optimise quality, 
transforming the health workforce, and igniting people’s 
demand for quality (figure 16). These actions are based on 
successes and failures from all countries, best practices 
from high-performing health systems, research and 
evaluation, and the experience and deliberation of the 
Commissioners. This Commission sees these universal 
actions as the start of a paradigm shift towards a more 
Panel 12: Section 5 key findings 
1 Addressing the quality deficits in many countries today will require expanding the 
solution space— the feasible set of solutions that satisfy the constraints of the 
problems—for improvement to include macro-level, meso-level, and micro-level 
interventions.
2 Countries should invest in the foundations of high-quality health systems by 
considering four universal actions: governing for quality, redesigning service 
delivery to maximise quality; transforming the health workforce to provide 
high-quality, respectful care; and igniting people’s demand for high-quality care.
3 Several commonly used approaches, such as accreditation and performance-based 
financing, have not been consistently effective in improving quality.
4 District-led collaborative learning has the potential to foster improved quality 
through better system functioning and communication, but more research on 
most effective models is needed.
5 Research on strategies to directly improve health worker and facility performance 
found that most micro-level solutions have modest effect sizes. Studies tend to be 
small and brief, limiting conclusions about sustainability and effects at scale. This 
Commission recommends that selected meso-level and micro-level interventions 
be implemented alongside efforts to improve the foundations of health systems.
6 Development partners should support health system reforms that improve the 
foundations of high-quality care.
7 Monitoring and evaluation of the impact of all improvement efforts at national and 
subnational level is needed to drive learning and improvement.
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Figure 15: Types of interventions and levels targeted to improve quality of 
primary health care according to published literature from 2008 to 2017
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ambitious health system improvement agenda. Beyond 
the universal actions, countries can select additional 
targeted oppor tunities that fit their needs and context. All 
universal and targeted actions are predicated on having 
adequate health system inputs, such as staff, medication, 
and equipment. The optimal composition, design, and 
implementation of the improvement agenda will vary by 
country, because approaches that work in one setting 
might not work in another. Countries need to monitor the 
implementation of this agenda to permit adaptation and 
assess the effects on health and other valued outcomes.
Universal action 1: Govern for quality
Health-system-wide change demands that the improve-
ment and maintenance of quality be woven into the fabric 
of a health system. Governing for quality means reframing 
the pursuit of quality health care from a peripheral activity 
to the mandate of a health system, and making sure that a 
commitment to quality is actually translated from paper to 
actions that improve the health of people.225,226 Governing 
for quality includes several elements: adopting a national 
quality policy and strategy, improving capacity for 
management at all levels of the health system, strengthen-
ing regulation and account ability, and collecting and 
learning from health system data.
Governing for quality requires high-level political 
commitment to a shared vision for improving quality of 
care and translating this commitment into action across 
the health system (panel 13). Well aligned policies and 
strategies should be based on this vision, locally accepted 
definitions of quality, and national goals for improved 
outcomes.212 In response to requests from countries for 
guidance on how to design and implement these health-
care policies and strategies, WHO produced the National 
Quality Policy and Strategy Handbook.212 The handbook 
outlines eight elements of the strategy and argues that 
quality must be elevated nationally and become a priority 
across sectors. These policies, and the strategy linked to 
them, should ideally outline the roles and responsibilities 
of the organisational bodies and actors that participate in 
sustaining and improving quality of care. A plan for 
coordinating these elements is also needed, so that quality 
improvement programmes are harmonised to maximise 
learning and results at the system level.227 For example, an 
analysis228 of surveys from 310 health system leaders in 
Mexico identified insufficient coordination of quality 
improvement agendas and an unclear system of roles and 
responsibilities as key barriers to the translation of federal 
policies into improved quality of care. The successful 
development of shared vision, policies, strategy, co-
ordination, and implementation are needed to design a 
choice architecture for health systems that directs patients 
and providers towards decisions that produce quality care 
and good health outcomes.
Improving the quality of the health system requires 
action from multiple sectors and stakeholders. Governing 
for quality includes managing these relationships and 
convening stakeholders under the shared vision of making 
large-scale sustainable improvements in quality and 
health outcomes.229 Inclusive processes that bring a 
diversity of voices together to solve problems are complex 
and difficult to manage, but they help to make action on 
quality possible, they foster innovation, and they lead to 
more comprehensive solutions.230 Building partnerships 
means aligning all stakeholders, including international 
donors, with national needs and priorities, which is a 
challenging goal. For example, in 2016, only 16% of 
development assistance for health went to the 
strengthening of health systems, despite evidence 
showing that condition-specific funding can compromise 
overall quality of health care and crowd out existing health 
services.231–233
Adopting a national quality policy and strategy, and 
engaging stakeholders around it, requires not only 
strong leadership skills, but also good management at 
all levels of the health system to effectively use available 
resources to realise the vision of high-quality health 
care.234 Middle management at the district or regional 
level could play an important role at the intersection of 
policy and implementation, although management 
capacity inter ventions at all levels have been linked to 
better health sector performance.235,236 Although the 
literature consistently points towards the importance of 
good management across health system levels, 
insufficient attention has been paid to creating the 
capacity for health-care management in LMICs.235,236 
Data from multiple LMIC settings showed that manage-
ment is a key factor that differentiates between high-
performing and low-performing facilities.237,238 Bradley 
and colleagues235 outlined eight key manage ment 
competencies and recom mended designing training 
programmes for management professionals to achieve 
them. These key management competencies are: strat-
egic thinking and problem solving, human resource man-
age ment, financial management, operations man age ment, 
performance management and accountability, govern-
ance and leadership, political analysis and dialogue, 
and com munity and user assessment and engagement. 
Examples of effective training pro grammes239,240 exist in 
various settings, including Ethiopia,239 where hospital 
performance improved under the manage ment of 
graduates of the Masters in hospital and health care 
administration programme.
Figure 16: Universal actions for improving quality of care
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To improve and guarantee quality care, good leadership 
and management competences must be buttressed by 
regulatory structures that create accountability. Strong 
regulatory mechanisms, ie, so-called regulation with 
teeth—and transparency through good monitoring, meas-
ure ment, and reporting practices—support accountability 
both internally within the health sector and externally with 
civil society and citizens.225,241 The accountability 
mechanisms, in turn, should be operated by leadership 
and management that can pull together a complex array of 
regulatory domains (eg, workforce, facilities, products, 
and service delivery) that might be administered by 
multiple institutions. Lessons from the regulation of 
medicines suggest that multipronged collaborative ap-
proach es that include a suite of regulations, mechanisms 
for legal redress, and training of inspectors in the public 
and private sector are most likely to be effective in mixed 
health systems.242 These accountability mechanisms 
should also include mon itoring of the flow of providers 
between private and public practice.243 Two first steps that 
are yet to be taken in many LMICs are gathering accurate 
descriptive data about private health care (see Section 4) 
and maintaining the capacity for ongoing monitoring. 
Local regulations that apply to private health care vary 
considerably and need to be explored in detail. Finally, 
regulatory bodies that can enforce compliance across 
public and private sector institutions are often severely 
under-resourced, do not have basic capacity, and will need 
to be strengthened.244
Governing for quality also means recognising the 
importance of, and making space for, civil society in 
regulating the quality of care. Professional organisations 
that regulate their members have an important role to 
play in health system quality by promoting high-quality 
performance of their members and by sanctioning them 
when they fail to meet minimum standards. Self-
regulation is underused in LMICs, where professional 
organisations mainly advocate for their membership. 
Experience in high-income health systems has shown 
that the privilege and responsibility of self-regulation 
promotes professional ism, the sense of accountability 
among professionals to people, and reduces transaction 
costs for governments. For example, in Canada,245 
physicians successfully self-govern all aspects of the 
profession, from setting nationally uniform entrance 
exams to monitoring and remediating substandard 
clinical practice among practising physicians. However, 
self-regulation is not without its challenges, as exemplified 
by the UK,246 which has moved towards joint government–
professional oversight because of a series of widely 
publicised physician scandals. When professional groups 
have primary fiduciary responsibility, care should be taken 
to involve both practising clinicians and citizens in 
governance and to avoid unnecessary fragmentation of 
Panel 13: Governing for quality: lessons from Nepal and Argentina*
Absence of multistakeholder commitment leads to minimal 
quality improvement in Nepal
In 2007, Nepal endorsed the Policy on Quality Assurance in 
Health-care Services, with the objective of ensuring “quality of 
services provided by governmental, non-governmental, and 
private sector according to set standards” and to establish an 
“autonomous body to ensure impartial decision regarding 
health services.” 11 years later, the success of this policy 
remains mixed. 
Why did the policy have low impact? The policy was created 
without a shared vision and buy-in from stakeholders, including 
the Ministry of Health. Important partners, such as the Ministry 
of Education, did not provide critical inputs. The policy designers 
also did not create consensus on a definition of quality or agree 
on indicators against which to measure progress. A centrepiece 
of the policy—to establish an autonomous body for quality of 
care— never materialised. A quality assurance section was 
established in the Department of Health Services, but it has little 
leverage over other units in the Ministry. 
The absence of a political commitment and involvement of all 
stakeholders has meant that the objectives of the Policy on 
Quality Assurance in Health-care Services have been largely 
unrealised, and health institutions continue to deliver subpar 
care quality.A90
Source: Amit Aryal and Franziska Fuerst. 
Governing for quality through strong accountability in 
Argentina
In 2005, Argentina implemented a public supplementary 
insurance program, SUMAR, designed to increase access to 
quality health care for uninsured children and pregnant women 
and to address large disparities in infant and maternal mortality 
rates.A91,A92 The programme is credited with decreasing the 
probability of low birthweight among beneficiaries by 19%.A91
In the setting of Argentina’s national decentralised health 
system, SUMAR’s success was dependent on high-level political 
commitments, buy-in from provincial governments, and well 
designed reporting pathways to ensure accountability. 
A presidential decree established the programme and provincial 
governments confirmed it under a collaborative agreement 
with their respective providers. The agreement is renewed 
yearly with review of procedures for expenditures and goals to 
be achieved. Federal commitments and provincial 
implementations were aligned through clear standards, and 
multidisciplinary oversight bodies monitored performance. 
A provincial level programmatic office regularly reported to the 
federal level. Local accountability was increased through the 
centralised monitoring of transferred funds to the provinces. 
The provinces were then responsible for enrolling beneficiaries, 
organising the provision of services, and paying providers. 
Source: Programme SUMAR, Argentina. *Panel references can be found in appendix 1.
www.thelancet.com/lancetgh   Published online September 5, 2018   http://dx.doi.org/10.1016/S2214-109X(18)30386-3 39
The Lancet Global Health Commission
regulatory responsibilities.247 Professional organis ations 
can also promote quality through continuing medical 
education and engaging directly with govern ments to 
address quality concerns. For example, the Philippine 
Medical Association has more than a century of experience 
in agitating for improvements in medical education, 
health facility infrastructure, and the regulation of 
pharmaceut icals.248
Social participation in health care, especially for the 
most marginalised, has intrinsic value as a human right 
and instrumental value in improving health care and 
keeping systems accountable.249 People and communities 
are experts in their local experience and, with skilled 
support, can wield this knowledge to help create highly 
valued solutions to health-care problems.250,251 Social 
participation can also increase the uptake and sustain-
ability of services.252,253 Although the composition of civil 
society varies by country, it is their diversity of 
perspectives, the opportunities for participation and 
action, and the availability of accurate and understandable 
information that will make this sector effective in hold-
ing governments accountable for high-quality health 
care.243,249,252,253 Civil society can be particularly powerful 
when adopting a human rights framework for advocacy.253 
For example, in Uganda,254 the Center for Health, Human 
Rights, and Development regularly uses legal avenues to 
challenge policy makers on issues such as essential 
medicines, safe and respectful maternity care, and fair 
treatment of patients with disabilities.
Institutional accreditation uses external evaluators to 
assess facility performance against health-care stan dards. 
Although frequently cited as a quality accountability 
mechanism, a scoping review of reviews done by this 
Commission found that the direct effect of institutional 
accreditation on quality of care is uncertain (appendix 1). 
In a systematic review of improve ment strategies, median 
effect sizes for institutional accreditation were modest: 
7·1 percentage point improvements in quality outcomes 
were reported (appendix 1).255 However, accreditation can 
indirectly affect quality through improved management, 
pro fessional development, and capacity of facilities to 
promote change.256
Improvement entails the continuous production of 
relevant data, which measures performance and 
outcomes, and the translation of those data into action—a 
learning system.226,257 This learning system facilitates the 
development of programmes and reforms based on the 
best available evidence (whether global, regional, or local 
data) and best practices. New initiatives should embed 
measurement, evaluation, and plans for how the results 
could be disseminated effectively to the people responsible 
for ongoing data use to inform adaptation of services. 
Learning systems should also identify best performers, as 
discussed in Section 2, and determine the basis for their 
success.
This set of intentional processes for actively learning 
and improving the health system is a goal that should be 
articulated and demonstrated first by the actions of 
senior leadership and subsequently echoed by middle 
management and the front-line staff. This system goal 
should become the primary guiding principle that 
creates the motivation for system improvement over 
time and for which health system actors hold themselves 
accountable.258 Planners should design better systems 
on the basis of lessons learned and then link back to 
system managers, supervisors, and front-line staff to 
support improvement. Developing well functioning 
learning systems is especially important because of the 
imperfect evidence base for quality improvement 
interventions and the large variation in effect sizes 
found between studies and contexts. Learning systems 
ensure that planners can make course corrections based 
on context-specific data. A meso-level strategy that 
illustrates this approach is the quality improvement 
collaborative, which we describe in the following 
subsection.
An analysis done by this Commission regarding five 
country experiences on governing for quality revealed 
practical lessons for operationalising the described 
principles (methods are described in appendix 1). District 
and facility-level health workers might be unaware of 
national quality policies and strategies or might not 
understand the implications of those on their daily work. 
The dissemination and translation of policies and 
strategies needs to be formally assigned, built into the job 
descriptions of public sector administrators, and included 
in performance reviews of these individuals. Additionally, 
the workforce might experience distracting and 
over whelming policy crowding, with poorly co ordinated 
and sometimes conflicting mandates. Countries are 
encouraged to review all policies affecting front-line 
workers; overlapping or conflicting policies can then be 
pruned, leaving a policy set that is coherent from the 
perspective of the service provider. For example, a nurse 
in primary care seeing a patient with diabetes and latent 
tuberculosis would benefit from having a single quality 
policy, not separate documents on diabetes and tuber-
culosis.
Informants from all levels of the health system 
discussed the challenges of good system-wide data use in 
the Commission analysis. Data generation and 
translation must start at the local level, but for system-
wide improvements to occur, these data need to be 
coordinated centrally. We suggest the creation of planned 
spaces for information exchange, such as district-led 
meetings to learn from the evidence generated. Success 
stories of improvements made possible by accurate data 
collection and skilled data translation can be shared with 
front-line health workers to motivate continued quality 
care and improvement.
Universal action 2: Redesign service delivery to optimise quality
Most LMIC health systems were originally designed to 
provide basic episodic care, especially for infectious 
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diseases. Many systems have not adapted to the changing 
landscape and challenges of caring for people with 
chronic diseases, mental health conditions, and more 
complex injuries and illnesses.20 Hospitals and health-
care facilities with advanced diagnostic and treatment 
capabilities are overcrowded with stable patients who 
could be treated in primary care facilities, whereas many 
first-level health clinics are expected to handle cases that 
are beyond their scope, with slow or non-functioning 
referral for emergencies.259,260 Poorly organised health 
systems lose lives, waste scarce resources, and squander 
the good will of populations.
To address this, this Commission calls for a quality-
focused service delivery redesign: a reorganisation of 
services within the health system to efficiently maximise 
health outcomes and user confidence, rather than only 
geographic access to clinics. Service delivery redesign 
capitalises on existing health system assets to provide 
services at the appropriate level and achieve the highest 
quality of care possible.
First, some services should be shifted to primary care. 
Reflecting the core principles of continuity, coordination, 
comprehensiveness, and first contact, competent primary 
care is ideal for treatment of chronic and stable conditions 
that require sustained engagement with the health system 
(eg, non-communicable diseases and stable HIV or 
tuberculosis infection), preventive care (eg, immunisation, 
antenatal or routine child care, and growth monitoring), 
and low acuity and algorithmic services (eg, care of minor 
child and adult illnesses and injuries).20,36 Palliative care 
can also be expertly delivered close to home by primary 
care and in partnership with families, community 
caregivers, and spiritual supporters.36
Examples of the partial implementation of quality-
focused service delivery in LMICs reveal the benefits of 
shifting these services to primary levels. In HIV care, 
stable patients are managed in primary care clinics 
with impressive results, and new patients can initiate 
treatment in their own communities.261 As a result, 
centralised specialty centres are less crowded, allowing 
higher-skilled providers to focus on more complicated 
cases, such as HIV treatment failures.260 A multicountry 
meta-analysis262 of 39 090 patients with HIV showed that 
patients in primary care were half as likely to be lost to 
follow-up than patients treated at a centralised HIV clinic. 
In tuberculosis care, community-based models are also 
substantially less costly to implement.263 Uncomplicated 
non-communicable diseases are especially well suited for 
care at the primary level, where providers can more 
effectively monitor chronic disease over time and build 
relationships that form the foundation for effective 
communication and counselling regarding crucial life-
style modifications.20 An important caveat is that current 
primary care models in many LMICs are outdated and 
ill-suited for these new tasks. New thinking is needed on 
primary care functions, capacities, and connections with 
specialised services, especially in urban settings.20,264 For 
example, experience from high-income settings suggests 
that non-visit care, in the form of virtual or phone visits, 
has the potential to extend the reach of primary care for 
low-acuity conditions.265
Acute or chronic conditions with higher risk of 
mortality or severe morbidity are best assessed at a 
hospital with emergency capacity. The correct health 
system level for some surgeries should be determined on 
the basis of availability of specific technical skills, 
laboratory, imaging, and intensive care infrastructure, 
acuity of the condition and projected procedure volume. 
Complex or rare conditions are ideally managed in 
tertiary, highly specialised, care centres.
Childbirth is one situation that benefits from care at 
hospitals with surgical and specialised newborn care 
services, because complications can arise without warning 
and require rapid, highly skilled care.266 However, in low-
income countries, a substantial proportion of obstetric 
and newborn care is provided in primary care facilities 
without adequate expertise or surgical capacity.267 For 
women and newborn babies who develop complications 
in primary care clinics, poorly functioning referral and 
transport to a higher level facility mean a much greater 
risk of morbidity and mortality.267,268 Guided by this logic, 
many high-income and middle-income countries mandate 
that all women deliver in, or next to, hospitals with surgical 
and advanced newborn care services.269 The structural 
deficits in highly skilled health workers and surgery at 
primary care levels might explain why the Better Birth 
trial,39,270 a large randomised controlled study, found that 
imple menting a safe childbirth checklist and coaching for 
nurses and midwives at primary care centres in India did 
not reduce maternal and newborn morbidity or mortality.
We examined the practical implications of shifting 
delivery care to hospitals in a geographic modelling that 
linked facilities with pregnant women in six LMICs 
(Malawi, Haiti, Tanzania, Kenya, Namibia, and Nepal; 
methods are described in appendix 1). We found that 
delivery care redesign would result in substantial gains 
in technical quality for care of pregnant women without 
reducing interpersonal quality and with minimal 
reductions in 2 h access to care. For example, in 
Tanzania, hospitals score twice as high as primary care 
facilities on a basic measure of childbirth quality and, 
therefore, quality of care would improve by moving all 
deliveries to hospitals. Although this would increase the 
average distance from a delivery facility for rural 
dwellers, only 27% of pregnant women would live more 
than 2 h away from a delivery facility in Tanzania, 
compared with a current 17%. In the remaining 
countries, 1% to 7% of women lost 2 h access to care. 
This redesign can also produce efficiency gains because 
resources could be redirected from providing obstetric 
care in thousands of facilities to improving quality in 
fewer hospitals, promoting care integration across 
facilities, working with communities, and enabling 
transport to hospitals.
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Strong interfacility communication and referral 
networks are crucial to the success of quality-focused 
redesign, along with investments and participation from 
non-health-care sectors. Tools to facilitate redesign that 
warrant consideration include improved transportation 
(eg, community taxi services and ambulances),271 
communication (district-led learning, discussed in the 
following subsection), measures to reduce access barriers 
to high-quality facilities (eg, vouchers and maternity 
waiting homes),272,273 and public education to enhance 
population understanding of the right place for care.274 
Local context, with a focus on facilitating access to high-
quality care for the most marginalised subpopulations, 
should drive the mix of interventions and incentives.
Planning for quality-focused service delivery redesign 
in any country would require analyses of patient volumes, 
bed and surgical capacity, provider competence in 
existing hospital facilities, and potential upgrades to 
existing health-care centres to permit high-quality care, 
as well as attention to transport, costs, and building 
community demand.275
Universal action 3: Transform the health workforce
The data in Section 2 showed that providers often do less 
than half of recommended evidence-based care measures 
and that rates of diagnostic accuracy are low across health 
conditions and countries. A Commission analysis showed 
that this is also true of providers in their first 3 years of 
practice, suggesting a probable role of poor preservice 
education in provider performance (appendix 1).276 Low 
knowledge and competence of the health workforce is at 
risk of worsening over the coming years because 
of the rapid expansion of health workforce training 
institutions, resulting in dilution of already insufficient 
faculty and curricular resources.277,278 Despite this threat to 
health-care quality in LMICs, improving the education of 
health-care professionals has not been a central part 
of the improvement discourse.279 In the previously 
mentioned review of primary care quality improvement, 
only 16 of 379 articles addressed the preservice education 
of health professionals (figure 15). Fixing these gaps 
through in-service training is not an effective antidote,280 
and reforms in professional education are required to 
adequately equip these professionals to provide high-
quality care.
The Lancet commissions277,281 on health professionals for 
a new century and on the future of health in sub-Saharan 
Africa highlighted key steps to address the quality gap of 
the health-care workforce. First, the education of health 
professionals should focus on achieving competence 
through active learning, early clinical exposure, and 
problem-based learning. Competency should be defined 
by the gaps and needs of each individual country and 
include domains beyond the technical skills of providers. 
Ethical, respectful, and compassionate care, and the 
fundamentals of systems thinking and quality 
improvement should be additional core competencies. 
Dysfunctional systems will continue unless the workforce 
is prepared to improve them.
Second, the chronic understaffing of many health-care 
professional schools in LMICs must be addressed, along 
with support of high-quality teaching, for the quality of 
clinical education to improve.278 Possible solutions include 
increasing salaries, expanding professional development 
opportunities, using state policy levers to require 
practising clinicians to teach trainees, and providing small 
incentives, such as free housing or telecommunications.278 
Finally, health education insti tutions should establish 
student recruitment and retention policies to increase 
the representativeness of the student population.252,282,283 
Evidence has shown that care interactions between 
providers and patients who are racially, culturally, 
ethnically, or linguistically similar are associated with 
higher perceived quality of care, satisfaction, and improved 
medical communication.284,285 These changes within instit-
utions of higher learning must be supported by good 
governance and quality-informed policy making. Inter-
sectoral coordination between ministries of health and 
education would create a more direct link between the 
production of a health workforce and the needs of the 
health system.281
Third, health-care providers also need a work 
environment in which they can succeed beyond gradu-
ation. Many health-care providers face challenging 
conditions, including inadequate and delayed salaries, 
heavy workloads, ambiguous responsibilities, no oppor-
tunities for growth, and poor treatment by colleagues and 
patients.276,286,287 Not only do these conditions result in 
burnout, mental distress, and poor retention for providers, 
but they also result in poorer quality care.287–289 Motivated 
providers are less likely to make poor decisions or medical 
errors and are more likely to be empathic towards 
patients.290 Good working conditions, regular pay, clinical 
support, and opportunities to learn and grow are essential 
to maintain a workforce that is motivated and committed 
to providing high-quality care.286,291,292
WHO recommended a set293 of decent employment 
policies to support providers, including ensuring 
occupational health and safety, fair terms for workers, 
merit-based career development, and a positive practice 
environment. In addition to broader policies, a review294 
published in 2017 recommended a set of steps for facilities 
to foster joy and engagement in their own workforce. 
These include an initial process of inquiry to understand 
workforce priorities, followed by identifying and 
removing the primary annoyances, initiating simple 
fixes, and using improvement science methods to spur 
larger-scale change to create a fundamentally more 
satisfying and happier work environment. Although early 
reports suggest that sense of purpose can be strengthened 
through these approaches, much of this work has started 
in the past few years and the effectiveness of these 
interventions on improving quality of care in LMICs 
remains to be determined.
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Universal action 4: Ignite population demand for high-quality 
care
High-quality health systems respond to people’s expect-
ations, but if those expectations have been dampened by a 
history of disempowerment and poor-quality care, that 
response will not translate into better health care.295 Section 
2 shows that when expectations are low, quality ratings of 
objectively poor care are high. This discrepancy lets health 
systems disregard issues of quality. Beyond putting 
pressure on systems to improve, generating demand for 
quality through information sharing would increase health 
system accountability (see universal action 1) and has an 
ethical foundation: for patients to be autonomous decision 
makers, they must have access to usable information 
about the quality of their care.296 This is imperative because 
of the information and power asymmetry that exists 
between patients and providers. Finally, this Commission’s 
recommendation is based on evidence that people who 
already demand higher quality in LMICs and actively make 
decisions can extract higher quality care from their health 
systems.118,119,297,298 National quality improvement strategists 
are encouraged to explore demand-side approaches that 
raise people’s expectations of quality.
Very few improvement programmes are explicitly 
designed to raise demand for quality care. We used those 
few programmes to draw lessons on this understudied 
improvement opportunity. Participatory women’s groups 
are a well documented299 example, and improved 
outcomes for women and children in communities with 
these groups are believed to be partly due to participants 
demanding better care, such as safe hygienic practices 
during childbirth. Community monitoring programmes 
can generate demand for quality, although few high-
quality studies exploring this outcome exist (see 
Section 3).300 A programme301,302 in rural Uganda, for 
example, combined information sharing about quality 
care at local facilities with community participation and 
found reductions in neonatal deaths and improvements 
in measures of facility process quality 4 years after 
implementation. A study303 in Uttar Pradesh, India, 
showed that quality during prenatal visits was improved 
by sharing information about health and social service 
entitlements with pregnant women. A preliminary body 
of qualitative research304 also suggested that demand 
generation for quality might be especially well suited to 
improving user experience. Panel 14 includes examples of 
the use of advocacy to generate demand for high-quality 
care from the White Ribbon Alliance.
These interventions are based on sharing information 
with people and treating them as active agents in 
the health system. They are unlikely to work without 
system-level support that encourages patient-centred-
ness, power-sharing, communication, and inclusion.300 
Importantly, this supporting of people to be active agents 
should be done with careful attention to marginalised 
populations. The intersection of multiple sources of 
vulnerability is likely to make some groups less able and 
prepared to act on quality information than others. To 
prevent the exacerbation of existing disparities, particular 
attention must be paid to rural, less educated, and 
impoverished populations (see Section 3).
Interventions that might raise expectations and demand 
for quality often include social interaction through groups, 
committees, or meetings; this component is supported by 
social network science and evidence showing that people 
learn about quality from each other.305,306 This insight from 
social network science also suggests that demand generation 
interventions might take advantage of the increasing 
presence of interactive social media platforms in LMICs. 
Figure 14 gives an example of a people-facing dashboard 
that can be used to share information with populations. 
More country examples of improvement through the four 
universal actions can be found in appendix 2.
Targeted opportunities
In conjunction with system-wide reform through the 
universal actions just described, countries will likely 
require additional context-specific interventions, which we 
call targeted opportunities. Beyond increasing health 
system inputs, this subsection reviews the most commonly 
used quality improvement interventions, but does not aim 
to present a comprehensive list. As mentioned in Section 2, 
the cost of interventions is not addressed in this report. We 
used several sources, including the Health Care Provider 
Performance Review (HCPPR)—a systematic review of 
health worker performance improve ment strategies in 
LMICs (appendix 1).255 HCPPR was designed to develop 
evidence-based guidance on strategies to improve health 
worker performance and includes published and 
unpublished studies in any language from the 1960s to 
early 2016. Although the HCPPR is the most 
comprehensive and up-to-date review on the subject, it has 
limitations common to all reviews, such as implementation 
strength that varies across studies, and the unknown 
degree to which results from controlled study settings can 
be generalised to real-world programmes. The full review 
reported effect sizes for combinations of strategies, which 
are not discussed in detail here.
Macro level improvement: financing for quality
Health financing and provider payment can be used to 
leverage greater quality from the health system. Of the 
four core financing functions (revenue mobilisation, 
pooling, purchasing, and benefit design), purchasing—or 
the allocation of funds to providers—has the greatest direct 
influence on quality of care and we focus on it here.252
Strategic purchasing refers to funding providers on the 
basis of information about populations and providers to 
achieve performance goals. Examples include provider 
payment strategies and selective contracting of facilities 
on the basis of quality.307 Although most doctors and 
nurses are assumed to be motivated by altruism, they also 
seek a competitive wage. Input-based (eg, salary and 
capitation) and output-based (eg, fees-for-service, per case, 
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or pay-for-performance) payments tend to exert opposite 
effects on providers’ intensity of effort, with input-based 
payments disincentivising and output-based payments 
promoting the number and intensity of services, leading 
to the duelling challenges of under-treatment and over-
treatment described in Section 2. A mix of input and 
output financing might therefore be the best strategy to 
prevent undue attention to incentivised elements.
Aligning financing and provision arrangements is 
crucial to the success of strategic purchasing. For example, 
facilities subject to selective contracting should be able to 
make the necessary purchasing and hiring decisions for 
improvement. In some countries, facilities might not have 
sufficient managing authority and legal changes will be 
required. Output-based financing is also data intensive 
and can be a substantial burden for providers. To align 
different payment methods and incentives, a strong data 
system to capture information on provider payments is 
crucial.308 Such systems produce information with multiple 
uses beyond strategic purchasing. For example, in high-
income countries, insurance claims data offer information 
on services rendered, fees received, and diagnoses made 
that can be used by payers, insurers, and researchers.
One prominent form of strategic purchasing that has 
been widely implemented in LMICs is performance-based 
financing. Performance-based financing describes a set of 
approaches designed to improve health care by paying 
providers and facilities for the quantity and quality of care, 
though many programmes complement the financial 
incentives with direct improvement elements, such as 
training or supervision.184,309–311 Most performance-based 
financing programmes in LMICs incentivise primarily the 
quantity of services and, although they appear to increase 
utilisation of care and service volume, the effect of 
performance-based financing on quality is less clear.184,310 
Several impact evaluations are forthcoming from the 
World Bank’s Health Results Innovation Trust Fund, a 
large funder of performance-based financing.312,313
Overall, evidence to date suggests that performance-
based financing has insufficient potential as a stand-
alone strategy for system-wide quality improvement. 
Performance-based financing might modestly improve 
quality compared with no intervention in some contexts, 
but does not always outperform unconditional financing; 
the effect appears to be driven not by the financing 
mechanism as much as the equipment and workforce 
interventions.314–317 Compared with alternative inter-
ventions, performance-based financing incurs unique 
costs for performance verification that can account for 
10% to 15% of operating costs, including the cost of staff 
time.318 There can also be unintended consequences of 
performance-based financing programmes, including 
reports that providers have threatened patients to report 
positive outcomes, but these programmes can also 
Panel 14: Lessons in generating community demand for quality care from the White Ribbon Alliance (WRA)
Uganda
In 2011, WRA Uganda mobilised local advocacy teams to bring 
attention to the poor quality of obstetric services in the 
country in three underserved districts. The teams, comprising 
district leaders, health officers, community members, and 
midwives, assessed the status of facilities and found that none 
of the districts met the minimum requirements for treating 
complications: they had insufficient lifesaving commodities, 
skilled health workers, and infrastructure. On the basis of 
similar findings, WRA launched the Act Now to Save Mothers 
campaign to educate citizens on their rights and 
responsibilities related to quality health care. Community 
members participated in district planning and budget hearings 
and town halls. In one town hall, more than 2000 community 
members signed and presented a petition to district 
representatives and parliament demanding improvement. 
Community members served as citizen journalists, reporting 
on progress and budget allocations. The campaign resulted in 
increased procurement of essential medicines and equipment, 
increases in salary for—and recruitment of—additional health 
workers, and the reconstruction of dilapidated facilities.
Tanzania
After a woman died in childbirth in 2013, in Rukwa region, 
Tanzania, because of no available blood supply, communities 
demonstrated in protest of the poor-quality care. WRA Tanzania 
brought together citizens and decision makers to ensure that 
these concerns were heard. They worked with religious leaders 
and village health teams to raise awareness among community 
members, and they supported district and regional policy makers 
to respond and act on citizen demands. The Parliamentarian 
Group for Safe Motherhood was mobilised to add their support to 
the citizens’ voices. In 2015, Rukwa leaders expanded emergency 
maternal health services from only 10% to 50% of health centres. 
On the basis of this success, WRA Tanzania expanded their efforts 
nationally, resulting in the government approving an historic 
50% increase in funding for maternal, newborn, and child health 
to support expansion of facilities, blood banks, and the 
recruitment of health workers throughout the country. 
Lessons
• Mobilise around existing political commitments for 
improvement
• Educate citizens about rights, responsibilities, and how to 
advocate
• Use data to create pressure for accountability
• Identify champions to amplify the voices of people
• Support decision makers to respond to citizen demand and 
collaborate with them to make change
Source: Kristy Kade, Betsy McCallon, Rose Mlay, Robina Biteyi.
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improve unrewarded dimensions of quality, including 
patient satis faction.314,316,319 Overall, performance-based 
financing does not appear to be highly cost-effective, 
especially vis-à-vis unconditional additional financing.316,317 
The HCPPR showed that interventions that include 
financial incentives have a median increase on quality of 
7·6 percentage points.
For financial incentives, including performance-based 
financing programmes, to be successful, economic 
theory and research suggest that rewards will have 
smaller effects than penalties because of the tendency to 
avoid losses, and incentives are most effective when 
closely linked to processes under the direct control of 
providers.320,321 Extrinsic incentives might crowd out 
intrinsic motivation, underlining the importance of 
aligning incentives with professional expectations and 
work norms.320 Finally, aligning provider incentives with 
specific goals of care coordination or effective treatment, 
as opposed to inputs, offers potential for quality 
improvement.322
Meso-level interventions: district-led learning
District administrations and networks of facilities can 
be harnessed into learning systems that accelerate 
improvements in health-care performance with the 
potential for scale. This level of the health system is well 
positioned to facilitate systematic group learning among 
facilities of similar types and across tiers of the health 
system. District-led, area-based learning and planning 
brings together providers and administrators responsible 
for a catchment area to solve clinical and system problems, 
harmonise approaches, maximise often scarce resources, 
and create better communication and referral between 
facilities (panel 15).323
Formal quality improvement collaboratives involve 
the use of teams from multiple health-care sites that 
work to improve performance on a specific topic by 
collecting and using data to test ideas with so-called 
plan-do-study-act cycles supported by coaching 
and learning sessions. Systematic reviews324,325 of 
quality improve ment collab oratives in predominantly 
Panel 15: Case studies of learning at the district level*
Midwifery Coordination Alliance Teams (MCAT) in Cambodia 
The MCAT programme is an area-based approach that started 
in select provinces in Cambodia, in 2009, and has since spread 
to all midwives, health centres and hospitals in all 98 districts 
of the country. The programme aims to strengthen 
collaboration between primary health care and hospital 
providers. All primary care midwives in a meso-level area meet 
doctors and midwives from the local hospital every 3 months 
for data review, updates, problem solving, and refresher 
trainings. The sessions are duplicated over 2 consecutive days 
to accommodate all health centre midwives without closing 
any services. Providers view and discuss data, such as maternal 
and perinatal deaths or near-misses, contraceptive uptake and 
mix, case-fatality of common conditions, and supervision 
results. The meetings include participatory learning sessions 
with simulations and discussions of current clinical procedures 
and guidelines. Supply chain issues, for example, surface and 
are solved with feedback and joint problem solving. 
The teams also foster local innovations. For example, 
midwives in one province instituted a clinical hotline, which 
enabled health centre midwives to call a hospital midwife for 
advice on emergency referrals and follow-up. This idea has 
spread to other districts. Another MCAT team suggested and 
instituted an extension of the livebirth incentive to also 
include appropriate emergency referrals. Although a formal 
evaluation has not been done, the MCAT programme provides 
a team approach to gradually improving care of maternal and 
newborn complications in the district, and it is believed to be a 
factor in Cambodia’s large health gains for women and 
children.A93,A94
Source: Som Hun and Jerker Liljestrand.
Area-based planning and vertical integration in meso-
America  
The Salud Mesoamerica Initiative (SMI) aims to reduce maternal 
and child health inequities through a results-based funding 
model to improve quality and effective coverage in seven Central 
American countries and in Chiapas state, Mexico. The programme 
features area-based plans within each health district to translate 
national plans to local teams. These plans include locally-tailored 
targets, activities, and timelines. Local implementers review their 
progress with national stakeholders every 3 months, fostering an 
experience-based learning environment.A95 
SMI provides technical assistance to countries to create quality 
improvement strategies and standards through problem 
identification, prioritisation of areas for improvement, and 
development of improvement plans. Countries developed tools 
for data collection and analysis to support learning.  Each 
country has adapted implementation to fit their priorities and 
systems. In Belize, the process started at the comprehensive 
emergency obstetric and newborn care level, then gradually 
added basic and ambulatory levels of care to allow teams to 
have a more holistic view of the health network. Teams collect 
data and review their own progress each month, and every 
quarter, a quality improvement officer reviews the performance 
to allocate a small incentive to teams through a Quality 
Innovation Fund. The quality improvement officer also offers 
supportive supervision, shares challenges and best practices, 
and helps teams to develop and test new ideas. Independent 
evaluation results showed that all indicators across levels of care 
have improved relative to baseline, with gains ranging from 
30 to 85 percentage points.
Source: Emma Margarita Iriarte and Jennifer Nelson. *Panel references can be found in 
appendix 1.
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high-income countries showed modest improvements, 
particularly when addressing a clear gap between 
evidence and practice on straightforward aspects of 
care. Evidence from LMICs is more scarce, leading this 
Commission to undertake a subanalysis of quality 
improvement collaboratives based on the HCPPR 
systematic review.
Overall, the quality of evidence on quality improvement 
collaboratives from LMICs is low. Effect sizes for these 
collaboratives combined with clinical training were very 
large (mean range 52·4 to 111·7 percentage points) 
although how generalisable they are is uncertain, as three 
of the four reports targeted the same clinical outcome 
(postpartum haemorrhage), which was amenable to 
simple changes. The effectiveness of quality improvement 
collaboratives was more variable when implemented 
without training and when addressing other areas of care. 
Results on improving health worker practices ranged 
from modestly to highly effective (4·3 percentage points 
for continuous outcomes and 30·2 percentage points 
for percentage outcomes). For patient health outcomes, 
quality improvement collaboratives had no effect 
(1·4 percentage points for continuous outcomes and 
0·3 percentage points for percentage outcomes).255 Quality 
improvement collaboratives are not static structures, and 
they have been implemented and adapted in several ways 
to achieve their stated aims. Some common adaptations 
include their use for the generation of new ideas and for 
empowerment of health-care workers. In addition to 
understanding the effect of district-led learning on clinical 
practice and patient outcomes, the effects of this approach 
on communication, health worker motivation, and team 
dynamics are currently being explored.326
Micro-level interventions: directly improving provider and 
facility performance
Strategies that target the micro-level are presented here 
as opportunities to complement and extend broader 
systems-level reforms. For example, the improved 
education of health professionals can be reinforced 
through facility-level refresher training. This Commission 
recommends that, where possible, micro-level inter-
ventions should not be implemented in isolation or 
instead of strategies that assess and improve the 
foundations of health systems.
We present in table 3 results of approaches to improve 
health worker performance, focusing on the six 
strategies tested by the largest number of studies and 
that included at least four low or moderate risk-of-bias 
studies.255 All six strategies target the health system at 
the micro-level. Moderate effect sizes were found for 
training (9·7 percentage points) and supervision 
(11·2 percentage points). The combination of training 
and supervision had larger improvement effects, at 
17·8 percentage points. Providing only printed 
information or job aids to health workers and only 
Training only Training plus 
supervision*
Supervision* only Printed 
information or job 
aid for health 
workers only
Information 
communication 
technology 
(mHealth) only
Training plus 
supervision plus 
strengthening 
infrastructure*
Median effect size for percentage outcomes, percentage points 
(IQR)
9·7 (5·5–21·3) 17·8 (5·5–25·9) 11·2 (5·8–25·6) 1·5 (–4·5 to 6·1) 1·0 (–2·8 to 10·3) 9·4 (–0·1 to 40·5)
Study comparisons for percentage outcomes (comparisons with 
low or moderate risk of bias)
76 (32) 26 (11) 16 (8) 8 (5) 4 (4) 4 (1)
Median effect size for continuous outcomes, percentage points 
(IQR)
17·5 (0·1–23·7) 11·1 (7·3–60·4) –3·0 (no IQR) –3·4 (no IQR) –38·9 (no IQR) 64·3 (31·9–88·7)
Study comparisons for continuous outcomes (comparisons with 
low or moderate risk of bias)
16 (8) 8 (3) 3 (1) 3 (1) 1 (1) 4 (4)
Countries in which studies were done for both outcomes types 
(number of WHO regions)
2 (6) 17 (5) 13 (5) 7 (3) 4 (1) 6 (3)
Three most common categories of study outcomes for both 
continuous and percentage measures
Treatment, 
counselling, 
assessment
Treatment, 
counselling, 
assessment
Treatment, 
counselling, universal 
precautions
Treatment, 
documentation, 
case management†
Counselling, case 
management,† 
treatment
Treatment, 
diagnosis, referral
Median baseline outcome value for percentage outcomes, % (IQR) 43·0 (19·0–70·0) 25·2 (9·2–52·5) 53·8 (36·0–63·5) 32·8 (24·8–58·6) 36·5 (5·4–60·6) 31·2 (7·7–55·6)
Median number of health facilities in intervention group for 
percentage outcomes (IQR)
6 (1–20) 7 (2–32) 7 (5–24) 8 (5–10) 38 (35–47) 11 (2–21)
Median duration of study follow-up‡ for percentage outcomes, 
in months (IQR)
4·0 (1·3–6·0) 4·5 (2·0–6·0) 5·0 (2·0–9·0) 1·9 (1·0–4·5) 7·3 (4·1–9·4) 1·6 (1·0–2·4)
Strategies for health facility-based health workers were tested by at least four studies with low or moderate risk of bias, from at least one outcome group (percentage outcomes or continuous outcomes). 
Percentage outcomes are expressed as a percentage (eg, percentage of patients treated correctly) and continuous outcomes are outcomes that could not be expressed as a percentage (eg, average number of 
medicines prescribed per patient); for details, see appendix 1. *Supervision is either strengthened routine supervision visits (in terms of frequency or supervision quality) or other supervision-like strategies, such 
as audit with feedback; strengthening infrastructure is the provision of medicines or equipment, or otherwise improvement of conditions in health facilities. †The case management group of outcomes reflect 
multiple steps of the case-management process (eg, percentage of patients correctly diagnosed and treated). ‡Study follow-up time was defined as the time from when the strategy was initially implemented to 
the last eligible follow-up measure; for most study comparisons, the follow-up time was the same for all study outcomes; when follow-up time varied among outcomes for a given study comparison, the longest 
follow-up time was used in the analysis.
Table 3: Selected results of strategies to improve health worker performance from the Health Care Provider Performance Review255
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implementing mHealth (a mobile wireless technology) 
strategies tended to be largely ineffective.
Most strategies that focused on improving the practices 
of lay or community health workers were tested by a single 
study and the quality of evidence was generally low. Again, 
training alone tended to have modest effect sizes (median 
of 7·3 percentage points). Strategies that included 
mHealth had a median effect size of 8·7 percentage 
points. Strategies that included training and supervision 
had a median effect size of 9·6 percentage points, and 
strategies that included training and community support 
approaches, such as patient education, had a median 
effect size of 22·7 percentage points.
Despite the scope and range of the studies, it is difficult 
to draw conclusions about how generalisable these 
strategies are. Studies tended to only include small 
numbers of health facilities in the intervention group 
(often less than ten) and short post-intervention follow-up 
times (median of 7 months or less). Effect sizes for 
strategies tested by multiple studies included in the 
HCPPR also varied considerably, which might be due to 
study biases, random variation, and considerable 
heterogeneity of study methods and context. For example, 
the effectiveness of complex, multifaceted interventions 
with at least four strategy components varied substantially 
(from nearly 0 to 61 percentage points), which suggests 
that complex strategies are sometimes, but not always, 
more effective than simpler ones, and clearly more work 
is needed in designing and testing these approaches. The 
variability of effect sizes for a given strategy also shows the 
difficulty in predicting how effective a strategy will be in a 
given context. Therefore, it is important for programmes 
to monitor the effectiveness of any strategy implemented 
in the field, not just in the context of research.
Additionally, the duration of strategy effectiveness is 
uncertain. Using HCPPR data, we modelled the effect of 
follow-up time on strategy effectiveness, using random-
effects models (or fixed-effect models, if dealing with 
less than ten studies or outcomes) adjusted for baseline 
performance (appendix 1). We found that the effect of 
supervision appeared to increase over time, but we 
found no evidence of a time trend for group problem 
solving. Results for training were inconclusive. Our 
ability to examine time trends was limited by the small 
number of studies per strategy with repeated post-
intervention measures.
Section 5 conclusion
All reforms for quality will need to be country-led, 
starting with a vision for quality health care shared and 
actively supported by heads of state and their ministers. 
Many of these political leaders have already made 
commitments to UHC, but without improving quality, 
that promise is an empty one. Sequencing improvement 
efforts to first target populations who have the worst 
quality of care and health outcomes will also be important 
to realising high-quality UHC.135,327 Global partners are 
encouraged to support these efforts by aligning with each 
country’s priorities, not funding flotillas of small-scale 
interventions over short project-cycles, and instead 
selectively investing in fewer health system reforms over 
a longer time period. Reorienting research priorities to 
support country-led efforts for health system quality 
improvements is also sorely needed.
Every country will decide how to implement the systemic 
changes needed for high-quality care. This Commission 
recommends a careful assessment of the foundations of 
the national health system, consideration of the four 
universal actions we have presented, and a tailored 
strategy that addresses quality gaps and maximises 
existing assets. Finally, countries should not expect that 
every improvement initiative will succeed, but leaders 
should not be discouraged. The process of iteratively 
adapting and developing effective solutions for a given 
context takes time. The key is to get started, monitor 
progress, and learn from both successes and failures.
Section 6: Recommendations
In this Section, we identify opportunities for national 
governments, civil society, global partners, and 
researchers to contribute to a global effort towards high-
quality health systems.
National governments
(1) Invest in health systems and make them more 
accountable to people. National governments need to 
invest in high-quality health systems for their own people, 
and they must also be accountable to people for their 
performance. This requires legislating for people’s right to 
quality health care, educating the population and health 
system stakeholders about these rights, enacting strong 
regulation and standard setting, sharing actionable 
information on health system performance, and creating 
mechanisms for remedy and redress. These actions should 
be complemented by social accountability mechanisms 
that promote the participation of the population in health 
system decisions. Countries will know they are on the way 
towards a high-quality, accountable health system when 
policy makers choose to receive their health care in their 
own public institutions.
(2) Look beyond the government health sector. Building 
high-quality health systems requires strong primary, 
secondary, and professional education, solid road and 
transport networks, and reliable communication infra-
structure. Partnering with other sectors will be essential to 
create the conditions for health system reform. Involvement 
of private health-care providers and institutions can expand 
people’s choices and might spur the system to improve 
user focus; these private providers will need to be effectively 
regulated and incentivised to produce desired impacts.
(3) Embed quality of care in UHC. Quality should be at 
the core of UHC initiatives, alongside coverage and 
financial protection. For this, countries should begin by 
establishing a national quality guarantee for services 
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provided through UHC that specifies the level of 
competence and user experience that people can expect 
in the health system. To ensure that poor people benefit 
from improved services, expansion should start with 
them. Progress on UHC should be measured through 
effective (quality-corrected) coverage.
(4) Measure better. Quality measurement should 
be parsimonious, timely, and transparent. Health 
systems should report their performance to the public 
annually using dashboards on health and wellbeing, 
user experience, system competence, and population 
confidence. Data should further be disaggregated across 
regions and vulnerable groups. Countries need to update 
their health system data toolkits, and they can begin by 
shedding uninformative indicators and instruments and 
improving data quality in existing systems. The high-
quality health systems toolkit should include vital 
registries and real-time health system intelligence systems 
on supply chain and human resources, reliable routine 
information systems, and targeted studies, such as rapid 
facility surveys and updated population surveys. Investing 
in national institutions and expertise for measurement 
and trans lation of evidence to policy is crucial for making 
use of the data. Health and data literacy are also crucial for 
health-care users.
(5) Improve quality by starting with four universal 
actions. This Commission recommends that countries 
consider four universal actions to shift the trajectory 
toward high-quality health systems. Additional targeted 
opportunities in areas such as health financing, district-
level learning, and others can complement these efforts. 
All strategies need careful monitoring and evaluation to 
measure their effect and allow local adaptations.
The first action is to govern for quality; this means 
creating a shared vision for a high-quality and learning 
health system with a national quality policy strategy and 
mechanisms for implementation and accountability. 
These should be developed in partnership with the 
private sector, civil society, and in collaboration with non-
health sectors. A learning system needs accurate and 
timely data and a health system leadership committed to 
improvement. Improving data literacy for health workers 
and consumers will be needed to make use of the data.
The second action is quality-focused service delivery 
redesign; this requires reorganising health services to 
maximise health outcomes rather than solely geographic 
access to clinics. Primary care clinics should not tackle 
serious or rare health needs with elevated risk of mortality, 
such as deliveries, but should instead expand on their core 
competencies: integrated and continuous care for stable 
patients and community outreach and prevention. 
Governments and civil society need to work together to 
ensure that people can reach the care they need, when they 
need it, and that they receive respectful care; a range of 
strategies within and beyond the health sector are available.
The third action is transforming the workforce, starting 
with a move to competency-based clinical education that 
includes active learning, early clinical exposure, and 
problem-based learning. The curriculum should include 
ethics, respectful care, and core quality concepts. 
Classroom instruction needs to be buttressed with role-
modelling and supervision in practice settings. The 
workforce should be supported with good working 
conditions, regular pay, and clinical mentorship and be 
provided with opportunities to learn and grow. Health 
workers and their professional associations must redouble 
efforts to maintain and enforce high standards of practice 
to earn and keep the public’s trust.
The fourth action is igniting demand for quality, which 
requires educating people about their health entitlements 
according to national resources and use targeted quality 
reporting, social networks, and mobile technologies to 
empower people to become active patients who seek and 
motivate health workers to provide good quality care.
Civil society and non-governmental organisations
(1) Demand more from providers and health systems. 
People need to inform themselves on their rights and 
entitlements in the health system, including the right to 
competent care, respect, information, privacy, consent, 
and confidentiality. People enrolled in UHC programmes 
need to understand their benefit packages, care options, 
and communicate their needs and preferences to their 
providers. They should make use of redress options 
when care falls below the quality standard.
(2) Agitate for change and hold systems to account. Civil 
society should insist on transparent sharing of health 
system capacity and performance. They should press for 
greater social accountability through citizen report cards, 
community monitoring, social audits, participatory 
budgeting, citizen charters, and health committees. 
However, social accountability is not a replacement for 
government-led accountability; they are most successful 
in improving health system performance when combined.
Global bilateral, multilateral, and foundation partners
(1) Invest in national institutions to produce evidence on 
health system quality. Many LMICs do not have effective 
institutions to do the functions in metrics, research, and 
evidence-based planning required for a learning health 
system. Global partners should support the international 
and national training of data scientists and help build 
institutional capability through mentoring and sharing of 
organisational best practices. Policy uptake of analytical 
findings from local institutions can in turn build 
confidence in and demand for locally generated evidence.
(2) Support development of health system quality 
measures. LMICs do not have measures that capture the 
elements of health system performance that matter to 
people and can inform improvement. Continued support 
of vital registries and health information systems to 
measure health and impacts is crucial. Agile facility 
surveys and real-time measures that capture quality of 
care and people’s voice and that can be linked to 
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population health data are needed. Global repositories of 
validated comparable measures, instruments, and best 
practices in analysis can be a valuable resource.
(3) Include quality in tracking progress of global 
initiatives. Progress on UHC and the SDGs should 
include both coverage and quality, and effective (quality-
corrected) coverage brings these concepts together. 
Several appropriate indicators are available while others 
require validation; more work is needed to build these 
indicators into global measure sets.
(4) Channel donor funding to universal actions for 
improvement. Large-scale improvements such as health 
education reform or service delivery redesign are costly, 
and some low-income countries will require external 
financing to undertake it. More generally, funders 
should align their support with country strategies that 
promote the evolution toward a higher-quality health 
system and avoid funding a multitude of small scale or 
vertical initiatives, which contributes to policy and 
programming confusion and reduces resources for 
large-scale action.
(5) Fund research on system-wide improvement 
strategies. Rigorous evaluation of improvement reforms 
is needed to gauge the effect of investing in reforms on 
health. Research can inform future national investment, 
help develop local capacity, and benefit other countries 
with similar contexts. Creating platforms for regional 
learning through networks and meetings can promote 
dissemination of success and avoid the replication of 
failed ideas.
Panel 16: High-quality health systems research agenda
Measuring and analysing quality
• Develop and validate quality measures suitable for resource-
constrained settings for: health outcomes that can be 
attributed to health systems and patient-reported outcomes; 
competent care for mothers and newborn babies, 
cardiovascular diseases, chronic respiratory diseases, diabetes, 
cancer, mental health, and injuries; user experience, including 
respect, dignity, and autonomy; system and platform 
competence (eg, timeliness, safety, and integration), 
including quality of community outreach, primary care, and 
hospital care
• Understand the extent and causes of variations in quality: 
identify best performing countries, regions, and facilities 
and determine the factors contributing to their 
higher-quality care; explore causes of poor quality across 
different contexts
• Assess equity of quality care across dimensions of 
vulnerability, including setting of care, demographics, and 
disease type
• Analyse the effect of quality care on health, confidence, and 
economic outcomes, including patient-reported outcomes, 
demand for health care and bypassing, health system waste, 
and catastrophic and impoverishing expenditures
Improving quality
• Test the effect of innovations in the preservice education of 
health professionals on delivery of competent and 
respectful care
• Evaluate effects of quality-centred health service design on 
health, user experience, equity of care, and health system 
function
• Explore individual and combinations of interventions to 
generate community demand for quality, including 
dissemination of locally relevant information and 
innovations that use new technologies 
• Refine the best design for district-level learning strategies 
(eg, quality improvement collaboratives and other 
approaches)
• Analyse the effects of legal, performance, and social 
mechanisms to promote accountability in low-income and 
middle-income countries
• Test management innovations and intrinsic and extrinsic 
approaches to motivate providers
• Measure the costs and cost-effectiveness of improvement 
approaches and their sustainability
Methods and tools
• Develop an agile facility survey for rapid measurement of 
health system quality that focus on measures that matter: 
competent care and systems and user experience
• Update population surveys to measure a broader range of 
health conditions 
• Explore new technologies to improve accuracy and reduce 
the burden of process and outcome measurements (eg, 
wearable trackers, big data analytics) 
• Expand and validate methods for measuring effective 
coverage
• Develop new methods to test system competence over 
time, such as tracer patients
• Incorporate implementation science in assessments of 
health system improvement strategies to understand what 
works, why, and in what contexts
• Expand the use of qualitative methods and approaches 
from social sciences, such as political and management 
science, in describing and diagnosing quality failures and 
successes
• Expand sample sizes and extend length of time in studies of 
all improvement strategies, to characterise the 
generalisability and sustainability of these approaches 
• Include patient experience and patient-reported outcomes 
in improvement research
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Researchers
(1) Measure quality and evaluate quality improvement. 
Research is not a luxury: mismeasurement, reliance in 
assumptions rather than evidence, and the replication of 
failed ideas costs lives, squanders trust, and wastes 
resources. Data on health-care quality in LMICs do not 
reflect the current disease burden; for example, we know 
little about quality of care for diabetes and cardiovascular 
diseases and almost nothing about respiratory disease, 
cancer, mental health, injuries, and surgery. Adolescents 
and older adults are less visible in the available data than 
other age groups. Available data give a better picture of 
episodic, routine care than of longitudinal services or 
treatment of acute events, such as maternal or newborn 
complications or medical and surgical emergencies. 
Filling in these gaps will require better routine data 
collection and new research. In assessing quality 
improvement, we found that the evidence base for many 
popular approaches is surprisingly weak. Rigorous 
assessments of all improvement strategies, ideally with 
implementation science methods, will be essential to 
justify their scale-up. This Commission’s research 
priorities are shown in panel 16.
Conclusion
Although health systems will look different in different 
settings, all people should be able to count on receiving 
high-quality care that will improve their health and earn 
their trust. It is time to rethink our past approaches: to 
ask more from and invest more in this crucial 
determinant of health.
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